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Abstract
Synthetic phospholipid membrane structures have been studied, primarily by
X-ray diffraction and the swelling series phase assignment method. The first part of
this thesis describes a study of the interaction of a small lipophilic molecule in two
different charge forms, amantadine free base and hydrochloride, with fluid phase
dioleoylphosphatidylcholine (DOPC) bilayers. Although diffraction data were
collected out to eight orders from these bilayers, the swelling series method could
only phase the first five orders of diffraction. Measurement of the meridional
diffraction spacing showed that the DOPC bilayer thickness decreased by 1 to 2.5A
on addition of either charge form of amantadine. Little more could be deduced
about the interaction of amantadine with DOPC bilayers, because of the limited
ability of the swelling series method to phase the diffraction data.
The second part of this thesis describes the study of a brominated
phospholipid, which might provide an alternative to the swelling series phasing
method. The synthetic brominated phospholipid is an analogue of dipalmitoyl-
phosphatidylcholine (DPPC), where the terminal methyl group of the sn-2 chain has
been exchanged for a bromine atom. This bromine atom 'label' has been
incorporated into a phospholipid by substitution for a group of similar atomic
radius, 1.85A versus 2.00A, thus creating a molecule which is sterically similar to
its unlabelled analogue.
The bromolipid and DPPC were studied independently, in both the gel (Lp<)
and fluid (La) phase, and as mixtures, solely in the gel (Lp ) phase. Comparison of
the gel and fluid phase electron density maps showed that the major difference
between the DPPC and bromolipid bilayers was the presence of an electron dense
region at the centre of the bromolipid lipid layer. The mixture bilayer data (1:1, 7:2
and 4:1 DPPC:bromolipid mixtures) showed that the size of the bromine atom peak
correlated with the concentration of bromolipid in the bilayer. In the gel phase, the
electron dense region could be described by two Gaussian distributed atoms placed
2k apart.
The DPPC and bromolipid molecules did, however, form bilayers that
differed in thickness by 1 to 2.3A in the gel phase, and 2.2 to 3.8A in the fluid
phase. The 1:1 mixture formed bilayers with a thickness intermediate between those
of the pure forms. As well as the bromine atom peak, the gel and fluid phase
electron density maps also indicate that the bromolipid and DPPC bilayers differ in
their lipid layer structure, at ± 10A from the centre of the lipid layer in the gel
phase structures. The disruptive effects of bromolipid on the DPPC structure can be
limited, however, by placing only a small quantity of bromolipid into the bilayer.
In general, the addition of bromolipid to DPPC bilayers shifted the structure
factor amplitudes in the positive direction. This effect of the electron dense bromine
atoms on the diffraction data showed that the bromolipid may be used as a phasing
agent for future X-ray diffraction work. The bromolipid may also act as a phasing
agent in multiple anomalous diffraction (MAD) experiments.
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X-ray diffraction of biological membranes
l
1.1 Introduction.
The work presented in this thesis has been based on the X-ray diffraction
technique, applied to phospholipid membrane samples. The aims were two-fold:
1) To study the interaction of a small drug molecule with phospholipid bilayers
using X-ray diffraction and the swelling series phasing method.
2) To develop an alternative phasing method to the swelling series approach.
During this project, the interaction of an anti-influenza drug, amantadine,
with dioleoylphosphatidylcholine (DOPC) bilayers has been studied by X-ray
diffraction and the swelling series phasing method. In recognition of the limitations
of the swelling series method, a novel bromolipid has been synthesised and
characterised which might offer an improved method of phasing diffraction data.
The layout of the thesis is as follows:
Chapter 1 Membrane biology is introduced and the importance of phospholipids as
building blocks of the membrane bilayer structure is emphasised.
Chapter 2 The theory behind X-ray diffraction studies of membrane structures is
described.
Chapter 3 Materials and methods of X-ray diffraction and differential scanning
calorimetry (DSC) experiments described later in the thesis are
discussed. The synthesis and characterisation of a novel synthetic
bromolipid is also described.
Chapter 4 A study of the interaction of the anti-influenza drug, amantadine, with
fluid phase DOPC bilayers by X-ray diffraction is discussed, that
employs the established swelling series method to aid the analysis of the
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diffraction data. While this phasing technique has proved its worth over
many years, its limitations are highlighted.
Chapter 5 Studies of a novel brominated structural isomorph of DPPC (the
bromolipid described in Chapter 3) are described, in comparison with
DPPC, in the gel phase by X-ray diffraction. Studies of the two
phospholipids by DSC are also discussed.
Chapter 6 An X-ray diffraction study of three different bilayer mixtures of the
bromolipid and DPPC (1:1, 7:2 and 4:1 DPPC:bromolipid mixtures) are
described. While the diffraction studies of the bromolipid have employed
the swelling series phasing method, it was hoped that the work would
produce an alternative phasing method for the analysis of X-ray
diffraction data.
Chapter 7 This final experimental chapter describes the study of pure bromolipid
and DPPC bilayers, above the gel to fluid phase transition temperature,
by X-ray diffraction.
Chapter 8 The swelling series and bromolipid phasing methods are evaluated and
the findings of this thesis are concluded.
1.2 Introduction to membrane biology.
While the bilayer membranes studied in this thesis are artificial, the driving
force for such research is the importance of membranes to all living cells (Finean et
al., 1984). Membranes cover the outside of all living cells and also form the basis
of many internal organelle structures. The following four functions are general
features of all living membranes:
1) Membranes form the physical boundaries of compartments whose composition
can be controlled to permit biochemical processes to occur efficiently.
2) Membranes allow the transportation of a restricted range of molecules from one
compartment to another, i.e. they are selectively permeable.
3) Membranes act as interfaces which allow the transduction of energy or chemical
signals from one compartment to another.
4) Membranes provide the optimum environment for the functioning of certain
molecules (e.g. enzymes, ion pumps and receptors).
1.2.1 The surface membrane.
The surface membrane covers all cells, and divides the external medium
from the internal cytoplasm. Prokaryotes rarely have any membrane structures,
other than the surface or limiting membrane (Margulis and Schwartz, 1982). While
many viruses possess no membrane structures whatsoever, those such as influenza
have a relatively simple membrane envelope (Luria et al., 1978; Fields, 1985). The
surface membrane is freely permeable to a restricted range of small molecules, such
as water, urea, glycerol and many lipid soluble molecules (Kregenow, 1981). The
transportation of more complex molecules into the cell, such as glucose and amino-
acids, is facilitated by proteins embedded in the surface membrane (Mueckler et al.,
1985; Thorens et al., 1990). Another embedded protein, the Na+/K+ ATPase,
pumps Na ions out of the cell in exchange for K+ ions (Sweadner and Goldin,
1980; Cantley, 1981; Pedersen and Carafoli, 1987). Peptide hormones, such as
insulin and glucagon, bind to the external surface of cell membranes, eliciting a
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response from the internal surface via embedded plasma membrane proteins
(Ullrich et al., 1985; Schlessinger and Ullrich, 1992).
The surface membrane of many cells is divided into separately functioning
regions. The plasma membrane of epithelial cells, such as those found in the gut or
kidney, is segregated by a tight junction into apical and basolateral domains (Da
Silva and Kachar, 1982; Schneeberger and Lynch, 1992; Anderson et al., 1993). In
hepatocytes, the basolateral membrane is subdivided into a blood-bathed sinusoidal
domain and a lateral domain that interacts with neighbouring cells (Bartles et al.,
1985; Simons and Fuller, 1985). The hepatocyte membrane regions have been
shown to differ in both their physical and biochemical properties (Evans, 1977).
1.2.2 Internal membranes of eukaryotic cells.
Unlike prokaryotes, eukaryotes have a variety of membrane-bound
organelles within their cytoplasm (de Duve, 1975; Tolbert and Essner, 1981),
several examples of which are given below:
1) The mitochondrion has a double membrane structure which encapsulates a
central matrix compartment containing all the enzymes associated with the final
oxidation of carbohydrate, lipid and protein metabolites (Lanoue and
Schoolwerth, 1979; Bereiter-Hahn, 1990). The inner mitochondrial membrane
is highly folded into cristae and holds the membrane proteins of the electron
transport system (Srere, 1982). As well as having proton pumping capabilities,
these membranes have transport systems for metabolites and breakdown
products that are used or produced in the central matrix.
2) Lysosomes are membrane bound organelles which typically have a low pH that
is generated by a proton pumping ATPase (Ohkuma et al., 1982). The organelle
contains a wide variety of hydrolytic enzymes such as phosphatases, sulphatases,
esterases, proteases and glycosidases (Bainton, 1981; Kornfeld and Mellman,
1989) which must be prevented from digesting other cell components by the
barrier qualities of the surrounding membrane.
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3) Peroxisomes, another form of membrane bound organelle, contain a variety of
oxidases that produce hydrogen peroxide during the oxidation of substrates such
as D-amino acids and hydroxyl acids (e.g. lactate) that must be prevented from
digesting other cell components by the membrane barrier (Tolbert and Essner,
1981; Taiz and Zeiger, 1991).
4) The nuclear membrane is a double membrane structure, with large well defined
pores, that surrounds the genetic material of cells (Franke et al., 1981; Forbes,
1992).
5) The endoplasmic recticulum and Golgi membranes separate the cytoplasm from
the cisternal space (Novikoff, 1976; Farquhar and Palade, 1981; Griffing,
1991). The rough endoplasmic recticulum bears ribosomes on its cytoplasmic
face and is the site of membrane protein synthesis (Lake, 1981). The smooth
endoplasmic recticulum synthesises membrane lipids such as cholesterol and
phospholipids (Bishop and Bell, 1985).
6) Membrane vesicles transport proteins and lipids to specific destinations in the
cell, and act as carriers in exocytosis and endocytosis (Helenius et al., 1983;
Davey et al., 1985; Bradshaw, 1989; Watts and Marsh, 1992).
From this great diversity of roles, it is easy to appreciate the importance of
membranes to life and the understanding of their function and mechanism of action
is well worth studying and characterising (Evans and Graham, 1989).
1.3 The structure of membranes.
Membranes are composed mainly of protein and lipid molecules (Wallach
and Zahler, 1966; Unwin and Henderson, 1984) which may be modified by
covalent attachment of carbohydrate residues (Hirano et al., 1972; Hakomori,
1986). It is generally accepted that the molecular organisation of cell membranes
broadly conform to the fluid-mosaic model of Singer and Nicholson (1972), a
general structure which has a hydrophobic (non-polar) interior and hydrophilic
















Figure 1.1 The general structure of phospholipid bilayers (Luzzati, 1968).
Phospholipids are amphipathic molecules, comprised of a hydrophilic phosphate
headgroup attached to hydrophobic lipid chains, which spontaneously form ordered
structures. The bilayer structure, drawn above in two dimensions, is the structural
basis of membranes which cover all living cells, where two layers of phospholipid
molecules form opposing sides of the structure. The membrane exterior is
hydrophilic (phosphate headgroups), whilst the centre of the membrane is
hydrophobic (lipid chains).
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form the basis of the membrane structure, where two layers of molecules facing one
another form a bilayer (Figure 1.1). Protein molecules can either bind to the
surface of, or penetrate into, the bilayer structure. Sterols, typically ergosterol in
plants and cholesterol in animals, are also found in eukaryotic cell membranes.
The major classes of membrane amphipathic molecules, in both prokaryotes
and eukaryotes, are based predominantly on a diacylglycerol backbone structure
(phospholipids), although animal cell membranes are also comprised of amphipathic
molecules based on a ceramide (N-acylsphingosine) structure (Quinn, 1976). In
phospholipids, the free primary hydroxyl group of the diacylglycerol backbone is
phosphorylated. A variety of headgroup residues can be attached to the phosphate
group, forming a large family of related molecules (Figure 1.2). Phospholipids
commonly found in nature include: Phosphatidylcholines (PC),
Phosphatidylethanolamines (PE), Phosphatidylserines (PS), Phosphatidylinositols
(PI) and Phosphatidyl- and Diphosphatidyl- glycerols (PG and DPG).











Human erythrocyte 11 61 22
Myelin 28 41 22
Rat liver mitochondria <5 80 4
Rat liver E.R. <5 75 8
Bacterial protoplast trace 80 - 90 0
Plant chloroplast 80 12 0
The amphipathic molecules that are incorporated into membrane structures
vary with membrane type (Bollen and Higgins, 1980; Nillson and Dallner, 1977;
Crain and Marinetti, 1979). The relative amounts of phospholipid, glycolipid and
cholesterol, for example, have been found to vary widely between the membrane
structures of different organisms (Table 1.1). The individual phospholipid types
forming a membrane structure can also vary (Table 1.2) as can the sphingomyelin

























































Figure 1.2 Phosphatidyl headgroups commonly found in nature (Bach, 1983). Many
different headgroups can be attached to a phosphate group to form phospholipids
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Figure 1.3 The phospholipid compositions of the rat hepatocyte
endoplasmic recticulum, inner-mitochondrial and plasma membranes.
The data show that the phospholipid composition varies between the
different membranes of the same organism cell type (Evans and
Graham, 1989).
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membrane structure has also been shown to be dependent on the membrane type,
with cholesterol content tending to be highest in the plasma membrane and lowest in
the intracellular membranes (Yeagle, 1985). It appears, therefore, that the
molecules comprising a membrane are specifically selected to contribute to the
properties of that membrane.
Table 1.2 Percentage of each main phospholipid class present in the outer leaflet of
various animal membranes.
Cell membrane SM PC PE PS Reference
Human erythrocyte 80 77 20 <4 Zachowski, 1993
Human platelet 93 45 20 9 Peret etal., 1979
Rat erythrocyte 100 62 20 6 Renooij et al., 1976
Rat cardiac sarcolcmna 93 43 25 0 Post etal., 1988
Rat Hepatocyte bile
canalicular surface
65 85 50 0 Higgins and Evans, 1978
Rat liver rough ER 58 68 40 26 Bollen and Higgins, 1988
Transverse asymmetry has been shown to exist in natural membranes, where
the lipid composition is different on each side of the bilayer (Zachowski, 1993).
Since membranes separate two physiologically dissimilar compartments, they are
also likely to perform asymmetric functions. For example, the internal face of the
peroxisomal membrane must act as a barrier under harsher conditions (due to
presence of hydrogen peroxide) than the external face. Reconstitution experiments
indicate a marked variation in the lipid requirement of membrane associated
functions:
1) The Pi-ATP exchange and calcium pump reconstituted with lipid vesicles
containing Fi-ATPase and Ca2+-ATPase from mitochondria and sarcoplasmic
recticulum respectively, require the amino group of phosphatidylethanolamine
(PE) to be present, but the proton pump reconstituted with bacteriorhodopsin
functions actively in vesicles made from acetylated lipid instead of PE (Singer
and Nicholson, 1972).
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2) Cytochrome C activity requires the presence of long chain unsaturated fatty
acids that provide a fluid environment.
3) The purified (Na+/K+)-ATPase contains the phospholipids PC, PS and PE.
Removal of these phospholipids leads to the loss of enzymatic activity, which
returns when the phospholipids are reintroduced (Hokin, 1976).
Lipids also serve other roles in membrane function (Lenaz, 1977), such as
providing a suitable non polar environment in which lipid soluble membrane
components, for example ubiquinone (a coenzyme of the electron transport chain in
the inner mitochondrial membrane), may function. Lipids may also serve as a
barrier separating two different aqueous media and impose vectorial properties on
specific proton transport systems, as in oxidative phosphorylation.
1.4 Phospholipids.
Phospholipids are a major class of molecules which can spontaneously form
membrane structures (Table 1.1; Figure 1.1; Luzzati, 1968; Ceve and Marsh,
1987). As well as bilayer structures, phospholipids can form a wide variety of other
structures (e.g. micelle, inverted micelle, cubic), whose existence and stability is
dependant on environmental factors e.g. temperature; pressure; and water content
(Cullis and de Kruijff, 1979; de Kruijff et al., 1984). These diverse phases have
been extensively studied by X-ray and neutron diffraction as well as many other
methods, such as differential scanning calorimetry, infrared (IR) spectroscopy,
nuclear magnetic resonance (NMR) spectroscopy and freeze fracture electron
microscopy (Nilsson et al., 1991; de Kruijff et al., 1985; Tate and Gruner, 1989;
Sjolund et al., 1989; Turner and Gruner, 1992; Seddon, 1990). In this thesis only
the well characterised, biologically relevant structures formed by phospholipids
have been studied, namely the lamellar phases that many phospholipids form
naturally under physiological conditions (Luzzati, 1968).
The phase diagram of a typical phospholipid (Figure 1.4, from Stumpel et
al., 1983), especially those with identical lipid chains, shows how the structural
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form (phase) of DPPC varies with temperature. The nomenclature most commonly
used for describing bilayer lamellar phases is as follows:
L - lamellar bilayers, which run flat and parallel with one another;
P - a bilayer structure with a periodic ripple and 2 dimensional order either centred
or oblique,
subscripts often encountered include:
a - alpha, denoting that the bilayer is in the fluid phase, the lipid tails having melted
apart;
(3 - beta, the bilayer is in the gel phase, the lipid chains being close packed and
stabilised by hydrophobic interactions;
(3' - beta prime, states that the lipid chains are tilted, at an angle other than
perpendicular to the normal of the lamellae;
s - epsilon, the subtransition phase found in samples cooled for a long period of
time, having a two dimensional orthorhombic unit cell (Chen et al., 1980).
1.5 Molecular conformation of phosphatidylcholines.
Phosphatidylcholine is the most abundant phospholipid in rat liver cell
membranes (Figure 1.3). The two lipid chains attached to the PC headgroup, even
when chemically identical, are conformationally distinct (Figure 1.5). The
conformational difference between the two lipid chains at the glycerol backbone
results in the sn-1 chain penetrating deepest into the bilayer (Zaccai et al., 1979).
The phosphatidylcholine headgroup is hinged at the phosphate group (Figure 1.5)
and its orientation can alter as a result of changes in humidity and additions into the
bilayer of small molecules (Bechinger and Seelig, 1991).
The crystal structure of 1,2 dimyristoyl-sn-glycero-3-phosphorylchoIine
(DMPC), reported by Pearson and Pascher (1979), is similar to the molecular
conformation found for most symmetric chain PC bilayers studied to date. The
structure proposed for C(18):C(18) PC under none crystalline conditions is based
on the DMPC crystal structure (Figure 1.6). Although the phospholipid
conformation shown is based on the gel phase state, it still has many similarities
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Figure 1.4 Phases formed by phospholipids such as DPPC under physiological
conditions. The arrows denote the direction of increasing temperature (from





a) The conformational inequivalence of the two lipid chains in a symmetric chain
phospholipid. It has been found that the lipid chains of symmetric chain
phospholipids in bilayer structures differ conformationally. The sn-2 chain at
first travels parallel with the bilayer surface before heading down into the lipid
layer, compared with the sn-1 chain which heads directly into the lipid layer.
The chain length difference has been measured as 3 carbon bonds in the
phospholipid crystal structure (Pearson and Pascher, 1979) and 1.5 carbon
bonds in gel phase DPPC (Zaccai et al., 1979). The chain inequivalence is
exaggerated in the above diagram.
b) Conformation of the choline headgroup. The choline headgroup is hinged about
the phosphate group and the choline group to bilayer surface angle can vary with
humidity (Bechinger and Seelig, 1991).
Figure 1.5 Two aspects of the typical conformation of phosphatidylcholine
molecules in bilayers. (a) The two lipid chains are conformationally inequivalent.
(b) The phosphatidylcholine headgroup is hinged at the phosphate group.
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18:0/18:0-PC
Figure 1.6 A molecular model of a gel phase bilayer structure, based on the
conformation of C(18)C(18)PC (from Mattai et al., 1987). In spite of being in the
gel phase, the lipid conformation is still based on that found for crystalline lipids
(Pearson and Pascher, 1979).
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with the crystal structure of DMPC. The structure shown in Figure 1.6 exhibits the
lipid chain conformational inequivalence found in both crystalline and non¬
crystalline bilayer arrays of phospholipids (Pearson and Pascher, 1979; Zaccai et
al., 1979). Bilayers of the PC molecule can be divided up into 3 regions for
conformational analysis; the head group, glycerol backbone and the lipid chain
region. Each of the 3 regions are discussed separately below.
1.5.1 Phosphatidylcholine head group conformation.
Although X-ray diffraction experiments can locate the main electron density
groups in the bilayer, additional conformational information of the bilayer
molecules can come from other sources. Phosphorus NMR has been of some use in
elucidating the behaviour of the head group in bilayers. Studies of hydrated Lp-
phase DPPC bilayers by NMR (Griffin et al., 1978) show that the PC head group is
orientated perpendicular to the plane of the bilayer normal (see Figure 1.6).
Neutron diffraction experiments on deuterated DPPC (Buldt et al., 1979) also show
the head group to be roughly perpendicular to the bilayer normal in both the gel
(Lp-) and fluid (La) phases.
The head group dipole angle has been shown to change either with hydration
(Bechinger and Seelig, 1991) or due to the penetration into the bilayer by
amphiphiles (Scherer and Seelig, 1989). The hydration state of the head group has
also been shown to affect the lipid chain conformation (Buldt et al., 1979). At 20°C
and low hydration the DPPC lipid chains were found to be tilted at 11 degrees. On
increasing the hydration more water molecules penetrate around the head group,
decreasing the bilayer thickness and increasing both the area per lipid and the lipid
chain tilt angle (Katsaras et al., 1991).
1.5.2 Backbone or interface region.
The hydrophobic hydrophilic interface region of phospholipid bilayers
extends from the phospholipid glycerol backbone to the ester linkages and the a-
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methylenes of both the sn-l and sn-2 acyl chains. The ester bond linking the acyl
chain to the glycerol moiety can exist in two resonance forms, imparting double
bond character on the ester bond (Figure 1.7). Since rotation around the axis of a
double bond is highly restricted, the five atoms of the ester-glycerol group are
essentially co-planar. The sn-l acyl chain and the carbon atoms of the glycerol
backbone are oriented almost parallel to the bilayer normal. The initial section of
the sn-2 acyl chain extends out from the glycerol backbone at a right angle, running
perpendicular to the bilayer normal (Zaccai et al., 1979), before bending abruptly
by about 90°, at the a-methylene segment, allowing the remainder of the acyl chain
to run parallel with the sn-l chain. Because of the unique conformation of the initial
segment of the sn-2 chain, the terminal ends of a phospholipid with symmetric
chains display an axial displacement.
A variety of spectroscopic techniques have demonstrated that the
inequivalence of the two phospholipid chains, seen in the crystal structure, persists
in hydrated phospholipid phases (Zaccai et al., 1979; Gaber et al., 1978). Neutron
diffraction studies on DPPC specifically deuterated at the a-methylenes of the acyl
chains have confirmed the bent conformation of the sn-2 chains (Zaccai et al.,
1979), in both the gel and liquid crystalline phases. In these hydrated phases the
lipid chain inequivalence is reduced, from the 3A found for crystal structures, to
1.8A («1.5 carbon bond lengths). Deuterium NMR studies (Browning, 1981; Seelig
and Seelig, 1980) have been performed on a wide variety of phospholipids, with the
results suggesting that this interface region conformation is a general feature of
most phosphatidylcholines.
1.5.3 Lipid chain conformations.
Depending on temperature, humidity, pressure and lipid chain type,
phospholipid chains in the hydrophobic layer can pack together in a number of
ways. The close packing of lipid chains results in the formation of equilateral
diffraction maxima. The most common packing arrangement for lamellar phase
phospholipids, and their characteristic diffraction patterns, are summarised below.
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1.5.3.1 The a conformation.
Lipid chains in the a conformation have a liquid-like disorder, producing X-
• ° -1
ray diffraction patterns which are characterised by a broad band at around 4.6A
that is very similar to a band observed with liquid paraffins (Luzzatti et al., 1960).
The hydrocarbon chains in the a conformation behave like molecules in miscible
liquids. The a conformation is, to a large extent, insensitive to chemical
heterogeneity of the chain groups, which is in contrast to phases of a more ordered
nature where the chemical composition plays a critical role in phase stability.
Studies of oriented membrane preparations in the lamellar La phase (Levine and
Wilkins, 1971) have shown that even these 'fluid' bilayers are anisotropic at low
water content i.e. there is still some order in the lipid chain conformation.
Phospholipid bilayers in the a conformation exhibit a peculiar temperature effect, in
that the bilayer thickness decreases as the temperature increases (Luzzati, 1968).
This phenomenon, recognised in rubber, is typical of a polymer with a highly
disordered conformation, moderately stretched by an external force: a rise in
temperature increases disorder and decreases the elongation.
1.5.3.2 The P conformation.
X-ray diffraction patterns of oriented phospholipid samples in the |3
conformation are characterised by a sharp equilateral reflection at 4.2A"1.
Phospholipids in the (3 conformation have their lipid chains oriented parallel to the
plane of the bilayer normal. This conformation tends to appear in phospholipid
samples whose chains are of a chemically heterogeneous nature or contain only a
small amount of water (Luzzati, 1968).
1.5.3.3 The ft' conformation.
Sharp reflections at 4.1A ' and 4.4A ' are characteristic of phospholipids in













Figure 1.7 The two resonance forms of the ester linkage region. All five atoms are
coplanar imparting structural rigidity to the interface region.
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parallel, as is the case for the (3 conformation, packed with rotational disorder in a
two dimensional quasi-hexagonal lattice. The chains are, however, tilted with
respect to the normal plane of the lamellae. The amount of water incorporated into
3' type phases can be larger than for 3 type phases, with the angle of chain tilt
increasing with increasing water content (Katsaras et al., 1991).
For fully hydrated gel state phosphatidylcholines, the phosphorylcholine
head groups adopt a layer aligned orientation with surface areas in the range of 43
to 53A2, depending upon the hydrocarbon chain length (Tardieu et al., 1973). Thus
the observed chain tilting compensates for the large head group area, allowing the
chains to pack with optimal van der Waals contacts. Spectroscopic work has shown
that the carbon-carbon bonds are predominantly all-trans in the gel phase
(Mendelsohn et al., 1989) with an average of two gauche conformers in DPPC
bilayers (Casal and McElhaney, 1990). Due to the inequivalence of the two acyl
chains in symmetric chain phospholipids, there is a small segment at the terminal
end of the sn-1 chain which must be distorted, possibly by trans-gauche isomerism,
to fill the space under the methyl terminus of the shorter sn-2 acyl chain so as not to
leave a region void of van der Waals contacts (Mason and Huang, 1981; Nagle,
1980). This region may well be the predominate source of the gel phase gauche
conformers seen by spectroscopic methods.
1.5.3.4 The ripple phase.
The Pp< two dimensional ripple phase is an intermediate between the Lp- and
La phases (Caffrey et al., 1990). Its formation, also known as the pretransition, is
associated with a change from a one-dimensional to a two-dimensional monoclinic
lattice consisting of lipid lamellae distorted by a periodic undulation or ripple. X-
ray diffraction photographs of this ripple phase have been presented (Alecio et al.,
1985) suggesting the ripple to have a wavelength of 165A (DPPC at 39.5°C and
98% RH). The period of the ripple increases with decreasing water content,
reaching a minimum value at the swelling limit of the lecithin. The hydrocarbon
chains are tilted with respect to the plane of the bilayer and are packed in a
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hexagonal array. DPPC exhibits a pretransition endotherm at 35 °C and a main
chain melting endotherm at 42°C, when studied by DSC (Rand et al., 1975).
Techniques such as NMR spectroscopy show that there is an increase in molecular
mobility of the polar head group at the pretransition temperature (Velski et al.,
1969; Chapman and Chen, 1972; Darke et al., 1972; Okamura et al., 1990).
The pretransition endotherm has been shown to be affected by the presence
of small amounts of other molecules added into the bilayer, e.g. cholesterol
(Ladbrooke et al., 1968), drug molecules (Cater et al., 1974) and also by the
effects of various salts present in the aqueous channels separating the bilayers
(Chapman et al., 1977). Adding 7.5 mole percent cholesterol to DPPC bilayers was
shown to be enough to remove the pretransition, with the tilted lipid chains of
DPPC being forced into the untilted (3 form. Including small amounts of related
lipids, e.g. phosphatidylethanolamines (Chapman et al., 1974) removes the
pretransition, presumably by affecting the chain organisation. The effect of salts on
the pretransition endotherm suggests that the polar head group has the ability to
organise into ripples, as the salts are in the water layer bathing the head groups.
1.5.3.5 The s subtransition phase conformation.
The e subtransition, discovered more recently than the phases previously
described, is a phase whose formation is dependant on the thermal history of the
sample (Chen et al., 1980; Fuldner, 1981). Typically the sample must be held at
5°C for several days to achieve the formation of this phase. Using DSC it is only
on the first pass of a run that the phase is observed, at a temperature below that of
the pretransition. Joint X-ray and DSC results (Stumpel et al., 1983) suggest this
phase has a two-dimensional orthorhombic unit cell.
1.5.3.6 Conformations found in mixed chain phospholipids.
The reported crystal structure of a lysophosphatidylcholine (C(16):C(0) PC,
Hauser et al., 1980) shows that the phospholipids pack as a fully interdigitated
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lamellar layer with a greatly reduced thickness, of 24.5A, compared with the
equivalent bilayer thickness of a symmetric chain phospholipid (C(8):C(8) PC). The
head group of lysophosphatidylcholine pack in a layer parallel orientation, with a
° 2
large head group area of 52.1A . The chains are observed to be tilted with respect
to the bi layer normal by 41°. A similar interdigitated packing has been proposed
for C(18):C(10) PC (Hui and Huang, 1986).
It has been observed that the unit cell dimensions of C(18):C(10) PC are
identical to those found for C(14):C(14) PC (Tardieu et al., 1973). This
observation supports the idea of an interdigitated packing mode for C(18):C(10) PC
where the long lipid chain pairs with a short chain to produce a continuous chain of
28 carbons, as found in C(14):C(14) PC.
1.6 Phospholipids studied in the course of this thesis.
Phosphatidylcholine is the head group chosen exclusively for study in this
thesis. Various PC molecules, that vary in the lipid chain region, have been studied
during the course of this project.
1.6.1 Dipalmitoylphosphatidylcholine (DPPC)
Attached to the glycerol backbone of DPPC are two fully saturated, 16
carbon (palmitoyl), lipid chains. The carbon atoms are arranged topologically as a
straight chain formation, with no branching. The bonds between each carbon along
the chain are SPs hybrids, which means that each atom is free to rotate about each
bond axis. The carbon atoms are free to arrange into a tightly packed arrangement,
via hydrophobic interactions. This packing allows DPPC to be in the gel phase at up
to about 43°C, with the exact temperature being dependent upon the membrane
hydration state (Chapman et al., 1967).
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1.6.2 Bromolipid (1-Palmitoyl, 2-n-pentadecyl, 15-bromo-phosphatidylcholine)
The bromolipid molecule is a synthetic phospholipid derivative, not known
to exist in nature, that has been synthesised purely as an aid to the analysis of X-ray
diffraction data. The bromolipid differs from DPPC solely in the exchange of a
terminal methyl group, on the sn-2 lipid chain, for a bromine atom.
1.6.3 Dioleoylphosphatidylcholine (DOPC)
The two identical lipid chains of DOPC are 18 carbons long and have a
double bond located between carbons 9 and 10 (oleoyl). The double bond orbitals
are SP2 hybrids, which have a different geometry to SP3 orbitals. Rotation cannot
take place around the double bond with the result that DOPC cannot pack as tightly
together as the single bond equivalent disteroylphosphatidylcholine (DSPC). For the
same headgroup and extent of hydration, increasing the lipid chain unsaturation
reduces the transition temperature (Ladbrooke et al., 1968). Thus DOPC has a
chain melting transition temperature of ca -22°C whereas DSPC melts at ca 58°C
(Philips et al., 1969). The geometry of the oleoyl chain double bond forces a tilt on
the lipid chain, reducing the bilayer thickness (54A for DOPC at 20°C (Chapter 4)
versus 61A for DSPC (Stumpel et al., 1983).
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Chapter 2
Theory of X-ray diffraction ofmembrane structures.
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2.1 Introduction.
The first X-ray diffraction patterns recorded from biological membranes
were published in the early 1930s, although it was only in the late 1960s that
substantial progress was made in this field (Luzzati, 1968; Velski, 1969). X-ray
diffraction is a powerful technique which can identify the conformation of
molecules down to atomic detail. Present day membrane studies also employ a host
of other physical techniques, such as calorimetry, nuclear magnetic resonance
spectroscopy, and infra-red spectroscopy (Nilsson et al., 1991; de Kruijff et al.,
1985; Tate and Gruner, 1989; Sjolund et al., 1989; Turner and Gruner, 1992;
Seddon, 1990).
Pure phospholipid systems, the most commonly studied 'biological'
membranes, have been shown by X-ray diffraction to form a remarkable variety of
structures (e.g. lamellar, micelle, inverted micelle and cubic phases), depending on
environmental conditions such as temperature, humidity and pressure (Cullis and de
Kruijff, 1979; de Kruijff et al., 1984). The interaction of many small molecules
with phospholipid systems have also been studied by X-ray diffraction, including
studies on the interactions of cholesterol, drugs, toxins, anaesthetics, and peptides
(Katsaras et al., 1991; Duff et al., 1993; Dickinson et al., 1993; Brockerhoff et
al., 1990; Worcester and Franks, 1976; Franks and Leib, 1979).
2.2 Theory and practice of low angle X-ray diffraction.
In a typical diffraction experiment, X-rays (electromagnetic waves of typical
wavelength 1.54A) are fired at a sample and the resultant diffraction pattern
collected and analysed. If the pattern is analysed correctly and completely,
structural information about the sample can be obtained from the resultant
diffraction (Franks and Leib, 1981). X-rays are scattered by the electrons in the
sample and are collected as intensities of diffraction at a particular position, using
either X-ray sensitive photographic film or a radiation detector. The sample gives
rise to a diffraction pattern whenever it has some repeating nature, so that X-rays
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scattered from each repeat add together to give a pattern that is sufficiently intense
to detect. The amount of information that can be obtained in a diffraction
experiment is therefore limited by the degree of disorder in the structure averaged
over the time it takes to record the diffraction pattern.
Whilst the bilayer repeat distance (D) of a membrane can be obtained simply
by measuring the relative positions of intensity on the collected diffraction pattern,
there are two main problems to be overcome in order to completely analyse a
diffraction pattern.
1) In order to reconstruct the electron density profile both the amplitudes of the
scattered waves and their relative phases must be known, yet only the intensity
of the scattered wave can be measured (i.e. the phase information is lost).
2) The second problem is that even if the correct phases can be deduced there is no
simple way of assigning the various levels of electron density to the chemical
constituents; hydrated protein and lipid head groups, for example, have a
similar electron density (Nagle and Wiener, 1989).
Despite these problems, the technique of X-ray diffraction can provide valuable
information about the structure of both biological membranes and model systems,
which cannot be obtained by other methods.
2.3 Origin of the diffraction pattern.
X-rays fired at a sample interact with electrons, which then act as secondary
X-ray sources. The amplitude of the scattered radiation from each bilayer region is
directly proportional to the local electron density, and the interference between the
waves scattered by different regions gives rise to the diffraction pattern. Spots of
intensity on the diffraction pattern correspond to directions where waves 'in phase'
have interfered constructively to produce a peak or spot. Areas on the film lacking
intensity spots indicates that either no X-rays were scattered in that direction or
scattered waves have interfered destructively, cancelling one another out. The
diffraction pattern conveys information about the geometric arrangement in space of




Figure 2.1 A plane wave of X-rays incident upon two scattering centres, 0 and P
(from Makowski and Li, 1983). In a diffraction experiment the incident wave can
be represented by a vector Ki of modulus 1/A, pointing in the direction of
propagation. In the direction of the scattered wave represented by the vector IG, the
path difference between rays which have passed through the points O and P,
separated by a distance r, is A,r.(K- Ki).
Figure 2.2 A plane wave of X-rays incident upon two planes of constant electron
density, separated by the bilayer thickness, D, the distance b to d. All angles 0 are
equal and the angles b-a-d and b-c-d are right angles. The lower wave must travel
an extra distance before emerging from the multilayer stack, compared with the
upper wave. This extra path length a-b-c is equal to 2Dsin0, and is therefore related
to the bilayer thickness. For the two waves to exit the sample in phase, this path
difference must be exactly one X-ray wavelength or an integral number of
wavelengths (hk) in size, as described by Bragg's law (equation 2.2).
b
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Figure 2.1 demonstrates the interaction between a plane of X-radiation and
just two scattering centres, one of which is at an arbitrary origin in space while the
other is at a point P, whose position is described by the vector r from the origin.
The incident X-radiation can be characterised in terms of a wave vector Ki which
lies in the direction of propagation and has modulus | Ka | = 1/A,, where X is the
wavelength of the radiation. In the direction of the scattered wave (Figure 2.1),
represented by the vector K, the path difference between rays which have passed
through the points O and P is X,r.(Ks- Ki). The phase difference in radians is
obtained by multiplying by (2k/X) which gives
phase difference =27ir.(K- K) = 2iz (r.R) (2.1)
where we have defined a new vector R=(K- K). This vector has a simple
geometric interpretation since it is perpendicular to imaginary planes which contain
the scattering centres and from which the X-rays can be considered to have been
'reflected'.
W.L. Bragg was the first to suggest that X-ray scattering from crystals could
be described in terms of 'reflections' from planes of constant electron density
(Bragg and Perutz, 1952). The construction Bragg used is shown in Figure 2.2. For
planes of distance D apart, total constructive interference occurs only when the
angle of incidence is such that the path difference between the two rays is an
integral number of wavelengths, as shown in Bragg's law,
2 D sin 6 = h A. (2.2)
The integer h is called the order of the 'reflection'. The analogy with normal
reflection is not complete since X-ray 'reflections' only occur at specific angles for
a given D.
Figure 2.2 shows two 'in phase' waves incident on corresponding regions of
two bilayers separated by the bilayer repeat distance D which are 'reflected'. For
the two waves to interfere constructively on emerging from the sample they must
still be in phase. The lower wave (Figure 2.2) must travel an extra path distance,
2Dsin0, before emerging from the multilayer stack, compared with the upper wave.
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For the two waves to be in phase this path difference must be exactly one, or an
integral number of, wavelengths in size (Bragg's law, equation 2.2).
The angular deviation (20) of the scattered X-rays from the main beam
direction can be related to distances between planes of constant electron density in
the structure (Bragg's law, equation 2.2). When X-rays are diffracted from a stack
of membranes, long range structural periodicity gives rise to diffraction at low
angles, whereas the finer details of the membrane structure gives rise to diffraction
at higher angles. Thus X-ray diffraction patterns are recorded out to as high an
angle as possible so that these fine details may be resolved. The Bragg spacing D,
between membrane stacks, divided by hmax ,the highest angle order of diffraction
observed, is usually said to be the resolution of the pattern.
The reciprocal relationship between distances in the diffraction pattern and
distances in the structure can be seen more clearly by relating Bragg's law to the
vector R (Figure 2.2), which has a modulus
(The amplitude of the wave vector does not change during the diffraction process)
Combining equations (2.2) and (2.3) gives
The vector R is called the reciprocal space vector and is the co-ordinate used to
describe the positions of reflections in the diffraction pattern. Distances in the
structure, on the other hand, are said to be in real space.
One can then consider the diffraction pattern from a number of membranes
stacked regularly on top of one another, separated by fluid layers of constant width.
Most membranes that are studied have no well ordered repeating structure within
the plane of the bilayer, and can therefore be considered to have a characteristic
time averaged electron density distribution. The one-dimensional projection in the
direction of the bilayer normal can be thought of as a continuous distribution of
electron density p(x) at a distance x from some arbitrary origin, relative to the
electron density of the fluid. The amplitude of the scattered wave from this point
| R | =2 sin Q/X (2.3)
| R| = h/D. (2.4)
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will be proportional to p(x) and its phase relative to the origin will be 2nRx
(equation 2.1). To obtain the total resultant amplitude scattered from the whole
membrane array one integrates over the thickness of the array, thus
00
F(R) = J p(x) exp (27tiRx) dx (2.5)
x
F(R) is called the structure factor or structure amplitude and defines both the
amplitude and phase of the scattered radiation (i is the square root of minus one).
The integral of equation (2.5) has the form of a Fourier integral and
therefore defines a unique and reciprocal relationship between the electron density
structure factor F(R) and the distribution p(x). The structure factor F(R), therefore,
is the Fourier transform of p(x), so that if F(R) is known at every value of R then
the electron density distribution can be obtained using the inverse relationship
p(x) is referred to as being the Fourier transform of F(R) and therefore F(R) is the
inverse Fourier transform of p(x). Because of this reciprocal nature of the Fourier
transform one can think of either of the above as being the Fourier transform of the
other.
F(R) in equation (2.5) relates to the entire stack of membranes, but the
structure factor of a single bilayer still has to be extracted from it. If the membrane
stack consists of N membranes each of thickness Dm separated by fluid layers each
of thickness Df, then the electron density distribution will then be periodic in x,
repeating itself every distance D=(Dm+Df) i.e.,
00
p(x) = J F(R) exp (-27uRx) dR
R
(2.6)
p(x + nD) = p(x) ; 0 > x > D for n = 1, 2... N-l (2.7)
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Equation (2.5) can therefore be rewritten as a sum of integrals and factorised to
give
N-l D
F(R) = { Z exp (27riRnD) } 1 p(x) exp (27uRx) dx
n=0 0
N-l




Fu(R) = \ p(x) exp (27riRx) dx (2.9)
0
is the structure factor of an isolated repeat unit of the array. It is thus apparent that
the structure factor of the array can be factorised into a product of the structure
factor of a single repeat unit and a sum of terms which represent the phase
differences introduced into the scattering waves by the spatial separation of the
repeat units. This sum is a geometric series, called the interference function G(R)
N-l
G(R) — 2 exp (27iiRnD)
n=0
= exp [tuR(N-1)D] sin(NTrRD) (2.10)
sin(7iRD)
The interference function has maxima whenever all the terms in the series
have the same value of +1, and this happens only when
RnD = m;m = 0, + 1, ±2... (2.11)
Since both n and m are integers, then equation (2.11) will be satisfied for all
n if R times D is also an integer, i.e.,
RD = h;h = 0, ±1, ±2... (2.12)
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which is a restatement of Bragg's law (equation 2.2). In other words, the
interference function has peaks in reciprocal space at positions where reflections are
predicted to occur by Bragg's law.
The wave interference function for a stacked multilayer sample consists of a
series of sharp peaks at points R= +h/D in reciprocal space. Since the amplitude of
the interference function is
1 G(R)1 = sin(NTtRD) (2.13)
sin(7iRD)
(the exponential factor of equation (2.10) giving the phase) then the maxima in the
interference function will have height I G(h/D)| =N. The half-widths will be of
order 1/(ND) so that the widths of the Bragg reflections will be inversely
proportional to the number of coherently diffracting units in the array. Thus for
large N the interference function exists only in the neighbourhood of the points
R=h/D and effectively samples the function Fu(R), the Fourier transform of the
single repeat unit, at equal intervals of reciprocal space. Because diffracted X-rays
are concentrated into small regions of reciprocal space, membrane stacks can
diffract X-rays out to quite high angles, giving high resolution structural
information.
As discussed above, there is a unique relationship between the structure
factor F(R) and the electron density distribution p(x), through the Fourier
transformation, so that if one is known the other can be calculated. Unfortunately,
in a diffraction experiment we do not observe the function F(R) but rather the
diffracted intensity I(R). The observed intensity distribution is related to the
diffracted amplitude by
I(R) = F*(R).F(R) = I F(R)|2 (2.14)
where F*(R) is the complex conjugate of F(R). Thus from the observed intensity
we can only directly calculate the modulus of the structure factor, while we lose the
phase information. This is the well-known phase problem and constitutes the
principal difficulty in the complete analysis of X-ray diffraction patterns.
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2.4 Corrections to the value of the measured intensity.
Due to technical difficulties in measuring absolute intensities (Luzzati, 1960;
Kratky, 1967) only relative intensities are recorded in an experiment and thus
electron density profiles can only be calculated on a relative scale. The measured
intensity value has to be corrected by a number of geometrical factors, the most
important of which is the Lorentz factor, which takes into account the disorientation
of the membranes with respect to the X-ray beam. For a point focus beam the
diffracted intensity will spread out in reciprocal space at constant R so that the
measured intensities will be reduced by a factor proportional to R2. If the intensities
on a film are integrated around an arc or a circle, as is the case in this thesis, then
they need only be multiplied by R rather than R2.
A minor correction is needed because oscillating electrons, which act as the
secondary X-ray sources, do not radiate energy isotropically and the measured
intensities have to be divided by [l+cos2(29)]/2 to take this effect into account,
although it is only a small correction at low angles.
2.5 Centrosymmetric structures.
The phase problem is greatly simplified when studying centrosymmetric
structures, i.e. p(x) =p(-x). As this is always the case in this thesis (but not true
for all membranes) equation (2.9) can be rewritten as
D/2
Fu (R) = \ p(x) exp (27uRx) dx
-D/2
D/2 D/2
= I p(x) cos (27tRx) dx + i J p(x) sin (27iRx) dx (2.15)
-D/2 -D/2
The sine transform, the second term of equation (2.15), is zero since the sine
function is anti symmetric (i.e. sin(x)=-sin(-x)). In general, we can also write the
structure factor Fu(R) in terms of its amplitude I Fu(R)| and phase (a) as
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Fu(R) = I Fu(R)| exp (ia)
Fu(R)| cosa +i| Fu(R)| sin a (2.16)
and since equation (2.15) shows that Fu(R) is purely real for a centrosymmetric
structure, we see that for this case
i.e. the phase angles of the structure factor Fu(R) can only be integral multiples of
71. These phase angles correspond to the structure factor having either positive or
negative values and thus the phase problem reduces to simply determining the sign
associated with the observed structure factor amplitude I Fu(R)|.
2.6 Analysis of diffraction patterns.
When a membrane is centrosymmetric then, in principle, all that has to be
done in order to calculate the electron density distribution p(x) is to identify the
zeros in intensity, i.e. where the sign changes. The Fourier cosine transform can
then be applied to the phase assignments together with the observed I Fu(R)| to
calculate an electron density profile. One problem that immediately arises however,
is that, since there is a practical limit to how close to the main beam direction
scattered X-rays can be observed, the region close to and including the origin in
reciprocal space has to be extrapolated from the observed data. The value of the
transform at the origin has a simple physical interpretation. From equation (2.9) we
can see that when R=0
Thus, as p(x) is a contrast function defined relative to the electron density of the
fluid, Fu(0) is simply the total number of electrons in the structure in excess of the
sin a =0 so that a = mt; n=0, +1, ±2 ... (2.17)
D




number in an equivalent volume of the fluid. In most membrane experiments Fu(0)
will be positive. If the sign is not known then, strictly speaking, even if the relative
signs of the peaks could be deduced, this would still leave an ambiguity between the
electron density distribution and its negative. In practice this choice is not difficult
as a bilayer type profile can be assumed.
A more serious difficulty is that the observation of zero intensity is only a
necessary but not a sufficient condition for the phase sign to change, and accurate
intensity data are required to determine whether or not a sign change in fact occurs.
If zeros are not observed between the peaks then this may mean that the membrane
electron density profile is asymmetric, although there are a number of other factors
that may result in diffraction being observed where zeros should occur. For
example, if either the incident beam is not sufficiently monochromatic, the
membrane thickness is not uniform or there is scattering from structures within the
plane of the membrane or indeed from non membranous structures in the sample,
then clear zeros will not be observed. Also, if the membranes are not large sheets
but have significant curvature, then transform zeros will not be expected either
(Moody, 1975).
2,7 The Fourier series.
The relationship between the electron density distribution p(x) and the
structure factors Fu(h/D) can be conveniently represented in terms of a Fourier
series rather than a Fourier transform. The Fourier series for a centrosymmetric
electron density function is
ham
p(x) = Fu(0)/D +2/D z F(h/D) cos (2hx/D) (2.23)
h=l
where hmax is the order of highest observed reflection. The term p(x) therefore
consists of a sum of harmonics whose amplitudes are the structure factor amplitudes
I Fu(h/D)| and whose frequency increases with increasing Bragg order. Therefore,
as higher orders are added to the Fourier synthesis, finer detail can be resolved in
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the structure. The first term on the right hand side of equation (2.23) is a constant
and defines the mean value of p(x); note that if the electron density is defined
relative to the fluid level, it does not represent the mean absolute electron density.
In general, it is more difficult to assign phases to the weaker reflections but,
luckily, these same terms have the least effect in the Fourier synthesis.
2.8 Truncation (termination) error.
It is not permissible to calculate a Fourier synthesis using only the low
orders and consider the resulting electron density map to be an accurate
representation of the structure at low resolution, if there are higher order terms of
significant amplitude. The exclusion of important higher orders introduces a
truncation artefact, which appears as a ripple in the electron density map.
2.9 Methods of solving the phase problem.
As has been stated previously, the outstanding difficulty in diffraction lies in
solving the phase problem. Several methods have been devised to overcome the
phase problem in X-ray diffraction, which include the now well-known "swelling
series" and "isomorphous replacement" approaches (Perutz, 1954; Wilkins, 1972;
Torbet and Wilkins, 1976). There are some methods which attempt the
determination of phases using only a single data set. Luzzati et al. (1972) used a
pattern recognition approach where all possible phase combinations were considered
and the correct solution chosen on the basis of known or postulated properties of
the electron density profile, such as levels of electron density and partial specific
thickness of particular components. For a high resolution pattern, however, with a
large number of orders, there are a large number of possible phase assignment
combinations.
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2.9.1 Shannon's sampling theorem.
The Shannon sampling theorem states that the complete continuous Fourier
transform Fu(R) can be reconstructed using just the set of observed I Fu(h/D)l
together with their chosen signs, and a value of Fu(0) (Moody, 1963). Thus
hmax
Fu(R) = Z Fu(h/D) sin faCRD-h) 1 (2.24)
-hmax 7t(RD-h)
This means that in principle only two sets of intensities, collected at different
sample humidities so that the bilayer thickness changes, are needed. Since for a
constant structure, only the correct combination of signs for the two sets of
amplitudes will result in the same continuous Fourier transform (Fu(R)) of equation
2.24) as calculated using the Shannon theorem (Worthington et al., 1973).
However, the use of just two data sets relies heavily on both the accuracy of the
experimental measurements and the assumption that the bilayer structure does not
change whilst swelling. It is therefore more prudent to measure as many sets of data
as possible so as to reduce and quantify random experimental errors.
2.9.2 The swelling series method.
If the repeat units of a multilayer sample can be swollen apart, provided the
structure does not change, then the signs of the structure factors can be obtained.
Since the values of Fu(h/D) represent sampled values on the continuous Fourier
transform then, if enough swelling states can be measured, the transform can be
mapped out and zero values (phase changes) identified. Before the data for a
swelling series can be plotted, the intensities from these different swelling states
have to be scaled together. Blaurock (1973) showed that the intensities in any one
data set at a spacing D could be scaled so that
00
Z I(h/D) = D/Dmin (2.25)
—00
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where Dmin is the minimum spacing in the swelling series. Blaurock also pointed out
that since in practice 1(0) is not observed and that only a finite number (hmax) of
reflections are recorded, only an inexact version of equation (2.25) can be used.
The basis of the swelling series phasing method is to construct a smooth
continuous Fourier transform by sampling different parts of the continuous
transform. The size of the water layer, that separates the phospholipid bilayers in
the multilayer stack, is varied by changing the sample humidity as part of the
swelling series process. There are several assumptions that are made when utilising
the swelling series method:
a) A structure which remains constant with hydration is physically plausible. It is
possible to assign phases if during swelling the bilayer structure remains
constant except for the thickness of the solvent layer (Perutz, 1954).
b) Phases can still be assigned as long as any structural changes that occur with
swelling are simple and continuous through the experiment (Torbet and Wilkins,
1976).
c) A simple and unique solution is more likely to be correct than any one of a
number of complicated alternative solutions.
The swelling series method, if successful, will result in electron density
maps being constructed at each of the humidities that experiments were carried out.
From assumption (b) of the swelling series method, we would expect the electron
density maps to vary with humidity in a predictable way, i.e. any major change as
the humidity is varied should only affect the size and possibly the shape of the
water layer. Assumption (c), above, states that the phases of each diffraction order,
between differing humidity data sets, should vary in a simple way that is predictable
by the form of the plotted continuous Fourier transform.
If a smooth continuous Fourier transform is plotted during the swelling
series process it is sometimes thought that no structural changes can have taken
place in the sample during swelling i.e. the modulus of a single continuous Fourier
transform has been sampled. This is not so, as continuous changes in the sample
structure will also result in the plotting of a smooth continuous Fourier transform.
If, on the other hand, the data points for each order vary gradually but these
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individual curves do not make up a smooth function, then this is clear evidence of a
structural change. What is important is that the changes are small and continuous in
nature, so that phases can still be assigned on the assumption that the reconstructed
Fourier transforms should change in a reasonable and consistent way with swelling.
2.9.3 The isomorphous replacement method.
Isomorphous replacement is a phasing method used extensively in protein
crystallography, where a heavy atom is added into a native sample. The method
requires that the addition of the heavy atom does not substantially alter the native
structure. The use of heavy atom methods have had limited success when used on
biological membrane samples (Akers and Parsons, 1970; Harker, 1972; Blaurock,
1973). Phases have been determined for bilayers of fatty acids associated with a
series of alkaline earth metals (Mcintosh et al., 1976) using a method similar to that
of Hargreaves (1946). Franks et al. (1978) have used halogenated cholesterol
analogues in isomorphous experiments, that were used to phase the signs of the
lamellar reflections (for orders up to h=7). This method works well, but can only
be used when studying a system containing inserted molecules, such as cholesterol,
that can be labelled with a heavy atom.
2.9.4 The multiple anomalous dispersion (MAD) method.
Anomalous scattering as a method of phasing is still relatively new to
protein crystallography (Hendrickson, 1985a, b), although it has already been used
to analyse complex crystal structures such as that of crambin (Hendrickson and
Teeter, 1981). Although the MAD technique has yet to be used in membrane
diffraction experiments, it would be a possible application for a synthetic
phospholipid such as the bromolipid that has been synthesised and studied during
this thesis. The MAD technique has been made possible by major advances in the
field of X-ray instrumentation, such as the introduction of synchrotron radiation.
Synchrotron radiation is a high intensity source of X-rays, produced in a wide
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spectrum of wavelengths. A desired wavelength for study can be chosen from this
spectrum and tuned onto a sample. Diffraction patterns can be collected from the
same sample at different X-ray wavelengths, the crux of the MAD technique.
X-ray scattering is perturbed through resonance between the electronic
vibrations excited by an incident X-ray wave and the natural oscillations of bound
electrons in atoms. The resulting anomalous scattering includes a phase shift that
makes anomalous scattering centres distinct. The effect increases sharply as the X-
ray energy approaches an atomic absorption edge, although they are also
appreciable throughout the range of wavelengths of interest in X-ray diffraction
experiments for all but the lightest of atoms. Bijvoet (1949) first recognised the
potential of anomalous scattering in structure analysis long before the
instrumentation was available. Conventional diffraction analysis takes scattering by
electrons to be directly proportional to electron density and insensitive to atom type.
Such a description is only adequate for the lightest of elements (e.g. nitrogen or
lighter). In general, resonance between electronic vibrations, induced by the
incident X-rays, and the characteristic frequencies of bound electrons modifies the
diffraction scattering. This change, the 'anomalous' scattering, has two especially
pertinent features: the magnitude of the effect varies with X-ray wavelength, and
each type of atom gives a distinctive response.
For most systems of interest, the diffraction due to anomalous scattering is
very small compared with the total scattering. Effective exploitation of anomalous
diffraction therefore requires precise measurements of small differences between
relatively large values. Thus experimental methods must be designed so that
systematic errors are minimised, Hendrickson (1985a, b). It may be that for
membrane diffraction the sample is too disordered, with the natural thermal and
stacking disorder of a typical sample being too great for such small differences in
diffraction to be measured. Membrane diffraction has the advantage over crystal
diffraction that with each phospholipid unit containing an anomalous scatterer, the
ratio of anomalous scatterers to normal scatterers is much higher, as a typical
phospholipid is much smaller than a typical crystal protein. As MAD is a multi-
wavelength experiment, diffraction data can be collected at either side of a suitable
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atom's absorption edge, thus greatly enhancing the magnitude of the anomalous
scattering effects. Complementary to this, extra phase information is obtained, due
to the experiment having been performed at different wavelengths (Hendrickson,
1985a, b).
MAD experiments have a major advantage over isomorphous replacement
experiments. In a typical isomorphous replacement experiment one might study
several samples, each with increasing amounts, or type, of heavy atom present, and
hope that there is no major structural change around the heavy atom. In the MAD
experiment one need only study a single sample, incorporating a heavy atom.
Throughout the MAD experiment, therefore, there would be no structural
variations whatsoever, as it is the X-ray wavelength and not the sample that is
varied.
The bromolipid that has been synthesised and studied in this thesis appears
to satisfy all predictable requirements for a membrane based MAD experiment to be
successful. It contains an anomalous scatterer, the bromine atom, which sits in a
precise position in the bilayer. The bromine atom was specifically chosen in the
design of a structural isomorph of DPPC, so that MAD experiments might be
possible in the future. Other atoms, such as other halogens, could have sufficed if
the requirement was to have a synthetic phospholipid to use purely in isomorphous
replacement experiments. The bromine K shell electrons have an absorption edge
energy (ca lA X-rays) which can be obtained by existing synchrotron facilities,
such as the SRS at the Daresbury laboratories, Warrington, England (Hendrickson,
1991). There is a natural heavy atom in a phospholipid, the phosphorus atom,
which is an anomalous scatterer. Unfortunately the absorption edges for a
phosphorus atom are not obtainable with modern synchrotron sources, and so a





3.1 X-ray diffraction set-up.
The X-ray diffraction experiments were carried out using a Marconi-Elliot
GX-13 rotating anode X-ray generator (Plates 3.1 and 3.2). The GX-13 accelerates
electrons towards a copper target using a potential difference of up to 70 kilovolts
(kV). A usable X-ray beam was generated by a minimum voltage of 30kV and a
current of 30kA, with higher voltages reducing the exposure time required to
collect a photograph. The X-ray diffraction experiments used the 1.54A (Ka)
wavelength radiation emitted by the copper target. Other wavelengths produced by
a copper target, which make up 15 % of the total beam (mostly copper Kp with a
1.39A wavelength), were removed by passing the beam through nickel foil (Franks
and Levine, 1981).
X-rays were directed into a purpose built sample holder, through mylar
windows (Plate 3.1), using a thin metal tube that collimated the X-rays into a
parallel 0.30mm beam. Diffraction patterns were collected by a stack of X-ray
sensitive films, positioned 175cm behind the sample holder. A small lead backstop
was positioned between the sample holder and film to absorb any undiffracted main
beam X-rays that would otherwise fog the film. Air was evacuated from the main
camera casing during an exposure to reduce noise from air-scattered radiation.
3.1.1 X-ray camera sample holder.
The sample holder was constructed from a metal can which contained mylar
windows. Shelves allowed a bilayer sample, mounted on a curved glass slide, and a
perspex bath to be loaded into the sample holder (Plate 3.2). The salt solution
placed in the perspex bath allowed the humidity of the membrane sample to be
controlled. Around the sample holder were metal tubes that carried water from a
temperature controlled bath. An electronic probe, inserted into a hole in the sample
holder, measured the sample temperature, which over a 24 hour exposure was
maintained to within ±0.5°C of the desired temperature.
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PLATE 3.1 (top) GX-13 X-ray generator and sample camera. X-rays, from the
rotating anode, feed into the camera via a 0.30mm collimator. A tube inserted into
the top of the camera allows a vacuum to be created between the sample holder and
the X-ray sensitive film. Another tube carries water, from a water bath, to allow
the temperature of the sample to be controlled.
PLATE 3.2 (bottom) Camera and sample holder. The camera, taken off its support
mounting, is turned to show how the sample holder fits into the camera. The sample
holder has been opened up to show the position of the water bath under the sample.
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3.2 Collection of X-ray diffraction patterns.
X-ray patterns were collected on multiple packs of 130x180 mm and
130x90mm Agfa-Gevaert Osray film. A stack of films were used so that all orders
of diffraction could be recorded in an unsaturated form. Relating all the diffraction
orders to each other requires an overlap of unsaturated intensity spots on
consecutive films in the stack, i.e. the same unsaturated order on sequential pieces
of film so that a scaling factor between films can be estimated. Four to six films
were typically used in a pack, depending on the predicted number of diffraction
orders and the likely intensity ratio of strongest to weakest order.
Collecting the whole diffraction pattern on one stack of film was not always
feasible during a single exposure. The length of exposure required to collect weak
outer orders often resulted the first order being saturated, or fogged by background
noise, on all films in the stack. Separate short exposures onto a few pieces of film,
typically for 5 to 20 minutes depending on sample and power of X-ray generator,
were therefore regularly used to collect the lower (1-4) diffraction orders.
3.2.1 X-ray film analysis.
Diffraction photographs were scanned on a Joyce Loebl Chromoscan 3
microdensitometer. Scanning involved positioning the film on a glass surface which
then allowed each diffraction order to be passed through a light beam. The ability
of the light beam to penetrate through the X-ray film provides a measure of the
darkness of the film. As the light beam passes through the centre of each diffraction
spot, a record is obtained of the position and intensity of each meridional order.
The scan peaks were background corrected by constructing a baseline under each
peak, using the Chromoscan 3 microdensitometer software, which also calculated
the integral of each peak. Any saturated peaks were ignored, with the data for that
order coming from other films in the film stack.
The intensity data for each humidity were then scaled to one another using
equation 2.25 (Blaurock, 1973). The Lorentz factor was then used to correct each
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order for the spreading of intensity in reciprocal space and the sampling of peaks by
the Ewald sphere. This factor multiplies each order by sin(20h), where 0 is the
Bragg angle and h the order of diffraction. A further correction is then applied for
absorption of the incident and diffracted beams by the lipid film (Franks and Leib,
1979). The square root of each corrected intensity value gives the structure factor
amplitude value. The phase of the calculated amplitude is, however, unknown and
must be deduced using techniques such as the swelling series method.
3.3 Phase assignment using the swelling series method.
X-ray diffraction patterns obtained during the course of this thesis have been
analysed using the swelling series method, which involves collecting diffraction
patterns from the same membrane sample at different humidities. The basis of the
swelling series phase assignment method is to analyse changes that occur in
diffraction patterns with increasing humidity. Whilst the bilayer thickness at each
humidity can be calculated without phase information (Bragg's Law; equation 2.2),
further diffraction analysis requires phases to be assigned to the data.
A swelling series plot aims to reconstruct the form of a continuous Fourier
transform, by plotting each diffraction amplitude against (h/D), where h is the order
number and D the bilayer thickness. Swelling series data are phased by judging the
goodness of fit of the reconstructed continuous Fourier transform through the
putatively phased data points. The electron density maps, constructed using the
putative phase assignments, are then inspected. Phase assignments that result in the
construction of electron density maps incompatible with the accepted bilayer
structure are rejected (Franks and Leib, 1981).
3.4 Assessment of errors in the swelling series data.
Many errors can combine during experimentation to affect the accuracy of
the final product of the swelling series method, the bilayer electron density map.
The assessment of these errors is discussed below.
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3.4.1 The Monte Carlo simulation method of estimating confidence limits for the
bilayer electron density distribution.
The uncertainty in electron density map distributions can be determined by
the Monte Carlo sampling procedure (Press et al., 1989), using each structure
factor amplitude and an associated error level to define a normal distribution of the
structure factor (Wiener and White, 1991). The upper and lower 95% confidence
limits of the electron density distribution are generated and stored during the Monte
Carlo simulation process. Sets of mock diffraction data are repeatedly generated, by
random sampling from the structure factor normal distributions, and used to
construct electron density maps, typically for 1000 cycles. During each cycle, if the
latest calculated electron density value lies outwith (either maximum or minimum) a
previous value then the new value is stored in its place. Figures 3.2 and 3.3 depict
the 95% confidence limits for the electron density distribution of bromolipid and
DOPC bilayers respectively calculated using a Monte Carlo simulation program.
3.4.2 Accuracy of data collected from X-ray film scanning.
X-ray diffraction patterns collected on film were scanned manually, using a
Chromoscan 3 microdensitometer. There are systematic errors associated with the
scanning method, namely:
1) The film must be aligned by hand so that, when the glass table moves, the light
beam passes through the centre of all spots on the film. In practice, lining up
films accurately is difficult as, especially on a film with twelve diffraction spots,
minimal error can result in the centre of extreme orders being missed. The
alignment error acts to reduce the measured size of a spot and may result in the
existence of a weak spot being missed altogether.
2) As X-ray diffraction pattern spots from membranes tend to be arced in shape,
the finite sized scanning beam of light may not capture the whole of some
diffraction spots. Thus, some spots may register as being smaller than they
really are. This error can be avoided by using the next film in the film stack.
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3) Many intensity spots on the X-ray films are overexposed, i.e. the X-ray film has
been blackened non-linearly, so that the intensity spots appear smaller than
reality. Care had therefore to be taken so that these over-saturated intensity
spots were discarded.
A single film was repeatedly scanned to assess the accuracy of the scanning
process. A film, taken from a 1:1 (DPPC:bromolipid) mixture sample at 20°C and
57% RH, with eleven orders of diffraction was scanned fifteen times. Between each
scan reading, the film was taken out and then realigned in the microdensitometer
the machine. The results (Table 3.1) illustrate the variation observed in each of
unsaturated orders of the X-ray film being scanned. Using the same scan data, the
bilayer repeat distance was also estimated fifteen times and was shown to be 56.55A
+0.06A (SD). The level of error in the electron density distribution, as a result of
film scanning errors, has been estimated for the 1:1 (DPPC:bromolipid) mixture
sample (Figure 3.1) using a Monte Carlo simulation program and an intensity data
standard deviation error estimate of 6% for all twelve orders of diffraction. The
95% confidence limits were calculated to be displaced approximately ±0.5 relative
units from the central 1:1 mixture electron density distribution.
Table 3.1 Results of scanning a single film fifteen times to assess the reproducibility
of the scanning process (film scanned was used to collect data from 1:1
(DPPC:bromolipid) mixture bilayers at 20°C and 57% RH).
Unsaturated Average spot Standard Percentage
diffraction orders intensity from 15 deviation (SD) of SD
scans (Absorbence) spot intensity
2 0.172 0.011 6%
5 0.157 0.005 3%
6 0.304 0.007 2%
8 0.164 0.010 6%
9 0.124 0.005 4%
11 0.079 0.010 12%
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3.4.3 Reproducibility of bilayer sample preparation, data collection and analysis.
Diffraction patterns were collected out to four orders from five separate
oriented samples of DOPC at 20°C and 57% RH. After film scanning and analysing
each sample separately, the five sets of data were then averaged and variations in
the diffraction data assessed (Table 3.2). The average electron density map of
DOPC, at 20°C and 57% RH, has been calculated (Figure 3.2), as have the DOPC
electron density distribution confidence limits, using the diffraction order accuracy
values (SD) in a Monte Carlo simulation program.
Table 3.2 Diffraction data collected from five oriented DOPC bilayer samples at
20°C and 57% RH.














± SD ( + %)
1 0.180 0.183 0.173 0.182 0.181 0.180+0.004
(+2%)
2 0.069 0.066 0.071 0.069 0.074 0.070+0.003
(±4%)
3 0.073 0.068 0.094 0.070 0.073 0.075+0.011
(±15%)





51.9±0.2 52.110.2 52.3+0.2 52.2±0.1 51.8±0.1 52.1+0.2
The 95 % confidence limits of the bilayer electron density distribution show
that large variations are possible in the bilayer profiles as a result of the diffraction
intensity data accuracy limits (Figure 3.2). The measured DOPC bilayer thickness
varied between 51.8 ±0.lA and 52.3 ±0.2A, where the variation in bilayer
thickness between 'identical' samples was greater than the accuracy with which a
single sample's bilayer thickness could be measured from the film stack data. The
five sets of diffraction data plot as a swelling series (Figure 3.3), indicating a
correlation between variations in bilayer thickness and the measured diffraction
intensity of each order, the basis of phasing by the swelling series method. The
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DISTANCE ACROSS THE BILAYER (A)
Figure 3.1 The average position and 95% confidence limits for the
electron density distribution of bromolipid bilayers (one half of
bilayer shown). X-ray diffraction data were collected from oriented
membrane samples at 20°C and 90% RH and phased using the
swelling series method. The bromolipid electron density map, above,
was constructed using twelve orders of diffraction. The 95%
confidence limits for the electron density distribution were calculated
using a Monte Carlo simulation program and a structure factor
amplitude error limit of 6% (SD). The bromolipid phosphate
headgroup, ester linkages and centre of the lipid layer can be located
at 21A, 17A and OA respectively. The 95% confidence limits,
displaced approximately ±0.05 relative units from the central
electron density distribution, were created to assess the level of
uncertainty introduced into bilayer profiles by the accuracy with
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DISTANCE ACROSS THE BILAYER (A)
Figure 3.2 One half of the electron density map of DOPC bilayers at
20°C and 57% RH. Four orders of diffraction data were collected
from five separate DOPC samples and used to create an averaged
electron density map (above). The 95% confidence limits for the
DOPC electron density distribution were calculated using a Monte
Carlo simulation program. The centre of the water layer, the DOPC
phosphate headgroup, and the centre of the lipid layer can be located
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Figure 3.3 A swelling series plot of the diffraction data collected
from five oriented DOPC bilayer samples at 20°C and 57% RH.
Variations in structure factor amplitude and bilayer thickness data
were measured between the five DOPC samples. The swelling series
method works on the premise that changing the sample humidity
allows the continuous Fourier transform to be sampled at multiple
points. The plot, above, suggests that the structure factor amplitude
data varies with the bilayer thickness (i.e. the '51%' RH sample
humidity actually varies), rather than as a result of random noise
acting on the data.
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relationship suggests that variations in the measured intensity between samples may
be a result of variation in the hydration state and therefore structure of the bilayer.
The ability to obtain data from a bilayer sample may, therefore, be better than that
suggested by the 'error levels' quoted in Table 3.2.
Variations observed in the structure factor data collected from a membrane
sample (Table 3.2) may be introduced by variations in the hydration state of that
sample (Figure 3.3). The difference in bilayer thickness of DOPC based bilayers at
20°C, between 98% and 57% RH, has been measured as 2.7A (Chapter 4, Tables
4.1, 4.2 and 4.3). The variation in bilayer thickness of 0.5A, found in the five
DOPC samples, might then represent a random variation in humidity about 57% of
((98-57/2.7)*0.5= 8% RH) i.e. 57% RH ± 4%. This sample humidity error is
additive upon the error with which diffraction data can be recorded on film and
must be considered when comparing bilayer structures i.e. bilayers with and
without a drug present. Failure to take into account variations in sample hydration
could result in the conclusion that the systems under study differ significantly, when
in fact they only differ in their hydration states.
3.5 Preparation of oriented multilayer samples for X-ray diffraction experiments.
X-ray diffraction experiments have been performed exclusively on oriented
stacked bilayer samples. The membrane systems studied during this thesis include:
1) Pure phospholipid systems (DOPC, DPPC and bromolipid)
2) Mixed phospholipid systems (DPPC:bromolipid mixtures of varying ratios)
3) Phospholipid systems incorporating small molecules (DOPC+amantadine FB and
HC1).
The preparation of oriented membrane samples required the phospholipids,
phospholipid mixtures and phospholipid/drugs to be dissolved and mixed together as
chloroform solutions. The chloroform solutions were then pipetted onto glass slides.
As the chloroform evaporates, multilayer samples spontaneously form on the glass
surface. The sample preparation process is described below.
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3.5.1 Preparation of DOPC and DOPC+5% (mol) amantadine solutions in
chloroform.
DOPC in chloroform (20mg/ml), amantadine hydrochloride (HC1) and
amantadine free base (FB) were all purchased from Sigma Chemical Company Ltd,
Fancy Road, Poole, UK. DOPC was used without further preparation in diffraction
experiments. Five molar percent amantadine (FB and HC1) in DOPC samples were
prepared by weighing out and dissolving amantadine in chloroform, which was then
mixed with DOPC in chloroform.
3.5.2 Preparation of DPPC and bromolipid solutions in chloroform.
DPPC was ordered from the Sigma Chemical Company Ltd, Poole, UK., in
a crystalline form. Solutions (20mg/ml) of DPPC were prepared by dissolving the
phospholipid in chloroform. The bromolipid was synthesised at Shell Research
Centre, Sittingbourne, Kent, under the guidance of Dr. M. R. Alecio and stored as
a (20 mg/ml) chloroform solution, under nitrogen and at -70°C. Samples requiring
mixtures of bromolipid and DPPC were prepared by mixing measured chloroform
solutions and vortexing.
Figure 3.4 The structures of amantadine freebase (FB) and hydrochloride (HC1).
NH2 NH3+CI-
a) Amantadine Freebase (FB) b) Amantadine Hydrochloride (HC1)
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3.5.3 Preparation of multilayer samples.
Solutions of phospholipids in chloroform were slowly pipetted onto a clean
glass slide, made from a tube of 20 mm radius, that had a surface area of 1cm2. The
chloroform was then slowly evaporated off, using a stream of nitrogen. Samples
were then placed in a vacuum, for at least two hours, to remove any further traces
of chloroform. The samples were then rehydrated, by placing the glass slides over
water in a glass dessicator, at 80 °C for two hours.
The slowly cooled sample was then transferred from the dessicator to the X-
ray camera sample holder. Into this environmental cell was then placed a perspex
bath, loaded with the appropriate salt solution for the relative humidity required.
Saturated salt solutions used were ZnSCti, KC1, NaCl, and NaBr, these giving
relative humidities of 90%, 81%, 74%, and 57% respectively (Handbook of
Chemistry and Physics, 1986-1987). In addition, water produces a 98% RH.
3.6 Differential scanning calorimetry (DSC) of membrane samples.
The principle of DSC is given by Steim (1974). A sample pan and a
reference pan having similar heat capacities are simultaneously heated at identical
rates. Each sample pan has a temperature sensor and heating element so that the
temperature of both pans can be identically matched i.e. the temperature differential
between the pans is always maintained at zero. The difference in power input,
necessary to keep the heating rates of both the sample and reference pans the same,
is recorded during the experiment, producing a plot of differential heating rate
against temperature.
When the sample and reference pans are precisely matched thermally over a
temperature range, the recorder traces a straight baseline at zero differential power
input. If a thermal event in the sample pan is not shared by the reference pan then
the heat requirements of the two are different, and the recorder pen is deflected
from the baseline. The direction of the deflection is dependent upon whether the
event was endothermic or exothermic. When the thermal event is completed, the
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pen returns to the baseline and a peak will have been traced whose position on the
temperature scale indicates the temperature of the event and whose area is a direct
measurement of the enthalpy of the event (Steim, 1974).
The thermal events measured in biological membrane calorimetric studies,
such as bilayer transitions, are often broad, ill defined and not very energetic. Also,
the unavoidably large amount of water in biological systems limits the mass of
sample that can be placed in a calorimeter pan and so the heat change cannot be
greatly improved by increasing the size of the sample. A DSC experiment is
expensive with respect to the amount of lipid consumed, usually using 7-8mg of
lipid per sample prepared, which compares unfavourably with the 2mg of lipid that
can generate a swelling series data set in X-ray diffraction experiments.
3.6.1 Materials and methods for the DSC experiments.
As per the diffraction experiments, DPPC was obtained from the Sigma
Chemical Company Ltd, Poole, UK., in a crystalline form. The bromolipid was
synthesised at Shell Research Centre, Sittingbourne, Kent, under the guidance of
Dr. M. R. Alecio and stored as a (20mg/ml) chloroform solution, under nitrogen
and at -70°C. Samples requiring mixtures of bromolipid and DPPC were prepared
by mixing measured chloroform solutions and vortexing.
Chloroform solutions of DPPC, Bromolipid and 1:1 (DPPC:bromolipid)
mixtures were first dried down in a rotary evaporator. The phospholipid samples
were then washed twice with acetone and dried down in a rotary evaporator to a
solid. The dry sample was then placed in a platinum pan and the total mass of lipid
weighed using a four point balance. Water (5.7pl water/mg) was injected by
syringe into the pan containing the dried lipid sample. A reference pan containing
only water was also prepared for the experiments. Pan lids were sealed onto the
sample pans by cold welding using a Perkin Elmer sealing press. As the sample
pans had to accommodate at least 5mg of dry phospholipid sample plus the water of
hydration, to get a large enough signal, 50pl volume sample pans were used. To
keep the pans clean, all sample pan operations were performed using tweezers.
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Samples were loaded into a Perkin Elmer DSC 7 machine with a Perkin
Elmer Tac 7/7 instrument controller. Samples were then cycled, typically from
10°C to 70°C, to anneal and homogenise the sample. The sample was then allowed
to equilibrate at 10°C for 30 minutes before an experimental run from 10°C to
70°C was recorded.
3.7 Synthesis of the bromolipid.
The bromolipid was synthesised and purified at the Shell Research Centre,
Sittingbourne, Kent, under the guidance of Dr. M. R. Alecio. Sn-l palmitoyl,
lysophosphatidylcholine and pentadecanolide were both purchased from the Sigma
Chemical Company Ltd., Poole, England, and stored at -70°C. Hydrogen
bromide, in a 30% (wt/vol) solution of acetic acid was purchased from the Aldrich
Chemical Company Ltd., New Road, Gillingham, Dorset, England. The synthesis
of the bromolipid (Figure 3.5) can be broken down into the following stages:
a) Preparation of a bromoacid.
The starting products of the bromolipid are 15-pentadecanolide (15-hydroxy-
pentadecanoic acid lactone), hydrogen bromide and lysophosphatidylcholine. The
first stage of the synthesis is to use the lactone and hydrogen bromide to make a
bromoacid. Lactone (2g) was dissolved, with warming, in glacial acetic acid (ca
2ml), before being cooled and added to a hydrogen bromide solution (10ml of 30%
(wt) solution in acetic acid). The solution was then stoppered and stored for 48
hours. The mass of crystals that formed during this period were suspended in cold
water, to wash out unreacted reagents. The crystals were then collected in a filter
and washed with more water, before being recrystallised in methanol, at low
temperature (5-10°C), and dried in a vacuum over phosphorus pentoxide overnight.
b) Preparation of the symmetrical bromoacid anhydride.
The symmetric bromoacid anhydride was prepared by following the method
of Selinger and Lapidot (1966). All equipment and reagents had to be water-free









React with sn-1 palmitoyl-lyso-
phosphatidylcholine, with
y pyrrolidinopyridine as catalyst
Forms bromolipid, an analogue of DPPC where the terminal
methyl group of the sn-2 palmitoyl chain is exchanged for a
bromine atom.
Figure 3.5 The synthesis of the novel bromolipid, a structural analogue of
DPPC. A bromoacid is formed by the opening of a lactone ring. A bromolipid
is then formed by reacting the bromoacid anhydride with a lyso-
phosphatidylcholine.
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phosphorus pentoxide overnight and all glassware and syringes to be used were
washed with acetone and oven dried. The synthesised bromoacid (2.2g) was
dissolved in chloroform, as was 0.7g of DCCI (N,N'-Dicyclocarbohexylcarbo-
diimide). The bromoacid and DCCI solutions were then mixed together in a
sealed flask and stirred overnight at room temperature. Excess DCCI and
solvents were filtered off and the remaining crystals recrystallised twice from
acetone to give 1.4g of crystals,
c) Coupling of the symmetric bromoacid anhydride and lysophosphatidylcholine to
form the bromolipid.
The symmetric bromoacid anhydride was coupled to lysophosphatidylcholine
to form the bromolipid, using the method of Mason et al., (1981). As in the
previous stage of the synthesis all equipment and reagents were ensured to be
water free. Lysophosphatidylcholine was dried, in a vacuum over phosphorus
pentoxide, then suspended in dried chloroform. The symmetrical anhydride was
similarly treated, before being injected into the lysophosphatidylcholine
suspension. Finally, 4-pyrrolidinopyridine (75mg in 1ml of chloroform) was
injected into the suspension, to act as a catalyst. The suspension was then stirred
for 4 hours at a constant temperature of 35°C. Towards the end of the 4 hours,
all the precipitate dissolved to give a clear yellow solution of bromolipid.
To the clear yellow bromolipid solution was added chloroform (12ml). The
solution was then poured into a separating funnel, to which was then added
methanol (6ml), water (4.5ml), and concentrated hydrochloric acid (4.5ml). The
funnel was then shaken and the upper organic layer extracted, with more
chloroform. The extract was then rotary-evaporated at room temperature to
dryness, producing a white, semi-solid residue (bromolipid).
The bromolipid was then purified using an open column chromatography
method. The bromolipid was applied to the top of a silica gel column, and
washed with a chloroform/methanol/ammonium hydroxide (200/15/1) mixture.
This mixture ratio was then gradually changed to a 65/15/1 mixture, to wash the
bromolipid. Finally, switching the wash mixture to 65/35/5 eluted the purified
60
bromolipid. The bromolipid was again rotary-evaporated to dryness, before
being stored as a 20mg/ml solution in chloroform, at -70°C.
3.8 Thin-layer chromatography (TLC) of the bromolipid.
Thin-layer chromatography of lipids employs two different immiscible
phases, making use of the fact that solutes in the liquid organic phase will have
differing affinities for the hydrophilic solid phase. Thus, as the liquid phase runs
through the solid gel, different lipids will be retained to different extents by the gel,
and will spread out at different distances behind the solvent front. The mobile phase
can be made either more or less hydrophilic (e.g. by variation of the quantity of
polar solvents, such as methanol in chloroform, or by the addition of water),
altering the partition coefficient of solutes between the two phases. For
phospholipids, the most commonly used stationary phase is silica gel, which is
moderately hygroscopic, and consists of granules which under normal conditions
are surface coated with a layer of tightly-bound water. The mobile phase is usually
a mixture of solvents including chloroform (New, 1990).
At the end of the chromatography run, lipids are visualised by either specific
stains, which are sprayed on to the plate, or by non-specific stains, using methods
such as charring, or iodine uptake. TLC can give information about the purity of a
lipid sample, as a compound that is pure should run to a single spot. Phospholipids
which have undergone degradation can be observed as a long smear with a tail
trailing to the origin.
3.8.1 Materials and methods for the TLC experiments.
Silica gel TLC plates, a molybdenum blue spray reagent and DPPC were
bought from the Sigma Chemical Company Ltd, Fancy Road, Poole, UK. Solid
DPPC was dissolved in chloroform to a form 20mg/ml solution, to be spotted onto
a TLC plate. The bromolipid was stored as a 20mg/ml solution in chloroform after
its synthesis, and so needed no further preparation. A TLC solvent mixture of
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freshly made chloroform:methanol:water:ammonium hydroxide (65:35:2.5:2.5 v/v)
was used in the TLC experiments. Chloroform (65ml) was mixed thoroughly with
methanol (35ml), ammonium hydroxide (2.5ml) and distilled water (2.5ml), in a
glass cylinder before use.
A TLC chromatography tank was lined with a Whatman No. 1 filter paper
sheet and filled with the solvent mixture. The tank was then sealed and left to
equilibrate for two hours. DPPC and bromolipid, 5pl, 8pl and 10pl of each
20mg/ml sample, were spotted 2.5cm from the lower edge of a TLC plate and
allowed to dry. The TLC plate was then placed into the tank and covered. The
solvent was allowed to ascend to within 3-4cm of the top of the plate, before the
plate was removed from the tank. The solvent front was then marked with a pencil
and the plate air-dried in a fume cupboard.
Two lipid visualisation methods were used.
1) The molybdenum blue reagent spray stains phosphate containing compounds.
The TLC plate was sprayed evenly with molybdenum blue spray, using a back
and forth motion across the entire plate. Care was taken to avoid saturating the
plate. The plate was then air dried in a fiime cupboard for 10 minutes, before
the results were recorded.
2) The uptake of iodine is a method which stains for general lipids. Approximately
lOg of solid iodine crystals were sprinkled on the bottom of a glass tank. The
dry TLC plate was then left in the closed tank for 1 hour, to allow the uptake of
iodine, before the results were recorded.
3.8.2 Results of TLC
TLC chromatograms of the bromolipid and DPPC have been obtained. The
aim of the chromatography experiments were to:
1) check that a pure phospholipid species (the bromolipid) has been synthesised and
purified;
2) show that neither the bromolipid nor the DPPC were contaminated with
impurities or breakdown products;
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3) test that the bromolipid and DPPC have similar hydrophilic/hydrophobic
affinities, as measured by their Rf values for the chromatography system used.
Plates 3.3 and 3.4 show the chromatograms recorded by staining the TLC
plates with molybdenum blue and iodine respectively. The Rf values for each lipid
have been measured directly from the TLC plates (Table 3.3).
Table 3.3 The Rf values, measured from TLC plates stained with either









0.40 ±0.01 0.38 ±0.03
Both bromolipid and DPPC produced single spots on the TLC plates (Plates
3.3 and 3.4). Staining the plates using either molybdenum blue or iodine located the
phospholipids in the same positions. The lipid groups (iodine) and the phospholipid
phosphate groups (molybdenum blue) are therefore located at the same position on
the plates. Both of the phospholipids therefore appear to be single, pure species that
have not degraded. Unknown phospholipids (such as the bromolipid) are often run
against standards. As the bromolipid appears to perform identically to DPPC in the
TLC experiments, it has not been necessary to run any other standards on the
plates.
3.9 Mass spectroscopy.
In the classical mass spectrometer, molecules are bombarded with a beam of
energetic electrons. The molecules are ionised and broken up into many fragments,
some of which are positive ions (Chapman, 1993). Each kind of ion has a particular
ratio of mass to charge, or m/e value. For most ions, the charge is 1, so that m/e is
63
simply the mass of the ion. The mass spectrum obtained from a compound is highly
characteristic of that compound. The mass spectrum can help to establish the
structure of a compound by either giving a molecular weight for the compound or
by indicating the presence of a molecule made up of certain structural units.
There are additional methods, to an electron beam, of ionising the molecules
under study (Rose and Johnstone, 1982). A beam of ions such as Xe+ (xenon) can
be produced by ionising xenon atoms and accelerating the resulting ions through an
electric field. The resulting (fast) ions are directed through a xenon gas chamber
where charge exchange occurs to give fast atoms,
Xe+ (fast) + Xe (thermal) -> Xe (fast) + Xe+(thermal)
Excess of fast Xe ions can be deflected leaving a beam of fast atoms.
When such beams of fast atoms impinge onto (bombard) a metal plate coated
with a sample of the substance being investigated, the large amounts of kinetic
energy in the atoms is dissipated in various ways, some of which lead to
volatilisation and ionisation of the sample. By maintaining a suitable electric
gradient from the plate, either positive or negative ions can be directed into the
analyser of the mass spectrometer. This technique is known as fast atom
bombardment (FAB). Usually best results are obtained by coating the plate with a
relatively involatile polar liquid such as glycerol and mixing the substance under
investigation into the glycerol. Due to the nature of FAB, the technique is especially
useful for studying thermally unstable compounds.
3.9.1 Mass (FAB) spectra of the bromolipid.
An MAT90 mass spectrometer machine, using the (Xe) FAB method, was
used to collect a mass spectrum of the bromolipid (Figure 3.6). Glycerol was used
to coat the metal sample plate. The sample was bombarded with atoms of energy
8.0kEv using a gun current of 2.0ma. Positive ions, produced by the bombardment
method, were directed into the mass spectrometer analyser.
The bromolipid mass spectrum has a base peak at 184.1 m/e, whose
intensity was set to 100 for reference. Two other major peaks were also recorded,
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at 798.7 and 86.1 m/e (Table 3.4). The presence of the peak at 798.7 confirms that
the anticipated bromolipid (Figure 3.6) has been synthesised. The base peak, at
184.1 m/e, confirms that the bromolipid has a phosphatidylcholine headgroup, with
the peak at 86.1 m/e (choline) further supporting this conclusion. The mass
spectroscopy results, therefore, are consistent with the conclusion that the
bromolipid (1-palmitoyl, 2-n-pentadeca-15-bromo-1s,n-glycero-3-phosphocholine) has
been synthesised. I would like to acknowledge the help that was received from Mr
T. Beer and Shell Research, Sittingbourne, Kent in collecting the Mass spectrum of
the bromolipid.
Table 3.4 Mass (FAB) spectrum results for the bromolipid.
M/e peak position molecular assignment
86.1 CH2=CH.N(CH3)3 +
184.1 0.0H.P=0.0.(CH2)2. N(CH3)3+
798.7 Positive ion bromolipid
3.10 Nuclear magnetic resonance (NMR) of phospholipids.
Nuclear magnetic resonance (NMR) can be used to elucidate the atomic
structure of molecules and can also provide conformational information about the
structure. The NMR technique is therefore very useful for testing the structure of
newly synthesised molecules. NMR occurs as a result of the interaction of a static
magnetic field with a nucleus possessing a magnetic moment. Only particles with
both an electric charge and a spin angular momentum, such as the proton (]H), and
isotopes of carbon and phosphorus (13C and 31P), have a magnetic moment.
For example, if a proton is placed in an external magnetic field, its magnetic
moment can be aligned either with or against the external field. Alignment with the
field is the more stable, and energy must be absorbed to 'flip' the tiny proton
magnet over to the less stable alignment, against the field. It is the measurement of
this absorption of energy as the nuclei flips between states that is the basis of the
NMR experiment. The frequency at which a proton absorbs energy depends on the
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Plate 3.3 Analysis of DPPC and the bromolipid by TLC, using a molybdenum blue
stain. A TLC chromatography tank was lined with a Whatman No. 1 filter paper
sheet and filled with freshly prepared chloroform:methanol:water:ammonium
hydroxide (65:35:2.5:2.5 v/v). The TLC plate was spotted with three different
quantities of DPPC and bromolipid. Lanes 1, 3 and 5 were loaded with 5pl, 8pl
and lOpl, respectively, of 20mg/ml bromolipid in chloroform and lanes 2, 4 and 6
were loaded with 5pl, 8pl and lOpl, respectively, of 20mg/ml DPPC in
chloroform. The molybdenum blue reagent spray was used to visualise any
phosphate containing compounds that might be present on the plate. The bromolipid
and DPPC samples produced single spots on the TLC plate, suggesting a single
species to be present in each sample. The two phospholipids also had a similar Rf
value, suggesting that a bromolipid, similar to DPPC has indeed been synthesised.
66
Plate 3.4 Analysis of DPPC and the bromolipid by TLC, using the iodine method of
staining. A TLC chromatography tank was lined with a Whatman No. 1 filter paper
sheet and filled with freshly prepared chloroform:methanol:water:ammonium
hydroxide (65:35:2.5:2.5 v/v). The TLC plate was spotted with three different
quantities of bromolipid and DPPC. Lanes 1, 3 and 5 were loaded with 5pl, 8pl
and lOpl, respectively, of 20mg/ml bromolipid in chloroform and lanes 2, 4 and 6
were loaded with 5pi, 8pi and lOpl, respectively, of 20mg/ml DPPC in
chloroform. The iodine uptake method was used to visualise any lipids in general
that might be present on the plate. The bromolipid and DPPC samples produced
single spots on the TLC plate, suggesting a single species to be present in each
sample. The two phospholipids also had a similar Rf value, suggesting that a
bromolipid, similar to DPPC has indeed been synthesised.
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magnetic field local to the proton, which is dependent not only on the
experimentally applied external field but also the local environment of the proton.
Each proton, or set of equivalent protons, in a structure has a slightly different
electronic environment from every other set of protons, absorbing energy at a
slightly different frequency.
The result of a proton NMR experiment is a spectrum showing many
absorption peaks, whose relative position reflect the differences in the electronic
environment of each of the protons. Differences between protons are measured as
chemical shifts, expressed in parts per million (ppm) of the total applied field. The
most commonly used scale is the 5 (delta) scale, whose origin is marked by the
tetramethylsilane ((CHb^Si) NMR peak. Chemical shifts previously assigned to
components of dilauroyl-lecithin (Table 3.5, from Hauser et al., 1975) indicate the
relationship between the electron environment and chemical shift. Electronegative
groups neighbouring a proton, for example, increase the chemical shift of that
proton. The area under each NMR signal indicates, relative to other peaks, the
number of equivalent protons giving rise to that peak. Areas under NMR signals are
measured by an electronic integrator, and are usually given on the spectrum chart in
the form of a stepped curve, whose heights are proportional to the peak areas.
NMR spectra are typically complicated by a process known as spin-spin
coupling, that splits the observed spectrum peaks into multiple peaks (multiplet).
Splitting reflects the environment of the absorbing protons, with respect to other
nearby protons. The distance between the peaks in a multiplet is a measure of the
effectiveness of the spin-spin coupling, and is called the coupling constant (J). Spin-
spin coupling is only observed between non-equivalent neighbouring protons. A
secondary proton with a neighbouring tertiary proton at a particular instant will
have its chemical shift slightly increased or decreased, depending on the orientation
of the neighbouring proton's magnetic moment. On average, half of the molecules
protons will be shifted upfield and half downfield, splitting the spectrum peak in
two, forming a doublet. Similarly a proton with two neighbouring tertiary protons
can have its NMR peak split into a triplet and in general, a set of n equivalent
protons will split an NMR signal into n+1 peaks. Many atomic structures can split
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the NMR signal into even more complex signals, such as pentets and double
doublets.
Table 3.5 Chemical shifts of selected components of dilauroyl lecithin in CDCh















3.10.1 NMR of DPPC and bromolipid.
Samples were prepared by dissolving approximately lOmg of phospholipid
in deuterated chloroform (CDCb). NMR ('H) spectra of the bromolipid and DPPC
in CDCb were taken on a General Electrics QE-300 machine and then analysed
(Tables 3.6 and 3.7). The spectral peak chemical shifts and proton assignments
compare well with those previously assigned to phospholipids (Table 3.5, from
Hauser et al., 1975). DPPC and bromolipid share many of the 'H NMR spectrum
features, due to protons remote from, and therefore unaffected by, the sn-2 chain
bromine atom. The DPPC and bromolipid headgroup, glycerol backbone, sn-1
chain and the sn-2 chain methylene groups from C(2) to C(12), protons all give rise
to similar peaks in the 'H NMR spectrum. Compared with DPPC, bromolipid lacks
a proton signal from the sn-2 terminal methyl group (3 rather than 6 protons make
up the peak at 0.85 ppm, as it has been exchanged for the bromine atom. The
electronegativity of the bromine atom also alters the NMR peaks of protons attached
to the sn-2, C(13) to C(15), palmitoyl carbons. The closer the protons are to the
bromine atom, the greater are they chemically shifted by the increased electron
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negative environment created by the bromine atom. At the extreme, the methylene
protons on the carbon adjacent to the bromine atom, are shifted from 1.2 ppm
(DPPC methylenes) to 3.4 ppm. The analysis of the 'H NMR spectrum indicates
that the bromolipid, whose structure is described in Figure 3.5, has indeed been
synthesised. I would like to acknowledge the help of Dr R. Alecio and Shell
Research that was received in obtaining the DPPC and bromolipid NMR spectra.
Table 3.6 'H NMR chemical shifts of DPPC in CDCb
Chemical Shift Peak shape Number Proton position in
of protons molecule
0.85 Triplet 6 (CH3).(CH2)l2.(CH2)2
1.2 Broad singlet 48 CH3.(CH2)l2.(CH2)2
1.55 Multiplet 4 O.CO.CH2.CH2
2.25 Multiplet 4 O.CO.CH2.CH2
3.3 Broad singlet 9 N+.(CH3)3
3.7 Broad singlet 2 P.O.CH2.CH2.N+.(CH3)3
3.9 Multiplet 2 CH.CH2.0.P
4.1 Double doublet 1 CH2.0.CO.R
(J= 7.5, 12.5)
4.25 Broad singlet 2 P.O.CH2.CH2.N+.(CH3)3
4.35 Double doublet 1 CH2.0.CO.R
(J- 2.5, 12.5)
5.2 Multiplet 1 CH.O.CO.R
7.25 Singlet Chloroform contaminant
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Table 3.7 'H NMR chemical shifts of bromolipid in CDCb
Chemical Shift Peak shape Number of Proton position in
protons molecule
0.85 Triplet 3 CH3. (CH2) 12
1.25 Broad singlet 42 CH3.(CH2)l2.(CH2)2,
Br.(CH2)3.(CH2)9.(CH2)2
1.4 Multiplet 2 CH2.CH2.CH2.Br
1.55 Multiplet 4 O.CO.CH2.CH2
1.85 Pentet 2 CH2.CH2.CH2.Br
2.25 Multiplet 4 O.CO.CH2.CH2
3.3 Broad singlet 9 N+.(CH3)3.
3.4 Triplet 2 CH2.CH2.(CH2) .Br
3.75 Broad singlet 2 P.O.CH2.CH2.N+.(CH3)3
3.9 Multiplet 2 CH.CH2.O.P
4.1 Double doublet 1 CH.CH2.O.CO.R
(J= 7.5, 12.5)
4.25 Broad singlet 2 P.O.CH2.CH2.N+.(CH3)3
4.35 Double doublet 1 CH.CH2.0.CO.R
(J= 2.5, 12.5)
5.2 Multiplet 1 CH.O.CO.R
7.25 Singlet Chloroform contaminant
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Figure 3.7 Proton 'H NMR spectra of DPPC (top) and bromolipid (bottom).
Differences between the two are due to the electro-negativity effect the bromine
atom has on nearby methylene protons. Samples were prepared by dissolving
approximately lOmg of phospholipid in deuterated chloroform (CDCb). NMR (1H)




A study of fluid phase DOPC and
DOPC plus amantadine (FB and HC1) bilayers
by X-ray diffraction and the swelling series method.
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4.1 Aim of studying the interaction of amantadine with DOPC bilayers.
Amantadine is a small drug molecule used in the treatment of influenza and
Parkinson's disease (Oxford and Galbraith, 1980; Obeso and Martinez-Lage, 1987;
Gilman et al., 1990). The aim of this work was to study the interaction of two
different charge states of amantadine with DOPC bilayers by X-ray diffraction,
using the swelling series phase assignment method. There were several reasons
behind the study of the DOPC-amantadine system:
1) To model studies of the small amphipathic molecule with fluid bilayers.
2) To study the effect of molecular charge on the lipid-drug interaction.
3) To evaluate the swelling series phasing method.
4,2 Background of amantadine.
A major component in the prevention and control of influenza is the use of
killed influenza vaccines, which may give protection from infection for over a year
(Ruben, 1987). Killed vaccines work by inducing serum antibodies against the
heamagglutinin and neuraminidase of the vaccine strains, with sufficient antibodies
ensuring protection against infection. Although no substitute for vaccination, an
alternative to vaccination is the use of amantadine, which is effective in the
prophylaxis and treatment of all strains of influenza A (Nicholson, and Wiselka,
1991). Prophylactic amantadine can be particularly helpful in high risk groups,
including those with cardiovascular and pulmonary diseases and those in chronic
care settings (Fedson, 1987). Amantadine does, however, have several known side
o
effects, including nausa and vomiting, loss of appetite and central nervous system
h
effects such as nervousness and insomnia (Monto, 1983).
Amantadine (1-aminoadamantane hydrochloride and 1-aminoadamantane
freebase), a small molecule comprised of a tri-cyclohexane ring structure polarised
by an amine group, can be purchased commercially in both the freebase (FB) and
hydrochloride (HC1) salt forms. The molecular structure of the two forms of
amantadine are depicted in Figure 3.4. The amphipathic amantadine molecule has a
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hydrophilic amine group and a lipophilic main body. NMR studies have shown that
amantadine perturbs the organisation and motional properties of phospholipid
bilayers (Cheetham and Epand, 1987), presumably by the insertion of the lipophilic
body of amantadine into the bilayer. The therapeutic effect of amantadine is thought
to involve the hydrophobic, lipophilic properties of the molecule (Phonphok et al.,
1991) and has been suggested to involve interruption of viral-host cell membrane
fusion or interference with haemagglutinin maturation (Hay, 1989; Sugrue et al.,
1990). More recently, amantadine has been linked to the influenza virus M2 protein
(Sugrue and Hay, 1991; Duff and Ashley, 1992).
4.2.1 The influenza A virus M2 protein.
The viral M2 transmembrane protein is a disulphide-bonded homotetramer
that forms a proton channel (Sugrue and Hay, 1991). The M2 protein is expressed
on the cell surface during viral synthesis (Lamb et al., 1985) and has been
identified in viral particles (Zebedee and Lamb, 1988). The protein has been
suggested to be important at two separate phases in the viral replication cycle
(Belshe and Hay, 1989). Immediately after viral endocytosis, and concomitant with
pH-induced fusion between the endosomal and viral membranes (Skehel et al.,
1982), mediated by haemagglutinin (HA), M2 is thought to conduct protons into the
interior of the virus leading to uncoating, acid-induced release of ribonucleoprotein
from the matrix protein (Ml), and eventual nuclear infection (Martin and Helenius,
1991). When HA is transported to the cell surface in post-Golgi vesicles (Sugrue et
al., 1990), M2 may also facilitate influenza synthesis and assembly by countering
any vesicular acidification. Amantadine is thought to inhibit these processes by
impeding proton flow during these events (Hay, 1989).
4.2.2 Interaction of amantadine with M2.
A wealth of evidence now supports the theory that amantadine interacts
directly with the viral transmembrane protein M2. It has recently been reported that
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the efficacy of amantadine is not due to any possible effects on the secondary
structure of the transmembrane domain (Duff and Ashley, 1992). In addition,
synthetic peptides representing this domain have been shown to possess an
amantadine-sensitive, proton channel function when incorporated into planar lipid
bilayers, suggesting that amantadine may operate via physical blockade.
A molecular modelling study has been published, in which an energy
minimum location for amantadine within the M2 transmembrane domain is specified
(Sansom and Kerr, 1993). The modelling work identified the energy minimum as
being in the vicinity of the M2 serine 31 oxygen atoms, when energy interactions
were evaluated as amantadine was moved along the length of the channel made of a
tetrameric association of M2. This minimum was shown to be derived from a
favourable electrostatic interaction between the cationic amine group and the ring of
serine 31 oxygen atoms. In addition, van der Waals contacts were observed between
the valine 27 side-chains of M2 and the amantadine cyclic ring structure. Overall
the ring structure of amantadine fitted into a hydrophobic pocket formed by the
valine 27 side-chains of M2, as the protonated amine group formed favourable
electrostatic interactions with the serine 31 oxygens. It was concluded that the
combination of a steric cut-off at isoleucine 42, and the favourable interaction at
valine 27/serine 31, provided a molecular explanation for block of M2 channels by
amantadine. Neutron diffraction work (Duff, 1993) shows that deuterium labelled
amantadine can indeed be located in an M2 transmembrane segment as predicted by
the modelling work.
4.2.3 Effect of charge on the interaction of small molecules with lipid bilayers.
An objective of this work was to study the effect that molecular charge, on
the amine group of amantadine, has on the DOPC-drug interaction. The local
anaesthetic tetracaine interacts with phospholipids in a manner influenced by the
charge state of the drug's tertiary amine group (Smith et al., 1991; Shinooka et al.,
1992). NMR has shown that drugs which contain an amino group have the ability
to interact strongly with the lipid phosphate group (Datta et al., 1992).
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The passive permeability of lipid bilayers is considerably greater for anions
than for cations (Franklin and Cafiso, 1993; Leiberman and Topaly, 1969; Leblanc,
1969, 1970; Flewelling and Hubbell, 1986). The bilayer translocation rate and
partition coefficient are both several orders of magnitude greater for the anion
tetraphenylboron (TPET) than they are for the structurally similar tetraphenyl-
phosphonium (TPP+) cation (LeBlanc, 1969, 1970; Anderson and Fuchs, 1975). It
has been proposed that the observed differential permeability to anions and cations
can be explained by an electrostatic potential in the interior of the bilayer which is
positive relative to the aqueous medium (Leiberman and Topaly, 1969; Leblanc,
1970; Haydon and Hladky, 1972; Hladky and Haydon, 1983; McLaughlin, 1977;
Flewelling and Hubbell, 1986; Honig etal., 1986).
The internal potential of fully hydrated phosphatidylcholine vesicles and
planar bilayers has been measured to be 240mV (Flewelling and Hubbell, 1986).
This internal potential is a dipole potential since it is found in phosphatidylcholine
where the head group has no net charge. There are three possible sources for this
internal dipole: oriented water molecules; the lipid polar head group; or the
glycerol acyl esters (McLaughlin, 1977; Zheng and Vanderkooi, 1992). If the
internal potential of a bilayer is indeed positive, cations will tend to be excluded
from the hydrophobic region, compared with anions or neutral species, thereby
causing a relative decrease in both the membrane/water partition coefficient and
bilayer translocation rate for cations. Zheng and Vanderkooi (1992) calculated that
increasing the water content of a bilayer will make the membrane potential more
positive, thus further excluding cations. This effect of hydration has also recently
been shown to be important by others (Gawrisch et al., 1992).
4.3 X-ray diffraction study of DOPC bilayers containing amantadine (FB or HC1),
The interaction of amantadine (both FB and HC1 forms) with DOPC bilayers
has been studied by X-ray diffraction and the swelling series method (described in
Chapters 2 and 3). Swelling series data were compiled for three different systems:
1) Pure DOPC bilayers at 20°C and 98%, 90%, 81%, 74% or 57% RH.
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2) DOPC plus 5% (mol) amantadine freebase (FB) bilayers at 20°C and 98%,
90%, 81%, 74% or 57% RH.
3) DOPC plus 5% (mol) amantadine hydrochloride (HC1) bilayers at 20°C and
98%, 90%, 81%, 74% or 57% RH.
Diffraction patterns were collected from oriented samples of each system, using the
sample preparation and diffraction methods described in Chapter 3.
4.3.1 Phasing of diffraction patterns using the swelling series method.
X-ray diffraction patterns were collected from oriented multilayer samples
on X-ray sensitive films. Plate 4.1 shows typical meridional diffraction patterns
collected from these fluid (La) phase bilayers. Meridional diffraction data were
collected out to seven orders from pure DOPC bilayers, to eight orders from
bilayers of DOPC+amantadine FB, and to six orders from bilayers of
DOPC+amantadine HC1 (Tables 4.1, 4.2 and 4.3). The bilayer thickness can be
calculated, without phase information, using the meridional diffraction data and
Bragg's law (equation 2.2). Plotting the calculated bilayer thickness (including the
water layer) against the relative humidity shows that the bilayer thickness decreases
with decreasing humidity for all three systems studied (Figure 4.1). The bilayer
thickness also decreases by 1-2-5A, on addition of amantadine (FB or HC1) to
DOPC bilayers, at each relative humidity studied.
4.3.2 Phasing the diffraction data collected from pure DOPC bilayers.
The swelling series phase assignment method involves plotting each structure
factor amplitude (Tables 4.1 to 4.3) against (h/D) (h is the diffraction order, D is
the bilayer thickness), in order to reconstruct the form of a continuous Fourier
transform. The 'phase-problem' is whether each structure factor
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(a) (b) (c)
PLATE 4.1 Diffraction patterns collected from (a) DOPC bilayers at 98 % RH, (b)
DOPC+amantadine HC1 bilayers at 81% RH and (c) DOPC+amantadine FB
bilayers at 57% RH. Each diffraction pattern was collected from a membrane
sample oriented on a glass slide, that was held in an environmental cell at 20°C.
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Table 4.1 Diffraction data collected from DOPC bilayers at 20°C.
Diffraction order Relative intensity of diffraction
1 0.726 0.672 0.730 0.789 0.733
2 0.138 0.171 0.120 0.037 0.069
3 0.096 0.093 0.098 0.091 0.172
4 0.031 0.050 0.043 0.080 0.027
5 0.008 0.013 0.009 0.003 0.002
6 0.001 0.001 0 0 0
7 0.001 0.001 0 0 0
Relative humidity 98% 90% 81% 74% 57%
Bilayer thickness
± SD (A)
54.0 +0.2 53.6 ±0.2 53.2 ±0.2 52.3 ±0.2 52.1 ±0.2
Table 4.2 Diffraction data collected from DOPC+amantadine FB bilayers at 20°C.
Diffraction order Relative intensity of diffraction
1 0.849 0.849 0.791 0.779 0.782
2 0.056 0.057 0.072 0.039 0.025
3 0.058 0.059 0.084 0.076 0.066
4 0.037 0.036 0.052 0.080 0.092
5 0 0 0 0.011 0.017
6 0 0 0 0.011 0.012
7 0 0 0 0.004 0.004
8 0 0 0 0.001 0.003
Relative humidity 98% 90% 81% 74% 57%
Bilayer thickness
± SD (A)
52.5+0.2 52.4+0.2 51.7+0.2 50.4+0.2 50.0+0.2
Table 4.3 Diffraction data collected from DOPC+amantadine HC1 bilayers at
20°C.
Diffraction order Relative intensity of c iffraction
1 0.739 0.745 0.881 0.876 0.690
2 0.128 0.131 0.019 0.037 0.137
3 0.095 0.100 0.039 0.055 0.151
4 0.038 0.024 0.057 0.030 0.002
5 0 0 0.002 0.001 0.001
6 0 0 0.002 0 0
Relative humidity 98% 90% 81% 74% 57%
Bilayer thickness
± SD (A)
53.1+0.2 52.1+0.2 51.4+0.2 50.7+0.2 49.5+0.2
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Figure 4.1 The effect of relative humidity on the DOPC,
DOPC+amantadine FB and DOPC+amantadine HC1 bilayer
thickness. Diffraction data were collected from oriented bilayer
samples at 20°C and either 98%, 90%, 81%, 74% or 57% RH. The
bilayer thickness of each of three systems increases with relative
humidity. The plots also show that adding amantadine (FB or HC1) to
DOPC decreases the bilayer thickness by ca 2A.
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amplitude is a positive or a negative value, information which is lost during the
diffraction process. Phase assignments that result in the construction of electron
density maps which differ markedly from known bilayer structures can be
discounted (Franks and Leib, 1981).
The phasing process for the first five orders of diffraction, collected from
the pure DOPC bilayers at 20°C, is illustrated in Figure 4.2. Assuming that the
first diffraction order phase is negative, the form of reconstructed continuous
Fourier transforms [solid and dotted lines of Figure 4.2, (A)] suggest that the
second order phase assignment is most likely to be negative, as the negative
assignment continuous Fourier transform (solid line) passes smoothly through the
second order data points. Assigning the third order phase [Figure 4.2 (B)] is less
obvious from the swelling series plot, but has been phased positive by assessing the
form of the continuous Fourier transform when higher orders were included in the
analysis. Both the fourth and fifth order data fitted a smooth continuous Fourier
transform when assigned a negative phase [Figure 4.2, (C) and (D)].
Whilst phases have been assigned out to five orders for the pure DOPC
bilayer data, further swelling series and electron density map reconstruction work
(Figures 4.3 and 4.4) do not differentiate between the four possible phase
assignments for the higher order data (h=6, 7). Due to the outer structure factor
amplitude values being small, all four possible outer order phase assignments plot
as plausible continuous Fourier transforms. The electron density maps, using the
seven order data set collected from DOPC bilayers 20°C and 98% RH, constructed
using the four plausible phase assignments to the higher orders (Figure 4.4), all
display characteristics of phospholipid bilayers (Danielli and Davson, 1934;
Lesslauer et al., 1972; Tardieu et al., 1973). The electron dense phosphate
headgroups (8-9A) are separated by a water layer (OA) and the lipid chain terminal
region is low in electron density (26A). As the phase assignment differences are
confined to the weaker, higher orders, they make only small differences to the
electron density distribution construction. A DOPC electron density map has also
been constructed using five orders of diffraction (Figure 4.4, a truncated Fourier
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Figure 4.2 Phasing the DOPC bilayer diffraction data using the
swelling series method. Diffraction data were collected from oriented
DOPC bilayer samples at 20°C and between 98% and 57% RH. The
four graphs (A, the second order to D, the fifth order) show different
stages of the phasing process, where the next order to be phased is
shown plotted both positively and negatively. The solid lines
represent the accepted, and the dashed lines the rejected, phase
assignments. Although diffraction data have been collected out to
seven orders from the DOPC bilayer samples, the swelling series
method has only successfully phased the first five orders.
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Figure 4.3 Phasing the DOPC bilayer higher (6 or 7) order
diffraction data using the swelling series method. Diffraction data
were collected out to seven orders from oriented DOPC bilayer
samples at 20°C and between 98% and 57% RH. The swelling series
phase assignment method has successfully phased the first five orders
of diffraction (Figure 4.2), leaving four possible combinations for the
final two orders of diffraction unresolved. All four phase assignment



























0 5 10 15 20 25
DISTANCE ACROSS BILAYER (A)
Figure 4.4 Construction of the possible DOPC bilayer electron
density maps, using each of the four phase assignment combinations
unresolvable by the swelling series method (Figure 4.3). Diffraction
data were collected out to seven orders from oriented DOPC bilayer
samples at 20°C and between 98% and 57% RH. The swelling series
phase assignment method has successfully phased the first five orders
of diffraction (Figure 4.2), leaving four possible combinations for the
final two orders of diffraction unresolved. The electron density maps
have been constructed using either all seven orders, and each of the
possible phase assignments, or using only five orders of diffraction,
the limit of successful phase assignment. All of the electron density
maps display the characteristics of phospholipid bilayers; a water
layer (OA); a phosphate headgroup (9A); a lipid chain terminal
methyl region characterised by low electron density (26A). For
clarity, only half of the bilayer unit is shown above. The five order
structure, compared with the possible seven order structures, gives
an indication of the level of truncation error present in a five order
electron density map construction.
86
The truncated construction has therefore been made with the higher orders set to
zero, resulting in the construction of electron density maps containing half the error
of incorrectly phasing an order (truncation error). The possible seven order versus
five order electron density map comparisons therefore provide an estimate of the
truncation error involved in constructing the DOPC electron density maps when
using only five orders of diffraction (approximately ±0.025 relative electron
density units across the bilayer).
The structures of DOPC bilayers at 20°C and between 98% and 57% RH
have been calculated using the truncated Fourier series of five orders of diffraction
(Figure 4.5). Decreasing the humidity reduced the DOPC bilayer thickness (Figure
4.1), an observation independent of phase information. The truncated DOPC
electron density distributions (Figure 4.5) suggest that the decrease in bilayer
thickness is caused by a reduction in the spacing between the phospholipid
headgroups across the water layer. To make this observation assumes that the
truncation error affects all the bilayer structures in a similar manner and to the same
degree. It would be impossible however, because of truncation error, to state an
absolute position for the phospholipid headgroups.
4.3.3 Phasing the diffraction data collected from bilayers of DOPC containing
amantadine FB.
Two of the five data sets collected from DOPC+amantadine FB bilayers
contain eight orders of diffraction (Table 4.2). As with the DOPC bilayer data, the
DOPC+amantadine FB diffraction data have been phased out to five orders (Figure
4.6). The swelling series method could not, however, resolve which of three
plausible combinations of phase assignments, for orders six to eight, might be the
correct ones (Figure 4.6). Electron density maps have been calculated using an
eight order data set (DOPC + amantadine FB at 20 °C and 74% RH) and the three
higher order phase assignment combinations suggested by the swelling series
method (Figure 4.7). All three of the generated electron density maps represent
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Figure 4.5 Construction of DOPC bilayer electron density maps
using five orders of diffraction. Seven orders of diffraction were
collected from oriented DOPC bilayer samples at 20°C and between
98% and 57% RH. The swelling series phase assignment method,
however, only successfully phased the first five orders of diffraction
(Figure 4.2), leaving four possible combinations for the final two
orders of diffraction unresolved. The DOPC electron density maps
have, therefore, been constructed using only five orders of
diffraction, the limit of successful phase assignment. The maps show
that the size of the water layer (OA) decreases with the sample
humidity, closing together the phosphate headgroups (±9A). The
electron density maps do not, however, take into account truncation
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Figure 4.6 Phasing the diffraction data, collected from DOPC+
amantadine FB bilayers, using the swelling series method.
Diffraction data were collected from oriented bilayer samples at
20°C and between 98% and 57% RH. Although the DOPC+
amantadine FB bilayers diffracted out to eight orders, the swelling
series method has only successfully phased the first five orders.
Three possible solutions to the phase assignments of the higher (6 to
8) orders are shown above. Each of phase assignment combinations
shown above form plausible continuous Fourier transforms, leaving
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Figure 4.7 Construction of possible DOPC+amantadine FB bilayer
electron density maps, using the phase assignment combinations
unresolvable by the swelling series method (Figure 4.6). The
diffraction data were collected out to eight orders from oriented
amantadine FB bilayer samples at 20°C and between 98% and 57%
RH. The swelling series method has only successfully phased the first
five orders of diffraction (Figure 4.6), leaving the phases of the
higher orders unresolved. The electron density maps have been
constructed using either all eight orders, and the three suggested
higher order phase assignments of Figure 4.6, or using only five
orders of diffraction, the limit of successful phase assignment. All of
the constructed electron density maps display the characteristics of
phospholipid bilayers; a water layer (OA); a phosphate headgroup (5-
8A); a lipid chain terminal methyl region characterised by low
electron density (25A). For clarity, only half of the bilayer unit is
shown above. The five order structure, compared with the possible
eight order structures, indicates the level of truncation error present
in five order structures.
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bilayer structure could be ascribed to the presence of amantadine. The
DOPC+amantadine FB electron density map calculated using five orders (Figure
4.7, solid line) indicates the likely level of truncation error present in five order
electron density maps due to the inability of the swelling series method to phase the
higher order (6 to 8) diffraction data (up to ±0.1 relative electron density units).
The structures of DOPC+amantadine FB bilayers at 20°C and between 98%
and 57% RH have been calculated using the truncated Fourier series of five orders
of diffraction (Figure 4.8). As with the pure DOPC bilayer data (Figure 4.5), the
truncated DOPC+amantadine FB electron density distributions suggest that
decreasing the relative humidity reduces the phospholipid headgroup spacing across
the water layer (Figure 4.8). The humidity dependent reduction in the size of the
water layer would account for the decrease in bilayer spacing with humidity (Figure
4.1). Making comparisons between five order structures, however, assumes that
truncation errors affect all the bilayer structures to a similar degree.
4.3.4 Phasing the diffraction data collected from bilayers of DOPC containing
amantadine HC1.
The DOPC+amantadine HC1 bilayers diffracted to a maximum of six orders
(Table 4.3) reducing the possible phase assignment combinations, compared to the
eight order DOPC+amantadine FB data. Using the swelling series method, phases
have been assigned to the first five orders of the DOPC+amantadine HC1 diffraction
data, with the phase of the sixth order remaining ambiguous (Figure 4.9). The two
electron density maps constructed using the alternative sixth order phase
assignments (DOPC+amantadine HC1 at 20 °C and 81% RH) both represent
structures characteristic of phospholipid bilayers (Figure 4.10). The five order
DOPC+amantadine HC1 electron density map has also been constructed for
comparison with the six order structures (Figure 4.10), indicating the level of
truncation error that exists in five order structure (approximately +0.015 relative
electron density units). It is possible that truncation errors greater than those
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Figure 4.8 Construction of DOPC+amantadine FB bilayer electron
density maps using five orders of diffraction, the limit of successful
phase assignment (Figure 4.6). Although diffraction data were
collected out to eight orders from the oriented bilayer samples, at
20°C and between 98% and 57% RH, electron density maps have
been constructed using only five orders of diffraction, the point of
successful phase assignment. The size of the water layer (OA)
decreases with the sample humidity, closing together the phosphate
headgroups (+5-9A). The electron density maps do not, however,
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Figure 4.9 Phasing the DOPC+amantadine HC1 bilayer diffraction
data using the swelling series method. Diffraction data were collected
from oriented bilayer samples at 20°C and between 98% and 57%
RH. Although diffraction data have been collected out to six orders
from the DOPC+amantadine HC1 bilayer samples, the swelling
series method has only successfully phased the first five orders. The
two possible phase assignments of the sixth order both form plausible
continuous Fourier transforms, leaving ambiguity in the sixth
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Figure 4.10 Construction of the five order and two possible six order
DOPC+amantadine HC1 bilayer electron density maps. Diffraction
data were collected out to six orders from oriented DOPC +
amantadine HC1 bilayer samples at 20°C and between 98% and 57%
RH. The swelling series phase assignment method successfully
phased the first five orders of diffraction (Figure 4.9), leaving the
phase of the sixth order unresolved. The electron density maps have
been constructed using either all six orders, with the sixth order
phased both positively and negatively, or using only five orders of
diffraction, the limit of successful phase assignment. All of the
electron density maps display the characteristics of phospholipid
bilayers; a water layer (OA); a phosphate headgroup (6-8A); a lipid
chain terminal methyl region characterised by low electron density
(25A). For clarity, only half of the bilayer unit is shown above.
Comparison of the five order and two six order structures, indicates
the level of truncation error likely in the five order structure.
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indicated by Figure 4.10 exist, if higher order diffraction spots exist but were
undetected on film at any humidity.
The five order bilayer structures of DOPC+amantadine HC1 at 20°C and
between 98% and 57% RH are shown in Figure 4.11. As was the case with the pure
DOPC and DOPC+amantadine FB bilayers, decreasing the humidity appears to
reduce the phospholipid headgroup separation across the water layer. As per the
pure DOPC and DOPC +amantadine FB data, making comparisons between the five
order DOPC+amantadine HC1 electron density maps assumes that the truncation
error affects all the bilayer structures in a similar manner and to the same degree.
4,4 Comparison of pure DOPC bilayers with DOPC bilayers containing either
amantadine FB or HC1.
In order to compare the electron density distribution of the DOPC bilayer
with that of the DOPC+amantadine bilayer it is important to have some knowledge
of the accuracy with which bilayer structures can be constructed. As the swelling
series phase assignment method, for all three DOPC based systems, has only been
successful out to five orders, truncation errors exist in the data. The accuracy and
reproducibility of the diffraction data must also be considered, as observed bilayer
differences on addition of drug might be of an order purely ascribable to normal
sample variation. The reproducibility of a membrane sample was investigated
(Chapter 3) for a pure DOPC bilayer sample at 20°C and 57% RH, the results of
which in a Monte Carlo simulation program provided an estimate of the 95%
confidence limits for the bilayer electron density distribution (Figure 3.3).
The confidence limits for the DOPC and DOPC+amantadine FB electron
density maps at 20°C and 98% RH (Figure 4.12) were created using a Monte Carlo
simulation program, five orders of diffraction and the order error estimate
calculated for DOPC data (Chapter 3). The Monte Carlo simulation program
calculates the upper and lower 95% confidence limits for the electron density
distribution of the bilayer. The two solid lines of Figure 4.12 are the upper and
lower electron density limits for the DOPC+amantadine FB bilayer, while the
95
-30 -20 -10 0 10 20 30
DISTANCE ACROSS BILAYER (A)
Figure 4.11 Construction of DOPC+amantadine HC1 bilayer
electron density maps using five orders of diffraction. The diffraction
data were collected out to six orders from oriented bilayer samples at
20°C and between 98% and 57% RH. The swelling series method
successfully phased the first five orders of diffraction (Figure 4.9),
leaving the sixth order phase assignment unresolved. The electron
density maps have, therefore, been constructed using only five orders
of diffraction, the point of successful phase assignment. The maps
show that the size of the water layer (OA) decreases with the sample
humidity, closing together the phosphate headgroups (+6-8A). The
electron density maps do not take into account truncation errors
(Figure 4.10) or data accuracy limits.
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Figure 4.12 Comparison of the 95% confidence limits for the
electron density distribution of DOPC and DOPC+amantadine FB
bilayers at 20°C and 98% RH. Diffraction data were collected from
oriented bilayer samples and phased out to five orders using the
swelling series method. The 95% confidence limits were constructed
using a Monte Carlo simulation program, five orders of X-ray
diffraction and structure factor amplitude error limits derived from
DOPC sample reproducibility experiments (Chapter 3). For clarity,
only one half of the bilayer unit is shown above, where the centre of
the water and lipid layers are located at OA and 26A respectively.
Although the two bilayer structures appear to differ significantly
between OA and 4A, the maps do not take into account truncation
errors which might strongly influence the shape and depth of the
water layer (Figures 4.4 and 4.7).
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dashed lines are those of the pure DOPC bilayer. For clarity only half of the bilayer
structure is shown, with the water layer and centre of the lipid layer being located
at OA and 26A respectively.
At first it might appear from Figure 4.12 that there is discernible difference
between the DOPC and DOPC+amantadine FB bilayer (between 0-4A), however,
uncertainty in the electron density distribution due to Fourier series truncation
errors are not included in the diagram. Truncation errors affect both the pure
DOPC (Figure 4.4, uncertainty of ±0.025 relative units) and the
DOPC+amantadine FB bilayers (Figure 4.7, uncertainty of ±0.1 relative units)
and are potentially quite large between OA and 3A, enough to eliminate any
conclusions of differences between the two bilayer structures being compared.
Comparison of DOPC and DOPC ±amantadine FB bilayers at other humidities
show the two water layer structures (0-3A) to be indistinguishable (Figure 4.13,
57% RH data), even before truncation errors are considered. The 57% RH data
indicate that there are differences in the headgroup positions (ca 7-10A for DOPC
and 5-7A for DOPC+amantadine FB) between the two systems. This structural
change would help to account for the alteration in bilayer spacing that occurs on
addition of amantadine (FB or HC1) to DOPC (Figure 4.1). The change in
headgroup position is also suggested by the 98% RH data (Figure 4.12), albeit less
conclusively, as well as at intermediate humidities.
Although a change in the phosphate headgroup position is suggested,
structural changes that might occur on addition of amantadine HC1 to DOPC
bilayers cannot be resolved using the five order diffraction data (Figure 4.14).
Whilst Figure 4.14 only shows the data from bilayers at 20°C and 98% RH, data
from other humidities give similarly inconclusive results about the interaction of
amantadine HC1 with DOPC. A comparison of the 95% confidence limits for the
DOPC+amantadine FB and the DOPC±amantadine HC1 electron density
distributions cannot distinguish any differences between the two charge states of
amantadine (Figure 4.15). Any differences in the DOPC-amantadine interaction,
due to charge effects, cannot be resolved by using only five orders (truncated
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Figure 4.13 Comparison of the 95% confidence limits for the
electron density distribution of DOPC and DOPC+amantadine FB
bilayers at 20°C and 57% RH. Diffraction data were collected from
oriented bilayer samples and phased out to five orders using the
swelling series method. The 95 % confidence limits were constructed
using a Monte Carlo simulation program, five orders of X-ray
diffraction and structure factor amplitude error limits derived from
DOPC sample reproducibility experiments (Chapter 3). For clarity,
only one half of the bilayer unit is shown above, where the centre of
the water and lipid layers are located at OA and 26A respectively.
The 57 % RH data indicates that there is a difference in the
headgroup positions (ca 7-10A for DOPC and 5-7A for DOPC+
amantadine FB bilayers). The change in headgroup position would
help to account for the change in bilayer spacing that occurs on
addition of amantadine (FB or HC1) to DOPC (Figure 4.1). The
change in headgroup position is also suggested by the 98% RH data












/ /' \ i. 95% confidence limit .
/ ' \












// /"/ /7'""y i'
\ \ \
\ \ \ \









Y " ' • \ N
K 1 vN \ \ N
s J N








5 10 15 20 25
DISTANCE ACROSS BILAYER (A)
Figure 4.14 Comparison of the 95% confidence limits for the
electron density distribution of DOPC and DOPC+amantadine HC1
bilayers at 20°C and 98% RH. Diffraction data were collected from
oriented bilayer samples at 20°C and 98% RH and phased out to five
orders using the swelling series method. The 95 % confidence limits
were constructed using a Monte Carlo simulation program, five
orders of X-ray diffraction and structure factor amplitude error limits
derived from DOPC sample reproducibility experiments (Chapter 3).
For clarity, only one half of the bilayer unit is shown above, where
the centre of the water and lipid layers are located at OA and 26A
respectively. The 95% confidence limits do not indicate any
differences between the two bilayer systems. Due to truncation error,
any electron density distribution changes that occur, on addition of
amantadine HC1 to DOPC bilayers, cannot be resolved using only
five orders of diffraction to construct electron density maps.
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Figure 4.15 Comparison of the 95 % confidence limits for the
electron density distribution of DOPC+amantadine FB and
DOPC+amantadine HC1 bilayers at 20°C and 98% RH. Diffraction
data were collected from oriented bilayer samples at 20°C and 98%
RH and phased out to five orders using the swelling series method.
The 95 % confidence limits were constructed using a Monte Carlo
simulation program, five orders of X-ray diffraction and structure
factor amplitude error limits derived from DOPC sample
reproducibility experiments (Chapter 3). For clarity, only one half of
the bilayer unit is shown above, where the centre of the water and
lipid layers are located at OA and 26A respectively. Due to truncation
error any electron density distribution differences between
amantadine FB and amantadine HC1 in DOPC bilayers cannot be
resolved using only five orders of diffraction to construct electron
density maps.
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4,5 Discussion of the swelling series method.
The swelling series technique relies on the assumption that the bilayer
structure does not change as the humidity increases. The water layer however is an
integral part of the membrane structure and variations in humidity do alter the
phospholipid structure (Tardieu et al., 1973). Indeed, the bilayer structure changes
significantly on the close approach of adjacent bilayers as the system is dehydrated
(Small, 1967; LeNeveu et al., 1976, 1977; Parsegian et al., 1979; Lis etal., 1981)
and this lateral compression can cause large changes in lipid area (Parsegian and
Rand, 1983; Lis et al., 1982a, b). The swelling series method assumes that the
continuous Fourier transform of a single structure is sampled at multiple points
along its length by the collection of data at different humidities. Because the bilayer
structure changes with humidity, however, each data set in a swelling series samples
a different continuous Fourier transform. While the swelling series can still be
effective as a phasing method, it is less reliable when large structural changes occur
with humidity, or for phasing higher orders of diffraction.
4.6 Conclusions of the diffraction study.
The interaction of amantadine (FB and HC1) with DOPC bilayers at 20°C
and between 98% and 57% RH has been studied. Oriented bilayer samples were
studied by X-ray diffraction using the swelling series phasing method. Although the
DOPC based bilayers diffracted to a maximum of eight orders, the swelling series
phasing method was only able to phase unambiguously the first five orders
produced by each bilayer system studied (Figures 4.3, 4.6 and 4.9). As a result of
\
this inability to phase the higher diffraction orders, the DOPC based bilayer
electron density maps all have truncation error associated with them (Figures 4.4,
4.7 and 4.10). The level of the truncation errors is such that little can be concluded
from comparisons made between bilayer structures with and without amantadine
present (Figures 4.12, 4.13 and 4.14). Also, any differences between the interaction
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of amantadine FB and amantadine HC1 with DOPC bilayers could not be
determined by the diffraction study (Figure 4.15)
The bilayer thickness can be measured from the X-ray diffraction data
without the need to assign phases to the data. Adding amantadine of either form to
DOPC bilayers at 20°C reduced the bilayer thickness by 1-2.5A, depending on
humidity. The bilayer thickness of all three systems also decreases with relative
humidity and the electron density map constructions appear to show that this
decrease in thickness is attributable in part to a decrease in the phospholipid
headgroup separation (Figures 4.5, 4.8 and 4.11).
It can be concluded that a change in bilayer structure occurs on addition of
amantadine to the DOPC bilayer, as the bilayer thickness is reduced significantly.
The process of swelling DOPC bilayers alters the bilayer structure and therefore the
form of the continuous Fourier transform, reducing the ability of the swelling series
method to phase higher orders. To analyse more fully the interaction between
DOPC bilayers and amantadine would require the ability to phase unambiguously




A study of a novel bromolipid.
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5.1 Aim of studying a novel bromolipid.
To date, the only popular phasing method used in X-ray diffraction studies
of membranes is the swelling series approach (Torbet and Wilkins, 1976; Franks
and Leib, 1981). Isomorphous replacement, the principle method used for phasing
diffraction data from protein crystals (Blundell and Johnson, 1976), has seldom
been used successfully on a membrane system (Makowski and Lee, 1983).
Compared with X-ray diffraction, more reliable phasing methods are available for
the analysis of neutron diffraction data from membrane samples, such as H2O/D2O
exchange (Franks and Lieb, 1979). Unlike X-rays which are diffracted by electrons,
neutrons are diffracted by nuclei and, as a result, the insertion of isotopes into a
membrane can significantly change the neutron diffraction pattern (the basis of the
H2O/D2O exchange phasing method). The isotope effect, therefore, provides
neutron diffraction with a phasing method which does not alter the membrane
structure. Conversely, the X-ray diffraction swelling series method alters the
membrane structure, thus reducing the effectiveness of this technique.
The aim of the work in this chapter was to study a novel phospholipid which
might provide an alternative phasing method to the swelling series approach. A
novel brominated phospholipid (bromolipid) derivative of DPPC has been
synthesised (Chapter 3), where the sn-2 terminal methyl group of DPPC has been
exchanged for a bromine atom. To characterise bilayers of the novel molecule, the
bromolipid has been studied by X-ray diffraction, using the swelling series method,
and by differential scanning calorimetry (DSC). It was hoped that, once
characterised, the bromolipid might offer two methods of phasing diffraction data:
Firstly by the bromolipid bromine atom acting as a heavy atom in isomorphous
replacement experiments and secondly by the bromine atom acting as an anomalous
scatterer in multiple anomalous dispersion (MAD) experiments.
Isomorphous replacement is a phasing method used extensively in protein
crystallography, where a heavy atom is added into the unit cell as a 'label' (Blundell
and Johnson, 1976). In a typical isomorphous replacement experiment several
samples might be studied, each with different heavy atoms, or increasing amounts
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of the same atom, present. As well as the presence of the heavy atom acting as a
phasing agent, it can also be used to put the relative electron density scale into one
of absolute density. The anomalous scattering (MAD) phasing method is still
relatively new to protein crystallography (Hendrickson, 1985a, b) and has yet to be
used in membrane diffraction experiments. In the MAD experiment only a single
sample, containing an anomalous scattering centre, need be studied. MAD
diffraction patterns are collected at different X-ray wavelengths (either side of a
suitable absorption edge), with differences between the collected patterns being used
as the phasing method (Hendrickson, 1991).
5.1.1 Incorporating heavy atoms into membrane structures.
The use of heavy atom methods have had limited success with biological
membranes (Akers and Parsons, 1970; Harker, 1972; Blaurock, 1973), where two
principle methods have been used to introduce a heavy atom into a membrane
structure:
1) Label a phospholipid molecule with the heavy atom (Wiener and White, 1991;
Mcintosh and Holloway, 1987).
2) Attach the heavy atom to a secondary molecule that is then inserted into the
membrane.
Adding bromine across a lipid chain double bond has been the main way in
which bromolipids have been synthesised and studied in the past (Wiener and
White, 1991; Mcintosh and Holloway, 1987), especially for use in fluorescence
quenching experiments (Leto et al., 1980; East and Lee, 1982; Holloway et al.,
1982; Markello et al., 1985; Everett et al., 1986). This addition across a double
bond method, however, creates a molecule that has a large atom attached
perpendicular to the direction of the lipid chains, which could sterically hinder
chain packing. Recent X-ray diffraction work has used such brominated lipids
primarily to locate the bromine atom for fluorescence work, rather than as a
diffraction phasing method (Wiener and White, 1991; Silvius, 1990; Yeager and
Fiegenson, 1990; de Kroon et al., 1990).
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The second approach to placing heavy atoms inside a membrane has been
that taken by Mcintosh et al., (1976) and Franks et al., (1978), who showed that
halogenated cholesterol analogues could be isomorphously exchanged with
cholesterol and used to phase the signs of the lamellar reflections. Katsaras and
Stinson, (1990) and Katsaras et al., (1991) have placed brominated palmitic acid,
brominated butylated hydroxytoluene (BHT) and brominated a-tocopherol, into
DPPC bilayers with varying success. The bromine atoms, attached to the small
molecules palmitic acid and a-tocopherol, tended to have a fairly wide distribution
in the bilayer (9A). The bromine atoms attached to BHT could not be located in the
bilayer at all. The bromine atoms placed into the bilayer, in the labelling
experiments were, however, for use as positional markers rather than as diffraction
phasing agents.
5.1.2 The use of bromine as a heavy atom label.
Bromine was chosen to be the heavy atom label in the DPPC analogue
because of its potential for use in both isomorphous replacement and MAD
experiments. The bromine atom is extremely electron dense, having thirty five
electrons in almost same volume as the nine electrons of a methyl group. The
bromine atom should, therefore, be easy to locate in X-ray diffraction electron
density maps. The bromine atom has a suitable absorption edge for use in MAD
experiments, with an energy in the X-ray wavelength range obtainable by current
synchrotron sources (ca 1A wavelength, obtainable at the synchrotron radiation
source (SRS), Daresbury Laboratory, Warrington, England). In addition, as the
o
bromine atom and the methyl group have a similar atomic radius (1.85A versus
2.0A), exchanging the bromine atom for a phospholipid methyl group should
minimise any changes in membrane structure. Bromine is also known to act
neutrally in a lipid chain environment and numerous X-ray and fluorescence
experiments have utilised a variety of brominated lipids without the bilayer being
distorted other than by steric effects (Leto et al., 1980; East and Lee, 1982;
Holloway et al., 1982; Markello et al., 1985; Everett et al., 1986).
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The bromolipid bromine atom was placed at the terminal position of a lipid
chain so that a layer of high electron density occurred at the centre of the bilayer,
the ideal position for a label in isomorphous replacement experiments (Franks and
Leib, 1981). Just one (the sn-2 chain) of the two inequivalent lipid chains of DPPC
was labelled with a bromine atom. The two lipid chains are inequivalent (Figure
1.5), as the sn-2 chain penetration into the bilayer is shortened by a sharp bend
between C-2 and C-3 (Zaccai et al., 1979). Two different populations of bromine in
the bilayer would have been created if both the sn-l and the sn-2 lipid chains of the
bromolipid had been labelled.
5.2 X-ray diffraction study of DPPC and bromolipid in the gel phase.
Oriented samples of gel phase DPPC and bromolipid bilayer were studied by
X-ray diffraction using the swelling series phasing method (described in Chapters 2
and 3). Swelling series data were compiled for two systems:
1) pure DPPC bilayers at 20°C and between 98% and 57% RH.
2) pure bromolipid bilayers at 20°C and between 98% and 57% RH.
Each system was studied at five different humidities (98%, 90%, 81%, 74% and
57% RH), using the sample preparation and data analysis methods described in
Chapter 3.
5.3 Results of DPPC and bromolipid bilayer diffraction analysis.
Meridional diffraction data (Tables 5.1 and 5.2) were collected out to
fourteen and twelve orders from DPPC and bromolipid bilayers respectively. At
20°C, both DPPC and bromolipid form bilayers in the Lp- phase (Plates 5.1 and
5.2), indicated by the equilateral diffraction at [4.1A1] (Stumpel et al., 1983) due
to the hydrocarbon chains being hexagonally packed (Chapman et al., 1967). The
[4.1A"1] equilateral diffraction angle, above the equator, provides a measure of the
lipid chain tilt (Levine 1972, 1973), that can be combined with the meridional
diffraction information to provide a better picture of the bilayer structure.
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PLATE 5.1 The diffraction pattern collected from an oriented sample of DPPC at
20°C and 90% RH. The gel phase sample diffracted meridionally out to twelve
orders. One can also see diffraction out to four orders resulting from phase
separation in the sample. These diffraction spots arise from membranes in the
sample with a larger bilayer thickness (D) than the bulk DPPC bilayers, possibly
from bilayers at the sample/air interface.
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PLATE 5.2 A diffraction pattern collected from an oriented sample of bromolipid
bilayers at 20 °C and 90% RH. Twelve orders of meridional diffraction can be
observed in the diffraction pattern. The gel (Lp) phase sample also diffracted
equilaterally, producing a diffuse spot at 4.1A"1, in agreement with that found for
DPPC by Stumpel et al. (1983). One can also see diffraction out to four orders
resulting from phase separation in the sample. These diffraction spots arise from
membranes in the sample with a larger bilayer thickness than the bulk bromolipid
bilayers, possibly at the sample/air interface.
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Table 5.1 Diffraction data collected from gel phase DPPC bilayers.
Diffraction
order
Phased structure factor amplitude diffraction data
collected from DPPC bilayers at 20°C.
Variation of
data (SD)
1 -0.191 -0.185 -0.189 -0.189 -0.191 2%
2 -0.082 -0.094 -0.091 -0.083 -0.070 11%
3 +0.077 +0.086 +0.081 40.078 40.072 7%
4 -0.151 -0.148 -0.149 -0.155 -0.160 3%
5 0 +0.025 +0.022 40.014 +0.010 31%
6 -0.065 -0.057 -0.048 -0.066 -0.075 14%
7 -0.015 -0.034 -0.028 -0.024 -0.009 38%
8 -0.039 -0.027 -0.024 -0.037 -0.057 31%
9 -0.036 -0.036 -0.036 -0.036 -0.036 7%
10 -0.030 -0.027 -0.022 -0.028 -0.031 11%
11 +0.034 +0.021 40.020 +0.033 36%





98% 90% 81% 74% 57%
Bilayer
repeat (A)
58.0 57.9 57.7 57.5 57.1
Table 5.2 Diffraction data collected from gel phase bromolipid bilayers.
Diffraction Phased structure factor amplitude diffraction data
order collected from bromol ipid bilayers at 20°C.
1 -0.113 -0.114 -0.117 -0.134
2 +0.034 40.019 40.018 40.071
3 40.202 40.207 40.210 40.164
4 -0.107 -0.107 -0.099 -0.100
5 +0.074 40.061 +0.052 40.067
6 -0.031 -0.019 -0.007 -0.048
7 0 0 0 40.022
8 40.041 40.020 0 +0.066
9 -0.028 -0.021 -0.023 -0.020
10 -0.025 -0.019 -0.017 0
11 40.057 40.030 40.025 -0.055
12 -0.040 -0.034
Relative 98% 90% 81% 57%
humidity
Bilayer 55.9 56.3 56.7 54.7
repeat (A)
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5.3.1 Estimating the error levels in the diffraction data.
Confidence limits for the distribution of electron density across a bilayer can
be estimated using a Monte Carlo simulation programme (Chapter 3). An error
limit estimate is, however, required for each structure factor amplitude value used
to construct the electron density distribution maps. The level of error in measuring
the intensity of a diffraction spot from a film was previously shown to be typically
in the region of 2-6% of the magnitude of the intensity spot (Chapter 3). Data have
also been presented showing the variation in the diffraction data between five
'identical' fluid phase DOPC samples (Table 3.3). While only four orders of
diffraction were collected from the DOPC bilayers, these results showed that the
measured intensity of a spot could vary by up to 26%. The data, however, also
suggested that these large variations in the collected diffraction patterns resulted
from variations in the structure of the DOPC bilayer sample, rather than the
accuracy with which diffraction data can be recorded.
Diffraction data have not been collected from a standard gel phase DPPC
sample enough times for structure factor error estimates to be assessed. The
variation in diffraction data of a 20°C DPPC sample over the relative humidity
range 98% to 57% has, however, been analysed (Table 5.1). The first four orders
of diffraction obtained from the DPPC bilayers, over all humidities studied, vary
considerably less than did the data collected from five 'identical' DOPC samples
(Tables 5.1 and 3.3). The DPPC structure factor amplitudes varied with a standard
deviation of between 3% and 38%, with the higher orders varying the most (Table
5.1). These variations in diffraction data represent an over-estimate of the
diffraction data error level, as variations in diffraction data with humidity are
expected.
5.3.2 Pure DPPC bilayers at 20°C.
The swelling series plot used to phase the diffraction data from DPPC
bilayers, at 20°C and between 98% and 57% RH, is shown in Figure 5.1. Phases
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were assigned to the diffraction data using the method of calculating continuous
Fourier transforms for the data, then analysing electron density maps constructed
using the chosen phases. Electron density maps of DPPC at 20°C and between 98%
and 57% RH (Figure 5.2) were constructed using up to twelve orders of diffraction,
if available, and the phase assignments obtained by the swelling series method
(Figure 5.1). The electron density distributions are orientated so that the centre of
the lipid layer is located at OA and the water layers are located at +29A.
The DPPC electron density maps locate the phosphate headgroup and ester
linkage regions at +22A and ±17A, respectively, from the centre of the lipid layer
(OA). Of note is the higher structural detail observable in the DPPC bilayer, which
regularly diffracted to twice the number of orders than were obtained from DOPC
bilayers (Chapter 4) at the same temperature. The resolution of a diffraction pattern
is calculated as being the unit cell size (D) divided by the number of the highest
order collected. Thus the twelve order DPPC data have a typical resolution of 58/12
= 4.8A, compared with the DOPC bilayer data with a resolution of 7.7A. DPPC
forms bilayers in the gel (Lp) phase at 20°C, whereas DOPC forms fluid (La) phase
bilayers, which accordingly diffract out to fewer orders.
The DPPC electron density maps (Figure 5.2) suggest that the shape of the
water layer changes only slightly with decreasing humidity and the phosphate head
group separation, across the water layer, remains relatively constant. That is not to
say that the head groups on the same side of the bilayer are not being pushed apart,
perpendicular to the bilayer normal, by the insertion of water around the
phosphatidylcholine headgroup. Previous work (Tardieu et al., 1973; Torbet and
Wilkins, 1976; Katsaras and Stinson, 1990; Katsaras et al., 1992) has shown that
raising the sample humidity increases the amount of water inserted around the lipid
headgroup, thus increasing the lipid chain tilt angle and reducing the bilayer
thickness. In contrast to gel phase DPPC bilayers, DOPC bilayers (Chapter 4)
exhibit a general increase in bilayer size with increasing humidity as they are in the
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Figure 5.1 The swelling series plot used to phase the diffraction data
collected from oriented DPPC bilayers at 20°C and between 98%
and 57% RH. Diffraction data were collected out to fourteen orders
from the DPPC bilayer samples. The symbols represent the structure
factor amplitude value of each order plotted against h/D (h is the
order number and D is the bilayer thickness). The plotted lines are
spline curves fitted to the data, as estimates of the form of the
continuous Fourier transform.
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Figure 5.2 The electron density distribution maps of DPPC bilayers.
Diffraction data were collected from oriented DPPC samples at 20°C
and between 98% and 57% RH and phased using the swelling series
method (Figure 5.1). The electron density maps were constructed
using up to twelve orders of diffraction, if available, at each
humidity studied. The DPPC phosphate headgroup, the ester linkage
group and the lipid layer can be located at ±22A, ±17A and -15A to
+ 15A respectively. The electron density distribution maps do not,
however, take truncation or data accuracy errors into account.
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The electron density maps of DPPC (Figure 5.2) were constructed using up
to twelve orders of diffraction and the phase assignments generated by the swelling
series method (Figure 5.1). It is the higher order phases, however, which are most
difficult to phase unambiguously using the swelling series method. To judge the
importance of the higher orders, DPPC electron density maps (data from DPPC at
20 °C and 90% RH) have been constructed using between nine and twelve orders
(Figure 5.3). The graphs show that each subsequent higher order of diffraction
contributes only a small amount to the electron density map construction. The
contribution of each order to the electron density map also indicates the error level
that would be incurred by incorrectly phasing that order. If the phase assignment of
an order were incorrect, the electron density distribution would be shifted in an
equal but opposite direction from the true distribution by the inclusion of that order.
Any single higher order (orders 10, 11 or 12) phase assignment error would not
appear to greatly distort the calculated electron density distribution (Figure 5.3).
The 95% confidence limits for the DPPC electron density distribution were
calculated by a Monte Carlo simulation program, using twelve orders of diffraction
and either the variation (over all humidities studied) in diffraction data listed in
Table 5.1, or a standard deviation error limit for all diffraction orders of 6%
(Figure 5.4). Both structure factor amplitude error estimates produce similar 95%
confidence limits for the DPPC electron density distribution, with the 6% estimate
giving a slightly narrower confidence distribution. As the error limits of Table 5.1,
calculated from the variation of DPPC diffraction data, are likely to represent an
over-estimate, Figure 5.4 suggests that 6% is the error limit value to use for the
structure factors.
5.3.3 Pure bromolipid bilayers at 20°C.
Oriented samples of the bromolipid at 20°C diffracted out to twelve
meridional orders (Plate 5.2, Table 5.3). The swelling series plot used to phase the
diffraction data from bromolipid bilayers, at 20°C and between 98% and 57% RH,
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Figure 5.3 The electron density maps of DPPC bilayers constructed
using a variable number of diffraction orders. Diffraction data were
collected from oriented DPPC bilayers, at 20°C and between 98%
and 57% RH, and phased using the swelling series method. The
electron density maps of the 90% RH data were constructed using
between nine and twelve orders of diffraction and the swelling series
phase assignments (Figure 5.1). In all the electron density maps, the
DPPC phosphate headgroup and centre of the lipid layer can be
located at +22A and OA respectively. The outer orders (9-12), which
are the most difficult to phase using the swelling series method, each
only contribute a little to the overall electron density map
construction. The incorrect phasing of one of these outer orders (9-
12) would, therefore, only affect the electron density map
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Figure 5.4 The 95% confidence limits for the DPPC bilayer electron
density distribution. Only one half of the bilayer unit is shown,
where the centre of the lipid and water layers are located at OA and
28A, respectively. Diffraction data were collected from oriented
DPPC bilayer samples at 20°C and 90% RH and phased using the
swelling series method (Figure 5.1). The 95% confidence limits were
calculated using a Monte Carlo simulation program and twelve orders
of diffraction. Error limits for the structure factor amplitude data
were either derived from the variations of the DPPC data with
humidity (Table 5.1) or set at 6% (SD) for all orders. The two data
error limits produce similar 95% confidence limits. The DPPC
phosphate headgroups (22A), the ester linkages (17A) and the low
electron density terminal methyl region (OA) are all still clearly
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Figure 5.5 The swelling series plot used to phase the diffraction data
collected from oriented bromolipid bilayers at 20°C and between
98% and 57% RH. Diffraction data were collected out to a maximum
of twelve orders from the bromolipid bilayer samples. The symbols
represent the structure factor amplitude of each order plotted against
h/D (h is the order number and D is the bilayer thickness). The
plotted lines are spline curves fitted to the data, as estimates of the
form of the continuous Fourier transform. The bromolipid
continuous Fourier transforms are positively shifted compared with
the DPPC data (Figure 5.1), a result of the electron dense bromolipid
bromine atoms being located at the centre of the lipid layer (Franks
and Lieb, 1981).
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method of calculating continuous Fourier transforms for the data, then constructing
electron density maps using the chosen phases. The bromolipid structure factor
phase assignments and bilayer repeats, calculated using Bragg's law (equation 2.2),
are given in Table 5.2. In comparison with the swelling series plot for DPPC
(Figure 5.1), the continuous Fourier transform fitted to the bromolipid data is
shifted in the positive direction (Figure 5.5). The positive shift is a direct result of
having a large scattering mass at the centre of the bilayer (Franks and Leib, 1981).
The electron density maps of bromolipid bilayers at 20°C, and between 98%
and 57% RH, were constructed using up to twelve orders of diffraction and the
phase assignments obtained using the swelling series method (Figure 5.6). The
electron density maps locate the bromolipid phosphate headgroups and ester-linkage
regions at +21A and +17A respectively from the centre of the lipid layer (OA).
The bromolipid formed bilayers that were several Angstroms thinner than the
equivalent DPPC bilayers under the same conditions of temperature and humidity
(Tables 5.1 and 5.2). The reduction in bilayer thickness could be attributable to
several factors:
1) an increase in the lipid chain tilt angle;
2) bromolipid and DPPC bilayers hydrate to different extents;
3) interdigitation at the centre of the bilayer;
4) the bromine atom creates disorder at the centre of the lipid layer or along the
lipid chain thus shortening it by the creation of gauche bonds;
5) impurities in the phospholipid samples alter the bilayer structure.
No impurities were detected in either the bromolipid or DPPC bilayer samples by
TLC (Chapter 3) and the chain tilt angle theory can be tested by analysis of the
equilateral diffraction obtained from the membrane samples.
5.3.4 Measurement of the bromolipid and DPPC lipid chain tilt angle.
The [4.2A1] equilateral diffraction data from gel phase bilayers (Table 5.3)
provide a measure of the lipid chain tilt angle (Stumpel et al., 1983). Equilateral
[4.2A1] diffraction peaks were measured at between 23° ±1° and 25° ±1° above the
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Figure 5.6 The bromolipid bilayer electron density distribution maps
at 20°C. Diffraction data were collected from oriented bromolipid
bilayer samples at 20°C and between 98% and 57% RH, and phased
using the swelling series method (Figure 5.5). The electron density
maps were constructed using up to twelve orders of diffraction at
each humidity studied. The bromolipid phosphate headgroup, the
ester linkage group and the centre of the lipid layer can be located at
±21A, +17A and OA respectively. The bromolipid bromine atoms
increase the electron density at the centre of the lipid layer,
compared with the DPPC sn-2 lipid chain terminal methyl group
electron density (Figure 5.2). The electron density distribution maps
do not, however, take into account truncation or data accuracy
errors.
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equator from DPPC bilayers and between 23° ± 1 ° and 28° +1 ° from bromolipid
bilayers. The observation that bromolipid bilayers, at 20°C, are up to 2.3A thinner
than the equivalent DPPC bilayers might be an indication of a lipid chain tilt angle
difference between the two bilayer systems. The tilt angle data (Table 5.3),
however, show that DPPC and bromolipid form bilayers with lipid chains packed at
similar tilt angles. Assuming that DPPC lipid chains pack at an angle of «25° to
form a lipid layer of width 30A (Figure 5.2), the bromolipid lipid chain tilt angle
would have to increase from that of DPPC to 32° to decrease the bilayer thickness
by 2A [30/cos(25)=28/cos(32)]. Clearly such a large increase in chain tilt (7°) does
not occur in the bromolipid bilayer compared with the DPPC bilayer.
Table 5.3 shows the thickness of DPPC and bromolipid bilayers, the
difference in the angle of the [4.2A1] equilateral diffraction, and the difference in
bilayer thickness that the chain tilt angle difference accounts for. Whilst at 90% RH
the lipid chain tilt appears to account for up to lA of the bilayer thickness
difference between DPPC and bromolipid bilayers, there appears to be no
difference in the chain tilt angle between DPPC and bromolipid bilayers at 57%
RH, even though the bilayer thickness difference (2.3A) is at its greatest at this
humidity. It appears therefore that factors other than the lipid chain tilt angle act to
decrease the thickness of the bromolipid bilayers.
Table 5.3 Measurements of the [4.2A1] equilateral diffraction spot angle above the





















Decrease in a 33A
lipid layer attributed
to a change in the
chain tilt angle
98% 55.9 28 ±1° 57.9 25 ±1° 0.8A of 2.0A
90% 56.3 28 ±1° 58.0 24 ±1° l.OAof 1.7A
81% 56.7 27 ±1° 57.7 25 ±1° 0.5A of 1.0A
74% 55.7 25 ±1° 57.5 24 ±1° 0.2A of 1.8A
57% 54.8 23 ±1° 57.1 23 ±1° 0.0A of 2.3A
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5.4 Scaling the DPPC and bromolipid electron density distribution maps.
The magnitude of the zero order structure factor defines the mean scattering
density (Franks and Leib, 1981). However, the zero order cannot be collected as it
is lost in the main beam, making the placement of electron density on anything
other than a relative scale difficult. An absolute scale for electron density maps can
be achieved, but requires knowledge of the average lipid area, which is not
determined from the diffraction experiment (Wiener and White, 1991). The DPPC
and bromolipid electron density maps were, therefore, only placed on a relative
scale. To scale the electron density maps to one another, the DPPC electron density
map was multiplied by a factor which matched the height of its electron dense
phosphate headgroup with that of the bromolipid (Figure 5.7). To match the
headgroup peak heights, the DPPC electron density profiles, at every humidity were
multiplied by a factor of 1.2. This scaling, however, presumes that the phosphate
headgroups of the two phospholipids should actually produce the same peak height.
As the two phospholipids only differ at the centre of the lipid layer, far removed
from the headgroup, the scaling method was felt to be reasonable approach to take.
Although conformational differences of the DPPC and bromolipid headgroup and
glycerol backbone regions could result in the two phospholipids having distinct peak
heights, the electron density maps do not suggest such a difference to exist.
5.4.1 Comparison of the DPPC and bromolipid electron density distribution maps.
Comparison of the DPPC and bromolipid electron density maps (Figure 5.7,
data from bilayers at 90% RH) shows that the major difference between the two
systems lies at the centre of the lipid layer, the location of the electron dense
bromolipid bromine atoms. The bilayer thickness difference between the bromolipid
and DPPC bilayers (56.7-54.7A versus 58.0-57.lA respectively, at 20°C and 98-
57% RH) is ca 2A. As both the DPPC and bromolipid headgroups (+22A for
DPPC and +21A for bromolipid) are located 7A from the centre of the water layer
(±28A for DPPC and +27A for bromolipid), the electron density maps show that
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the disparity in bilayer thickness between DPPC and bromolipid may be attributable
to differences in the lipid chain layer.
The bromolipid minus DPPC difference map (Figure 5.7 [bottom], data
from bilayer samples at 20°C and 90% RH) reveals a large peak of electron
density, presumably the bromine atoms merging to form a single peak, at the centre
of the bromolipid lipid layer. The difference map (Figure 5.7 [bottom]) does not
have a level baseline, suggesting that structural differences between DPPC and
bromolipid exist, a fact already highlighted by the bilayer thickness measurements.
5.4,2 Comparison of the DPPC and bromolipid bilayers 95% confidence limits.
A Monte Carlo simulation program has been applied to the diffraction data
obtained from DPPC and bromolipid bilayers at 20 °C and 90% RH, using a
structure factor amplitude error limit of 6% for all diffraction orders (Figure 5.8).
The calculated 95% confidence limits (Figure 5.8) indicate that the DPPC and
bromolipid bilayers are structurally indistinguishable from the centre of the free
water layer (28A) to the ester linkage region (17A). Major structural differences
between the two bilayer systems occur over the entire lipid chain region (17A-0A),
with the largest difference being at the centre of the lipid layer.
A Monte Carlo simulation program was used to calculate the 95 %
confidence limits of the bromolipid minus DPPC difference map, using the
difference structure factor amplitude standard deviation of 8.5% (8.5% =V[6%2
+6%2]). The difference map indicates that the major difference between the
bromolipid and DPPC bilayers is the existence of a large peak of electron density at
the centre of the bromolipid lipid layer (-5 to +5A). The data suggests that the
bromine peak of Figure 5.9 has a height of 0.52 ±0.05 relative units.
5.5 Gaussian distribution fitting to the bromine peak
The DPPC minus bromolipid distribution at the centre of the lipid layer
(Figure 5.9) is putatively the electron density of two bromine atoms (more
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Figure 5.7 Comparison of the bromolipid and DPPC bilayer electron
density maps. Each of the electron density maps (top) were
constructed using twelve orders of diffraction, collected from
oriented bilayer samples at 20°C and 90% RH. The two systems
were scaled together by multiplying the DPPC profile by a factor of
1.2. Although the bromolipid and DPPC bilayers differ in thickness
(56;3A versus 58A respectively), their phosphate headgroups (22-
21A) and ester linkage groups (17A) are similarly situated. Larger
structure variations occur between the two bilayer structures in the
lipid layer (-15A to+15A). The bromolipid minus DPPC difference
electron density map (bottom) highlights the presence of the electron
dense bromolipid bromine atoms at the centre of the lipid layer.
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Figure 5.8 Comparison of the 95% confidence limits for the
bromolipid and DPPC bilayer electron density distributions. Only
one half of each bilayer unit is shown, where the centre of the lipid
and water layers are located at OA and 27-28A, respectively.
Diffraction data, collected from oriented bilayer samples at 20°C and
between 98% and 57% RH, were phased using the swelling series
method. The 95 % confidence limits were calculated using a Monte
Carlo simulation program and twelve orders of diffraction. Error
limits for the structure factor amplitude data were set at 6% (SD) for
all orders. The two systems were scaled together by multiplying the
DPPC profile by a factor of 1.2. The bromolipid and DPPC bilayers
are indistinguishable from the centre of the water layer (27-28A) to
the ester linkages (17A), when using the 95% confidence limit
bounds. The bromolipid bromine atoms clearly increase the electron
density at the centre of the lipid layer (0-4A). There also appears to
be another discernible difference in electron density (5A to 15A)
between the bromolipid and DPPC bilayers.
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Figure 5.9 The 95% confidence limits for the bromolipid minus
DPPC difference map. Diffraction data were collected from oriented
bilayer samples at 20°C and 90% RH and phased using the swelling
series method. Twelve orders of structure factor amplitude difference
values (bromolipid minus DPPC) were used in a Monte Carlo
simulation program to calculate the 95 % confidence limits for the
difference map electron density distribution. A structure factor
amplitude difference value error limit of 8.5% (SD) was also used in
the map calculation. The difference map indicates that the bromolipid
bromine atoms substantially increase the electron density at the centre
of the lipid layer. The bromolipid and DPPC bilayers also differ
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Figure 5.10 Gaussian fitting to the bromolipid minus DPPC
difference map at the centre of the lipid layer. Diffraction data,
collected from oriented bilayer samples at 20°C and 98% and 57%
RH (90% RH data shown), were phased using the swelling series
method. The difference map (-6A to+6A, shown above) was
constructed by Fourier transforming the difference in structure factor
amplitude values, between bromolipid and DPPC bilayers, out to
twelve orders. Two mirror image (about OA) Gaussian distributions
were adjusted in size, shape and position, until their combined
distribution fitted the difference map electron density distribution.
Assuming that the difference map profile is the result of the addition
of two bromine atoms, each with a Gaussian distribution, the above
graph suggests that the two bromolipid bromine atoms are separated
at the centre of the lipid layer by only 2A.
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accurately the electron density of two bromolipid bromine atoms minus two DPPC
methyl groups). Assuming that the subtraction peak at the centre of the lipid layer is
wholly due to the overlapping electron density of two bromine atoms having a
Gaussian distribution in the bilayer, the separation of the bromine atoms at the
centre of the bilayer can be obtained by fitting two Gaussian distributions to the
subtraction peak. Gaussian fitting to the bromolipid/DPPC subtraction data has been
performed (Figure 5.10) and shows that the subtraction peak can be described by
two Gaussian distributed atoms placed ca 2A apart.
5.6 Differential scanning calorimetry (DSC) study of bromolipid and DPPC.
The aim of the differential scanning calorimetry (DSC) experiments was to
study the thermal behaviour of the bromolipid, in comparison with DPPC. As the
bromolipid was expected to be used in diffraction experiments mixed with DPPC,
calorimetry experiments have also been performed on a 1:1 mixture of the two
lipids. The DSC study can be divided into two sections:
1) A study of the phase nature of fully hydrated bromolipid and DPPC between
10°C and 70°C.
2) A study of the phase nature of a fully hydrated 1:1 (wt) mixture of bromolipid
and DPPC between 10°C and 70°C.
DSC sample preparation and methodology are described in Chapter 3.
5.6.1 Results of DSC experiments.
Figure 5.11 shows a typical thermogram of heat flow versus temperature for
pure DPPC in excess water. The main peak at 42.5°C is the lipid chain melting
transition between the Pp- (gel ripple) and La (fluid) phases (Chapman et al., 1967).
The peak at 37.3°C is the well documented Lp< (gel lamellar) to Pp- (gel ripple)
(Rand et al., 1975; Janiak et al., 1976) pretransition. The peak at 26°C is an
experimental artefact and can be discounted. Figure 5.12 shows the thermogram of
a pure bromolipid sample in excess water. The main peak transition of bromolipid
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(33.7°C) occurs nearly 9° lower than the equivalent DPPC transition.
Thermograms were also collected from a 1:1 mixture of DPPC and bromolipid
(Figure 5.13), showing the lipid mixture to have a main transition at 36.7°C and a
pretransition peak at 31.8°C (Table 5.4).
5.6.2 Conclusions of the DSC study.
The calorimetry results (Table 5.4) show that bromolipid bilayers melt co¬
operatively in a similar fashion to those of DPPC, as indicated by the shape and
enthalpy of the lipid chain melting peaks (42.5°C and 33.7°C for DPPC and
bromolipid respectively, Figures 5.11 and 5.12). Although they differ in their main
phase melting temperature, both DPPC and bromolipid bilayers melt into the L„
conformation with a similar enthalpy. However, the chain melting events of DPPC
and bromolipid samples occur at temperatures 9° apart, suggesting that the
bromolipid gel phase lipid chain packing is disrupted by the bromine/methyl
exchange. The results also show that the bromolipid has a gel to ripple phase
pretransition of a much smaller enthalpy than DPPC. Both DPPC and bromolipid
bilayers below the pretransition temperature form Lp< phase bilayers, verified by the
X-ray diffraction work, but the bromolipid chains incorporating a bromine atom are
packing in a way possibly hindering Pp< phase formation.
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A 1:1 bilayer mixture of DPPC and bromolipid had a main phase transition
temperature that was intermediate between those of the pure species. The
bromolipid bromine atoms, at a lower bilayer concentration, have a less disruptive
effect on the bilayer packing in the mixed phospholipid bilayer, shown by the
increase in size of the pretransition peak and the increase in phase melting
temperatures.
5.7 Discussion of the bromolipid study.
X-ray diffraction patterns were collected from both oriented bromolipid and
DPPC samples at 20°C and between 98% and 57% RH. The diffraction data were
phased using the swelling series phasing method (Figures 5.1 and 5.5). Electron
density map construction has shown that the bromolipid forms bilayers of a similar,
but not identical, structure to those of DPPC (Figures 5.7 and 5.8). The major
difference between bromolipid and DPPC bilayers is the presence of an electron
dense region at the centre of the bromolipid lipid layer, presumably the bromine
atom location in the bilayer. The two systems, however, also differ significantly
across the entire lipid layer length (0 to 15A, Figure 5.8).
Both DPPC and bromolipid form gel Lp< phase bilayers at 20°C (Plates 5.1
and 5.2). The two species form bilayers that differ in thickness by 1-2.3A at 20°C
(Table 5.3), depending on humidity. Whilst the tilt angle data accounts for some of
the difference in bilayer thickness between DPPC and bromolipid in all but the 57%
RH bilayers, the bromolipid chain tilt does not increase by enough at any humidity
to wholly account for the bilayer thickness differences. It appears therefore that
factors other than chain tilt angle decrease the bromolipid bilayer thickness.
The bromine atoms of opposing bromolipid molecules in a bilayer structure
have been estimated as being ca 2k apart by Gaussian fitting to electron density
map subtractions (Figure 5.10). As these sn-2 chain terminals are so close in space,
this would suggest that the sn-1 chains, which penetrate deeper into the lipid layer
for symmetric chain phospholipids (Zaccai et al., 1979) must either interdigitate at
the centre of the lipid layer or be distorted from their DPPC conformation (Figure
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5.14). Whilst interdigitation of lipid chains has previously been described and
characterised (Shah et al., 1990; Huang and Mason, 1986; Mattai et al., 1987) and
would be a possible mechanism of reducing the bilayer thickness, a disorder at the
centre of the lipid layer might be the more likely explanation.
The decrease in bilayer thickness of 1A to 2.3A represents only a change of
0.5-1.15A per bromolipid molecule on either side of the membrane leaflet, less than
the length of a single carbon-carbon bond. While the decrease in bilayer thickness is
significant, i.e. some change has definitely happened, it does not necessarily
represent a large distortion of the DPPC structure. The bromolipid has been
synthesised for use in X-ray diffraction studies, primarily in mixtures with DPPC.
In such mixtures, the bromolipid would be expected to have an even smaller
disruptive effect on bilayer structure. The calorimetry results (Table 5.4) show that
mixing bromolipid one to one with DPPC produces a bilayer with physical
properties that approach those of pure DPPC. As the quantities of bromolipid
required to be introduced into a DPPC bilayer for a 'labelling' effect in X-ray
experiments may be quite small, it would have been useful to obtain calorimetry
data from DPPC bilayers containing only small amounts of bromolipid.
Although designed as a symmetric chain analogue, the bromolipid is a
mixed-chain phospholipid, as the sn-1 and sn-2 lipid chains differ in composition.
While most investigations of phospholipid systems examine phospholipids of
identical chain composition, more recently mixed-chain lipids have been studied
(Keough and Davis, 1979; Stumpel et al., 1981, 1983; Mason et al., 1981 a, b,
1983; Huang et al., 1983; Huang and Levin, 1983; Mcintosh et al., 1984; Lewis et
al., 1984; Tummler et al., 1984; Hui et al., 1984; Serrallach etal., 1984). Even
symmetric chain phospholipids form structures where the chains are
conformationally inequivalent. The observed phospholipid chain length difference is
related to the conformational inequivalence of the two acyl chains (Hitchcock et al.,
1974; Elder et al., 1977; Pearson and Pascher, 1979). Neutron diffraction (Buldt et
al., 1979; Zaccai et al., 1979) has established that the sn-1 chain of gel phase
DPPC penetrates deeper into the bilayer than the sn-2 chain by approximately 1.5
carbon-carbon bond lengths, as the initial segment of the sn-2 lipid chain lies
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perpendicular to the sn-1 chain. The difference in observed chain length becomes
more pronounced as the length of the sn-2 chain is reduced in length (Mattai et al.,
1987). To maximise van der Waals contacts in these gel phase bilayers, there must
be interdigitation of the acyl chains across the centre of the bilayer (Chen and
Sturtevant, 1981; Mason et al., 1981b; Huang et al., 1983; Hui et al., 1984). In
the absence of interdigitation, an energetically unfavourable chain packing situation
would occur, with voids created toward the terminal methyl groups.
Figure 5.14 is a diagrammatic view of the centre of the bromolipid bilayer.
The bromolipid bromine atoms have been estimated as being 2A apart by Gaussian
fitting to difference map data (Figure 5.10). If the bromolipid were structurally
similar to DPPC at the centre of the bilayer, then the sn-1 palmitoyl chains would
penetrate approximately 2A deeper into the centre of the bilayer than the bromine
atoms, resulting in the palmitoyl chains interdigitating by ca 1A. It can therefore be
concluded that bromolipid is not identical to DPPC at the centre of the bilayer. The
clashing of lipid chains at the centre of the lipid layer, which must result in






Figure 5.14 Illustration of events at the centre of the bromolipid lipid layer
suggested by the X-ray diffraction study. The sn-l terminus of DPPC has
previously been estimated as being 1.8A apart from the sn-2 terminus (Zaccai et
al., 1979). The bromine atom of bromolipid clearly marks the position of the sn-2
terminus. Gaussian fitting to the X-ray diffraction data suggests that the bromine
atoms of opposing bromolipid molecules in a bilayer are ca 2A apart. The sn-l
methyl groups of bromolipid would then have to interdigitate by 1.6A to be the
same distance away from the bromine atoms that the DPPC sn-l and sn-2 groups
have been found to be apart. The diagram suggests that the bromolipid must differ
from DPPC at the centre of the lipid layer, with the bromolipid sn-l palmitoyl
chains being interdigitated or the lipid chains being disordered.
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Chapter 6.
The use of bromolipid in isomorphous replacement experiments.
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6.1 X-ray diffraction study of mixtures of DPPC and bromolipid.
A novel brominated structural analogue of DPPC, the bromolipid, has been
synthesised (Chapter 3) and studied by X-ray diffraction and DSC (Chapter 5). The
diffraction and calorimetry studies have shown that the pure bromolipid and DPPC
differ in their bilayer conformation. A study of the bromolipid as mixtures with
DPPC was carried out with several objectives:
1) to see if the DPPC:bromolipid mixture bilayer structure approaches that of the
pure DPPC structure;
2) to use the DPPC:bromolipid mixture bilayer data to help elucidate
conformational differences between pure bromolipid and DPPC bilayer
structures;
3) to see if the bromolipid can act as a phasing agent in isomorphous replacement
experiments.
The bromolipid, used as a phasing agent, would only be expected to make
up a small proportion of the total lipid present in the membrane under study.
Therefore, irrespective of the pure bromolipid structure, if the bromolipid is
structurally similar to DPPC when mixed with DPPC (or only differs in a small and
predictable manner) then it might be suitable for use as a phasing agent. Three
different DPPC:bromolipid mixture ratios (1:1, 7:2 and 4:1) have been studied by
X-ray diffraction and the swelling series method (Franks and Leib, 1981; Torbet
and Wilkins, 1976). The two lipid mixture ratios which are dominated by DPPC
(7:2 and 4:1) were chosen to be of a similar composition so that the sensitivity of
the DPPC X-ray diffraction patterns to the presence of the bromolipid could be
assessed. The mixture bilayers were studied as oriented samples at 20°C and
between 98 % and 57% RH.
6.1.1 Swelling series data from the DPPC:bromolipid mixture bilayers.
Meridional diffraction data were collected out to a maximum of twelve
orders from the 1:1 DPPC:bromolipid mixture bilayers. A maximum of nine orders
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PLATE 6.1 The diffraction pattern collected from an oriented sample of a 1:1
mixture of DPPC and bromolipid at 20°C and 57% RH. Eleven meridional orders
of diffraction can be seen on the plate, along with a diffraction spot at 4.1A"1. The
4. lA1 diffraction spot indicates that the mixture bilayers form the chain tilted gel
(LpO phase.
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Table 6.1 Diffraction data for the 1:1 DPPCibromolipid mixture bilayer system.
Order number Phased structure factor data
1 -0.159 -0.149 -0.147 -0.143 -0.160
2 -0.029 -0.034 -0.044 -0.040 -0.025
3 +0.118 +0.122 40.136 40.134 40.112
4 -0.109 -0.126 -0.121 -0.121 -0.110
5 +0.021 +0.028 +0.027 40.025 40.035
6 -0.033 -0.044 -0.037 -0.032 -0.052
7 0 +0.015 +0.012 0 0
8 +0.027 40.037 +0.024 40.018 +0.044
9 -0.032 -0.025 -0.025 -0.037 -0.039
10 0 -0.027 0 -0.011 -0.012




98% 90% 81% 74% 57%
Bilayer
thickness (A)




26° ±1° 24° ±1° 24° ±1°
Table 6.2 Diffraction data for the 7:2 DPPC:bromolipid mixture bilayer system.
Order number Phased structure factor data
1 -0.191 -0.191 -0.202
2 -0.085 -0.073 -0.054
3 +0.121 40.121 40.109
4 -0.112 -0.125 -0.112
5 0 0 0
6 -0.028 -0.047 -0.029
7 -0.022 -0.040 0
8 0 0 -0.017








Table 6.3 Diffraction data for the 4:1 DPPC:bromolipid mixture bilayer system.
Order number Phased structure factor data
[_ i -0.198 -0.185 -0.185
2 -0.084 -0.092 -0.098
3 +0.077 40.109 40.109
4 -0.098 -0.140 -0.142
5 0 +0.026 40.022
6 -0.034 -0.036 -0.035
7 -0.036 -0.037 -0.028
8 0 0 0







were collected from the 7:2 and 4:1 DPPC:bromolipid mixture bilayer systems.
Plate 6.1 shows a typical diffraction pattern collected from the 1:1 mixture bilayers,
with eleven meridional orders and a 4.lA1 equilateral spot indicative of
phospholipids in the Lp< tilted lipid chain phase (Chapman et al., 1967; Levine
1972, 1973). The meridional diffraction spacing and Bragg's law (equation 2.2)
were used, without phase information, to calculate the bilayer repeat distances (D)
for the mixture bilayers (Tables 6.1, 6.2 and 6.3). The 1:1 mixture bilayers have a
bilayer thickness that ranges between 57.0A and 56.5A, depending on humidity,
which are intermediate between those measured from the two pure species (56.7-
55.2A and 58.0-57.OA for bromolipid and DPPC respectively). The bilayer
thickness measurements from the 7:2 (58.OA) and 4:1 (58.0-58.7A)
DPPC:bromolipid mixture bilayers (Tables 6.2 and 6.3) are comparable to those
measured from pure DPPC bilayers (57.5 to 58.OA).
Except for the seventh order, the swelling series method assigned the same
phases to the 1:1 mixture diffraction data that were assigned to the pure DPPC
bilayer data (Figures 6.1 and 5.1). The second order, assigned a positive phase in
the pure bromolipid data (Figure 5.5), changes to a negative phase in the 1:1
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Figure 6.1 The swelling series plot used to phase the diffraction data
collected from 1:1 (DPPC:bromolipid) mixture bilayers. Diffraction
data were collected out to twelve orders from oriented bilayer
samples, at 20°C and between 98% and 57% RH. The symbols
represent the structure factor amplitude of each diffraction order
plotted against h/D (h is the order number and D is the bilayer
thickness). The plotted lines are spline curves fitted to the data, as
estimates of the form of the continuous Fourier transform.
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higher bromolipid concentration than the 4:1 mixture, the diffraction data collected
from both of these bilayer systems were similar (Tables 6.2 and 6.3) and have both
been allocated the same phases that were assigned to the pure DPPC bilayer data
(Figures 6.2, 6.3 and 5.1). The eighth order of the 7:2 and 4:1 mixture bilayer
data, which was assigned a positive phase for both the pure bromolipid and 1:1
mixture bilayer data (Figures 5.5 and 6.1), were either recorded as zero values, or
assigned a negative phase (Figures 6.2 and 6.3).
6.2 Electron density map construction using the mixture bilayer diffraction data.
Electron density maps of 1:1 DPPC:bromolipid bilayers were constructed
using up to twelve orders of diffraction (Figure 6.4). The maps locate the 1:1 lipid
mixture phosphate headgroups and ester linkage regions at ±21A and ±17A
respectively from the centre of the lipid layer (OA). Electron density maps of both
7:2 and 4:1 DPPC:bromolipid mixture bilayers were also constructed, using only
nine orders of diffraction (Figures 6.5 and 6.6). The electron density maps locate
both the 7:2 and 4:1 DPPC:bromolipid mixture bilayer phosphate headgroups at
+22A from the centre of the low electron density lipid layer (OA). The ester-
linkage region is more difficult to locate in these electron density maps (Figures 6.5
and 6.6), compared with the 17A peak in the 1:1 mixture bilayer (Figure 6.4).
6.2,1 Scaling the DPPC and bromolipid mixture electron density distribution maps.
The DPPC and bromolipid electron density maps were only placed on a
relative scale (Section 5.4). To scale the electron density maps to one another, the
DPPC electron density map was multiplied by a factor which matched the height of
its electron dense phosphate headgroup with that of the bromolipid (Figure 5.7). To
match the headgroup peak heights, the DPPC electron density profiles were
multiplied by a factor of 1.2.
The mixture bilayers were also scaled to the bromolipid data by matching up
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Figure 6.2 The swelling series plot used to phase the diffraction data
collected from 7:2 (DPPCibromolipid) mixture bilayers. Diffraction
data were collected out to nine orders from oriented bilayer samples,
at 20°C and either 98%, 90% or 74% RH. The swelling series has
assigned the same phases to the 7:2 mixture bilayer data as those
assigned to the pure DPPC bilayer data (Figure 5.1). The symbols
represent the structure factor amplitude of each order plotted against
h/D (h is the order number and D is the bilayer thickness). The
plotted lines are spline curves fitted to the data, as estimates of the
form of the continuous Fourier transform.
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Figure 6.3 The swelling series method plot used to phase the
diffraction data collected from 4:1 (DPPCibromolipid) mixture
bilayers. Diffraction data were collected out to nine orders from
oriented bilayer samples, at 20°C and either 98%, 90% or 74% RH.
The swelling series has assigned the same phases to the 4:1 mixture
bilayer data that were assigned to both the 7:2 mixture bilayer
(Figure 6.2) and the pure DPPC bilayer data (Figure 5.1). The
symbols represent the structure factor amplitude of each order plotted
against h/D (h is the order number and D is the bilayer thickness).
The plotted lines are spline curves fitted to the data, as estimates of
the form of the continuous Fourier transform.
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Figure 6.4 The electron density distribution maps of 1:1
(DPPC:bromolipid) mixture bilayers. The electron density maps
were constructed using up to twelve orders of diffraction collected
from oriented samples at 20°C and between 98% and 57% RH and
phased using the swelling series method (Figure 6.1). The DPPC
phosphate headgroup, the ester linkage group and the lipid layer can
be located at ±2lA, +17A and -15A to +15A respectively. The
electron density distribution maps do not, however, take truncation
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Figure 6.5 The electron density distribution maps of 7:2
(DPPC:bromolipid) mixture bilayers. The electron density maps
were constructed using nine orders of diffraction, collected from
oriented samples at 20°C and either 98%, 90% or 57% RH, and
phased using the swelling series method (Figure 6.2). The DPPC
phosphate headgroup and the lipid layer can be located at +22A and
-15A to +15A respectively. The ester-linkage group, locatable at
+ 17A in the twelve order 1:1 mixture bilayer maps (Figure 6.4), is
less obvious. The electron density distribution maps do not take into
account truncation or data accuracy errors.
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Figure 6.6 The electron density distribution maps of 4:1
(DPPC:bromolipid) mixture bilayers. The electron density maps
were constructed using nine orders of diffraction, collected from
oriented samples at 20°C and either 98%, 90% or 57% RH, and
phased using the swelling series method (Figure 6.3). The DPPC
phosphate headgroup and the lipid layer can be located at +22A and
-15A to +15A respectively. The ester-linkage group, located at
+ 17A in the twelve order 1:1 mixture bilayers (Figure 6.4), is less
obvious. The electron density distribution maps do not take into
account truncation or data accuracy errors.
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mixture profiles by a factor of 1.1 and both the 7:2 and 4:1 mixture bilayers by a
factor of 1.2 (the same factor applied to pure DPPC). The scaling factor required to
match the phosphate peak heights, therefore, appears to relate to the concentration
of bromolipid in the bilayer.
6.2.2 Comparison of pure DPPC, 1:1 mixture and pure bromolipid bilayers.
The electron density profiles of pure DPPC, 1:1 mixture and bromolipid
bilayers at 20°C and 90% RH, all constructed using twelve orders of diffraction,
are compared in Figure 6.7. The maps of the three systems show a progression
from a pure bromolipid to a pure DPPC bilayer structure (Figure 6.7), where the
lipid chain terminal region (-5 to +5A) electron density increases markedly with the
proportion of bromolipid in the bilayer. Increasing the bromolipid concentration, to
form a 1:1 mixture, significantly decreases the DPPC bilayer thickness (Table 6.4).
There appears, however, to be little variation in the phosphate headgroup
separation, across the water layer, compared with the difference in bilayer thickness
between the three systems (the two pure species and the 1:1 mixture). The variation
in bilayer thickness appears to be attributable to a decrease in the lipid layer, rather
than the water layer, thickness.
Table 6.4 Comparison of electron density data for DPPC, bromolipid and the 1:1
mixture at 20°C and 90% RH. Twelve orders of diffraction were used to construct







the water layer (A)
bromolipid 56.3 ±0.2 13.8 ±0.2
1:1 mix 56.8 ±0.2 14.1 ±0.2
7:2 mix 58.1 ±0.2 14.0 ±0.2 j
4:1 mix 58.2 ±0.2 14.0 ±0.2
DPPC 58.0 ±0.2 14.1 ±0.2
150
-30 -20 -10 0 10 20 30
















Figure 6.7 Comparison of the bromolipid (top), 1:1 mixture (middle)
and DPPC (bottom) bilayer electron density distribution maps. The
electron density maps were all constructed using twelve orders of
diffraction, collected from oriented samples at 20°C and 90% RH
and phased using the swelling series method. The 1:1 mixture and
pure DPPC maps were scaled to the pure bromolipid map by
multiplying the profiles by a factor of 1.1 and 1.2 respectively. The
three electron density maps show a progression from a pure DPPC to
a pure bromolipid bilayer, where the electron density at the centre of
the lipid layer increases with the bromolipid concentration. The
electron density distribution maps do not take into account
experimental errors.
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6.2.3 Comparison of 7:2 mixture, 4:1 mixture and pure DPPC bilayers.
The electron density maps of 7:2 and 4:1 DPPC:bromolipid mixture bilayers
and pure DPPC bilayers (Figure 6.8) have all been constructed using nine orders of
diffraction. The level of truncation error introduced into the DPPC bilayer structure
from using only nine orders of diffraction to construct electron density maps is
indicated in Figure 5.3. The electron density maps of Figure 6.8 suggest that a
small quantity of bromolipid in a DPPC bilayer increases the electron density at the
centre of the lipid layer, but also decreases the electron density at ± lOA. The
electron density increase is presumably attributable to the insertion of bromine
atoms into the centre of the lipid bilayer, whilst the decrease in electron density, at
+ 10A, has an unknown origin.
6.3 The 95% confidence limits of the mixture bilayer electron density maps.
The 95 % confidence limits for the electron density distribution across the
mixture (1:1, 7:2 and 4:1) bilayers have been estimated by a Monte Carlo
simulation programme. The confidence limits were calculated using a standard
deviation error limit estimate of ± 6% for all structure factor amplitude orders.
Comparing the 95 % confidence limits for the 1:1 mixture bilayer with those of pure
DPPC bilayers (Figure 6.9) shows that there are significant differences between the
two systems at +10A (the lipid chain layer), +18A (the ester linkage region) and
OA (the centre of the lipid layer). Any apparent distinctions between the two
systems across the headgroup region (+20-24A) are due to there being a difference
in bilayer thickness and all measurements being made relative to the centre of the
lipid layer.
Comparing the 95% confidence limits of the 4:1 and 7:2 mixture bilayer
systems with the pure DPPC system (Figure 6.10) shows that the addition of a
small quantity of bromolipid to DPPC appears to increase the bilayer electron
density at the centre of the lipid layer (OA), although not significantly for the 4:1
bilayer when using a structure factor amplitude error limit of 6%. The 95%
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Figure 6.8 Comparison of the 7:1 (top), 4:1 mixture (middle) and
pure DPPC (bottom) electron density maps. The electron density
maps were all constructed using nine orders of diffraction, collected
from oriented samples at 20°C and 90% RH and phased using the
swelling series method. Each of the profiles were scaled to that of
pure bromolipid by multiplication to match phosphate peak heights,
by a factor of 1.2. Using nine orders of diffraction, the maximum
available for the 4:1 and 7:2 mixture samples, introduces truncation
error into the pure DPPC structure (Figure 5.3), if not all three of
the structures shown above. Adding a small quantity of bromolipid to
the DPPC bilayer increases the electron density at the centre of the
lipid layer (OA). There also appears, however, to be a decrease in
electron density at ±10A as the bromolipid concentration increases.
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Figure 6.9 Comparison of the 1:1 (DPPC:bromolipid) mixture and
pure DPPC 95 % confidence limits for the electron density
distribution across the bilayer. Diffraction data were collected from
oriented bilayer samples at 20°C and 90% RH and phased using the
swelling series method. The 95% confidence limits, for the electron
density distribution across the bilayer, were calculated using a Monte
Carlo simulation program and twelve orders of diffraction. Error
limits for the structure factor amplitude data were set at 6% (SD) for
all orders. The 1:1 mixture and pure DPPC maps were scaled to the
pure bromolipid map by multiplying the profiles by a factor of 1.1
and 1.2 respectively. The comparison shows that the addition of
bromolipid to DPPC, to form a 1:1 mixture, significantly increases
the electron density at the centre of the lipid layer (OA). Other
significant differences between the two bilayer systems, at ±10A and
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Figure 6.10 Comparison of the 95% confidence limits for the 4:1
mixture, 7:2 mixture and the pure DPPC bilayer electron density
distributions. Diffraction data were collected from oriented bilayer
samples, at 20°C and 90% RH, and phased using the swelling series
method. The 95% confidence limits for the electron density
distribution across the bilayer were calculated using a Monte Carlo
simulation program and twelve orders of diffraction. Error limits for
the structure factor amplitude data were set at 6% (SD) for all
orders. Each of the profiles were scaled to that of pure bromolipid by
multiplication to match phosphate peak heights, by a factor of 1.2.
The 4:1 and 7:2 map comparisons with DPPC (top and middle)
shows that the addition of a small quantity of bromolipid to DPPC
appears to increase the bilayer electron density at the centre of the
lipid layer (OA), although not significantly in the case of the 4:1
mixture bilayer. The 4:1 and 7:2 mixture map comparison (bottom)
shows that the two bilayer systems only differ significantly at + 10A.
The origin of this structural difference is unknown.
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confidence limits for the distribution of electron density in the 4:1 and 7:2 mixture
bilayers (Figure 6.10, bottom) suggests that the small increase in bromolipid
concentration, from the 4:1 to 7:2 lipid ratio, reduces the electron density at 10A,
without significantly increasing the electron density at OA.
6.4 Electron density difference maps.
Difference maps have been constructed to analyse the pure DPPC, lipid
mixture (1:1, 7:2 and 4:1) and bromolipid bilayer structures (Figures 6.11 and
6.12). The bromolipid minus 1:1 DPPC:bromolipid mixture difference map (Figure
6.11 (a)) has a large peak in electron density at OA, due to the increase in bromine
atom concentration. The decrease in electron density along the lipid chain layer (4-
15A) that was shown to be a difference between pure bromolipid and pure DPPC
bilayers (Figure 5.8), is also evident between the pure bromolipid and 1:1 mixture
bilayers. The bilayer thickness difference between bromolipid and 1:1 mixture
bilayers is approximately 0.5A (Table 6.1 and 5.2). The difference map baseline
oscillates around zero electron density, and may be due to a combination of scaling,
truncation, changes in bilayer thickness and experimental errors.
The 1:1 lipid mixture minus pure DPPC bilayer difference map (Figure 6.11
(b)) reveals a sharp electron density peak at the centre of the lipid layer due to the
bromolipid bromine atoms. Calculating the electron density distribution confidence
limits (Figure 6.9) showed that the 1:1 mixture and DPPC bilayer systems differed
at OA, ±10A, and ±18A, all regions highlighted in the difference map. The large
oscillations of the difference map baseline, between 5 and 28A, may also arise due
to the large difference in bilayer thickness between the pure DPPC and 1:1
DPPC:bromolipid bilayers (1.2A at 20°C and 90% RH). The 1:1 mixture minus
DPPC and the bromolipid minus 1:1 mixture difference maps both have an electron
density peak at OA of a similar magnitude (0.25 versus 0.27 relative electron
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Figure 6.11 Electron density difference maps of a) bromolipid minus
1:1 (DPPC:bromolipid) mixture, b) 1:1 (DPPC:bromolipid) mixture
minus DPPC and c) bromolipid minus DPPC. The maps were
created using twelve orders of diffraction that were collected from
bilayer samples at 20°C and 90% RH. The difference profiles show
that the major effect of adding bromolipid to DPPC is to increase the
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Figure 6.12 Comparison of the pure bromolipid minus DPPC and the
three DPPC:bromolipid (1:1, 7:2 and 4:1) mixture minus DPPC
electron density difference maps. All the data shown were collected
from bilayers at 20°C and 90% RH. The graph shows that increasing
the bromine atom concentration in the bilayer increases the electron
density at the centre of the lipid layer (OA). Increasing the bromine



































The pure bromolipid minus DPPC difference map (Figure 6.11 (c)) shows
that the main difference feature between pure DPPC and pure bromolipid bilayers is
the increase in electron density at the centre of the lipid layer. Another feature of
the bromolipid minus DPPC difference map is the decrease in electron density,
centred at ± 10A, in the lipid chain region. A reduction in electron density could
result from a reduction in lipid chain tilt, which would also increase the bromolipid
bilayer thickness (which is not the case). The chain tilt angle observed in the 1:1
mixture data does not markedly differ from the pure DPPC or bromolipid measured
chain tilt angles (Tables 6.1 and 5.4).
All three difference maps of Figure 6.11, show a single peak at the centre of
the lipid layer, attributable to the two bromine atoms, suggesting that the bromine
atoms are close together in space (ca 2A in the pure bromolipid bilayer). The
difference map of bromolipid minus 1:1 (Figure 6.11 (a)) has a wider bromine
difference peak than that of the 1:1 minus DPPC difference map (Figure 6.11 (b)).
It may be that the more bromolipid there is present in the bilayer the more
disordered the chain terminal packing becomes, widening the bromine atom
distribution. Also, as the bromolipid concentration increases, the smaller the bilayer
thickness gets and the closer would the sn-1 and sn-2 lipid chain terminals become
in space, making an ordered structure at the centre of the bilayer less likely. Chain
terminal methyl groups, being sterically large, pack unfavourably next to similar
methyl groups of opposing molecules in the bilayer (Zaccai et al., 1979), preferring
to pack next to the smaller methylene groups.
The bromolipid and DPPC:bromolipid mixture minus DPPC difference
maps have all been superimposed to form one diagram (Figure 6.12). The size of
the difference peak at the centre of the lipid layer increases with the concentration
of bromolipid in the bilayer, strengthening the evidence that the subtraction peak is
attributed to bromine atoms at the centre of the lipid layer. The difference map
trough at ± 10A also appears to relate to the concentration of bromolipid in the
bilayer, with the region decreasing in electron density as the bromolipid
concentration increases. Comparison of the DPPC and bromolipid mixture electron
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density maps suggests that other features of the difference maps, such as the trough
at +25A, are merely artefacts of the subtraction method.
Confidence limits for the difference maps of Figure 6.12 (Figures 5.9 and
6.13) were calculated using a Monte Carlo simulation program and structure factor
amplitude error limits of 6% (SD). The maps reinforce the observation of the
growth of the bromine peak at OA and the decrease in electron density at ± 10A, as
the bromolipid concentration increases. The confidence limits have been used to
measure the heights and accuracy of the putative bromine peak in the difference
maps of Figure 6.12. The bromine peak height versus bromine atom concentration
(Figure 6.14) plots almost as a straight line, strongly suggesting a link between the
two.
6.5 Variation of structure factor amplitude data on exchange of bromolipid for
DPPC in the bilayer.
The general trend that increasing the proportion of bromolipid in a bilayer
positively shifts the continuous Fourier transform is demonstrated in Figure 6.15.
To observe a uniform positive shift across all orders would require there to be a
single bromine atom of point width at the centre of the bilayer, which is not the
case here. The bromolipid bilayer has two finite width (1.85A) bromine atoms
which are located approximately lA either side of the centre of the lipid layer. The
structure factor amplitude data is also affected by changes in bilayer structure and in
particular by variations in the bilayer thickness, which accompanies the addition of
bromolipid to DPPC bilayers. This is seen as an alteration in the sampling, in
reciprocal space, of the continuous Fourier transform.
In general, the bromolipid bilayer continuous Fourier transform is positively
shifted compared with the DPPC/DPPC:bromolipid mixture bilayer continuous
Fourier transforms (Figure 6.15). The effect that adding bromolipid to a bilayer has
on the structure factor amplitude data can be used as a phasing method. From the
intensity change that occurs on the addition of bromolipid, it should be possible to
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Figure 6.13 The 95% confidence limits for a) 4:1 mixture minus
DPPC, b) 7:2 mixture minus DPPC and c) 1:1 mixture minus DPPC
electron density difference distributions. Diffraction data were
collected from oriented bilayer samples at 20°C and 90% RH and
phased using the swelling series method. The 95% confidence limits
for the electron density distribution across the bilayer were calculated
using a Monte Carlo simulation program and either nine (graphs a,
b) or twelve (graph c) orders of diffraction. Error limits for the
structure factor amplitude difference data were set at 8.5% (SD) for
all orders. The equivalent bromolipid minus DPPC difference map is
shown in Figure 5.9. The graphs show that increasing the bromine
atom concentration in the bilayer increases the electron density at the
centre of the lipid layer (OA). Increasing the bromine atom
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Figure 6.14 A plot of the bilayer bromine atom concentration versus
the bromine atom difference map peak height. Diffraction data were
collected from oriented bilayer samples at 20 °C and 90% RH and
phased using the swelling series method. Difference maps were
constructed by Fourier transforming either the bromolipid minus
DPPC or DPPC:bromolipid (1:1, 7:2 and 4:1) mixture structure
factor amplitude difference data. Bromine atom peak error bar values
were obtained using a Monte Carlo simulation program to estimate
the 95 % confidence limits for the bilayer electron density
distributions. The putative bromine atom peak height plots almost as
a straight line against bromine atom concentration, strengthening the
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Figure 6.15 A plot of the pure DPPC, DPPCibromolipid (1:1, 7:2
and 4:1) mixtures and pure bromolipid structure factor amplitude
data. The diffraction data were collected from oriented bilayer
samples at 20°C and 90% RH. The plot shows that there is a
relationship between the bromolipid bilayer concentration and the
structure factor amplitude data. Increasing the bromolipid
concentration tends to shift the structure factor amplitude values in
the positive direction.
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Table 6.5 indicates the difference in diffraction data between bromolipid,
and DPPC:bromolipid mixture, bilayers and pure DPPC bilayers (nine orders,
collected at 90% RH). Adding the bromolipid to DPPC bilayers generally shifts the
structure factor amplitude values in the positive direction. The greater the increase
in bromolipid concentration, the greater is the shift in the diffraction data. It is,
however, a change in order intensity, not amplitude, that is observed on the
diffraction patterns which is dependant on the original diffraction phase. For
example, a negative phase amplitude order that is positively shifted on addition of
bromolipid would result in the observed diffraction intensity decreasing in
magnitude. Conversely, a positive phase amplitude order that is positively shifted
on addition of bromolipid would increase the observed magnitude of diffraction
intensity. The described decrease in intensity may not hold true, however, if a
positively shifted negative phase changes phase. The positively shifted negative
phase, which might be expected to get smaller, may either get smaller or larger in
intensity, depending on the original size of the amplitude and magnitude of the
positive shift.
Table 6.5 Changes in the structure factor amplitude data as the bromolipid
concentration in the bilayer increases.
Difference structure factor amplitudes out to nine orders for
bromolipid (and mixtures) minus DPPC. The data, collected











1 0.000 -0.006 40.036 40.071
2 40.002 40.021 40.060 40.113
3 40.023 40.035 40.036 40.121
4 40.008 40.023 40.022 40.041
5 40.001 -0.025 40.003 40.036
6 40.021 40.010 40.013 40.038
7 -0.003 -0.006 40.049 40.034
8 40.027 40.027 40.064 40.047
9 0.000 40.011 40.011 40.015
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6.6 Conclusions of DPPC:bromolipid mixture study.
In summary, the bromolipid has been studied in three different bilayer
mixtures with DPPC (4:1, 7:2 and 1:1) by X-ray diffraction. Both the 4:1 and 7:2
DPPC: bromolipid mixture bilayers have a bilayer thickness similar to that measured
from pure DPPC bilayers (Table 6.4). The 1:1 mixture bilayers have a bilayer
thickness that is closer in magnitude to that of pure bromolipid than pure DPPC
bilayers. The swelling series was used to phase the mixture bilayer diffraction data
(Figures 7.1, 7.2 and 7.3). Both the 4:1 and 7:2 DPPC:bromolipid mixture bilayer
data were assigned the same phases that were assigned to the pure DPPC bilayer
data, supporting the validity of the phase assignments. Increasing the bromolipid
concentration in the bilayer generally causes a positive shift the structure factor
amplitude values (Figure 6.15, Table 6.5). The positive shift is highlighted by the
change in phases (negative to positive), and appearance of zero values, of certain
order numbers as the bromolipid concentration increases. For example, the eighth
order, assigned a negative phase in the pure DPPC data, was either phased negative
or appeared as a zero value in the 4:1 and 7:2 mixture data and was assigned a
positive phase in the 1:1 mixture and pure bromolipid bilayer data (Figures 6.1 and
5.5). The second order, assigned a negative phase in the 1:1 mixture data, changes
to a positive phase in the pure bromolipid bilayer data (Figure 5.5).
Mixture bilayer (1:1, 7:2 and 4:1 DPPC:bromolipid) electron density maps
(Figures 6.4, 6.5 and 6.6) show that the phospholipid headgroup position (±21-
o
22A) varies little with either humidity or, unlike the bilayer thickness, bromolipid
concentration (Table 6.4). As the bromolipid concentration in the bilayer increases,
a growth in electron density at the centre of the lipid layer appears in the bilayer
profiles (Figure 6.7). Confidence limits (95%) calculated for the electron density
distributions reinforce the observation of a growth in electron density at OA as the
bromolipid concentration increases (Figures 6.9 and 6.10). The 95% confidence
limits also indicate that a significant decrease in electron density occurs, centred at
+ 10A, as the bromolipid concentration increases (Figure 6.10, middle). Electron
density difference maps also highlight both the growth of the bromine atom peak at
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OA and the decrease in electron density at ± 10A as the bromolipid concentration in
the bilayer increases (Figures 6.12, 6.13 and 6.14).
Generally, adding bromolipid to DPPC bilayers shifts the structure factor
amplitude values in the positive direction (orders 1 to 9, Table 6.5). The shift in the
diffraction data can be used as a phasing method, as changes in observed intensity
are dependent on the original phase of the order. The bromolipid method of data
phasing has the potential to be more conclusive than the swelling series method. Not
only will the diffraction data of a bilayer sample vary in a predictable way with
bromolipid concentration, that allows the data to be phased, but the reconstructed
electron density maps will also show a bromine atom peak of a predictable size and
position in the bilayer.
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Chapter 7.
Bromolipid and DPPC in the fluid (Lg) phase.
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7.1 Studying the bromolipid and DPPC in the fluid (Lra) phase.
Fluid (La) phase bilayers of the bromolipid and DPPC were studied by
X-ray diffraction and the swelling series method. The aim of the study was to see
whether structural differences that exist between the gel phase bilayers (Chapter 5)
also exist in the fluid phase. The study also investigated the potential of using the
bromolipid as a phasing agent in fluid phase bilayers.
7.2 Diffraction data from fluid phase DPPC bilayers.
Oriented DPPC bilayers were studied by X-ray diffraction at either 46°C,
50°C or 53°C, and between 98% and 57% RH. Plate 7.1 shows a typical fluid
phase diffraction pattern collected from DPPC bilayers in which eight meridional
orders of diffraction are clearly visible. The DPPC bilayer thickness was calculated
using Bragg's law (equation 2.2) and the meridional diffraction spacing, at each
temperature and humidity studied (Table 7.1). Sharp differences in bilayer thickness
resulting from a small adjustment in environmental conditions, such as temperature
or humidity, may indicate the occurrence of a phase change (Luzzati, 1968). The
bilayer thickness results show that the phase adopted by DPPC was dependent on
the sample humidity as well as the temperature (Table 7.1). The thickness of the gel
phase DPPC bilayers (Table 7.1, 56.2-57.2A bilayers) decreases markedly when
the phospholipids adopt the fluid phase conformation (Table 7.1, 51.5A to 53.9A
bilayers). These results are in line with the previous observation that increasing the
content of water in the bilayer decreases the phospholipid phase melting temperature
(Chapman etal., 1967).
A maximum of eight orders were collected from the fluid phase DPPC
bilayer samples, compared with up to fourteen collected from gel phase bilayers
(Figure 5.1). The fluid phase DPPC diffraction were phased using the swelling
series method (Figure 7.1). The phases independently assigned to the fluid phase
DPPC data using the swelling series method are identical to those assigned to the
gel phase bilayer data (Tables 7.1 and 5.1), supporting their assignment.
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PLATE 7.1 The diffraction pattern collected from pure DPPC bilayers in the fluid
(La) phase. The pattern was collected from an oriented DPPC sample at 53 °C and
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Figure 7.1 The swelling series plot used to phase the diffraction data
collected from fluid phase bilayers of pure DPPC. The diffraction
data were collected from oriented DPPC bilayers at either 46°C,
50°C or 53°C and between 98% and 57% RH. A maximum of eight
orders were collected from the fluid phase DPPC bilayer samples.
The symbols represent the structure factor amplitude of each order
plotted against h/D (h is the order number and D is the bilayer
thickness). The plotted lines are spline curves fitted to the data, as
estimates of the form of the continuous Fourier transform.
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98% 53.9 52.4 52.2
90% 57.2 52.2 -
81% - 56.5 51.6
74% - 56.2 51.8
57% 56.8 56.6 51.5
7.2.1 Electron density maps of fluid (L„) phase DPPC bilayers.
Electron density maps of fluid (La) phase DPPC bilayers at 46°C, 50°C and
53 °C (Figure 7.2) were constructed using the maximum number of diffraction
orders available (Table 7.2). The maps locate the fluid phase DPPC phosphate
headgroups at +20A from the centre of the lipid layer. The fluid phase DPPC
phosphate to phosphate headgroup distance, across the lipid layer, is therefore ca
4A shorter than that measured from the gel phase bilayers at 20 °C (40A versus
44A, Figures 5.2 and 7.2). Lipid chain carbon-carbon bonds, that are in the trans
form in gel phase bilayers, can adopt a gauche bond conformation in the fluid phase
bilayers, substantially reducing the width of the lipid layer.
More orders of diffraction were collected from fluid phase DPPC bilayers at
53°C (8 orders) than at 46°C or 50°C (6 orders), a fact reflected by the higher
resolution diffraction patterns obtained at 53°C (Plate 7.2). The effect of higher
orders (5-8) on the calculation of the DPPC electron density distribution has been
assessed by calculating electron density maps using between five and eight orders of
diffraction (Figure 7.3, data for DPPC at 53°C and 74% RH). The five order
electron density map agrees well with the higher resolution eight order map. With
increasing orders used to construct the maps, little change is seen in the position of
the DPPC phosphate group at +20A, in contrast to the lipid layer region which
becomes less rounded in shape. The electron density maps constructed using a
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Figure 7.2 The electron density distribution maps of fluid phase
DPPC bilayers. Diffraction data were collected from oriented bilayer
samples, at 46°C, 50°C and 53°C and between 98% and 57% RH,
and phased using the swelling series method (Figure 7.1). The centre
of the water layer, phosphate headgroups and centre of the lipid layer

























Figure 7.3 The construction of fluid phase DPPC bilayer electron
density maps, using a variable number of diffraction orders. The
maps were constructed using between five and eight of the diffraction
orders collected from DPPC (53 °C and 74% RH) and phased using
the swelling series method (Figure 7.1). The graphs indicate the
effect that increasing orders of diffraction have on the electron
density map construction. Comparison of the graphs also indicates
the level of truncation error present in electron density maps
constructed using less than the maximum available orders. The level
of error that would be introduced into a bilayer structure by the
incorrect phasing of an order, i.e. double the effect of not using that
order in the construction, can also be determined from the maps.
Comparison of the maps shows that the position of the DPPC
phosphate headgroup (±20A) only varies slightly with the number of
o
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indication of the level of error that would result from an incorrect phase assignment
to the data. For example, the difference between the electron density maps
constructed using six orders versus five orders is equal to half the error of
incorrectly phasing the sixth order. However, the higher order (5-8) structure factor
values are small in size (Table 7.2), and a large error would only be introduced into
the electron density map construction by multiple incorrect phase assignments.




1 -0.200 -0.206 -0.218 -0.201 -0.202 -0.201
2 -0.095 -0.095 -0.056 -0.033 -0.033 -0.041
3 +0.109 +0.100 +0.080 40.056 40.058 +0.061
4 -0.115 -0.094 -0.104 -0.112 -0.109 -0.109
5 0 0 +0.020 +0.017 +0.014
6 -0.026 -0.026 -0.044 -0.034 -0.034
7 0 -0.009 -0.011
8 -0.032 -0.025 -0.020
Temperature 46°C 50°C 50°C 53°C 53°C 53°C
Relative
humidity
98% 98% 90% 81% 74% 57%
Bilayer
Repeat (A)
53.9 52.4 52.2 51.6 51.8 51.5
7.3 Diffraction data from fluid phase Bromolipid bilayers.
Oriented bromolipid bilayers were studied by X-ray diffraction, at either
46°C or 53°C and between 98% and 57% RH. Plate 7.2 shows a typical fluid phase
diffraction pattern collected from bromolipid bilayers in which six meridional
orders of diffraction are clearly visible. At 46°C, and 98% to 57%
RH, the bromolipid formed fluid phase bilayers, in contrast to DPPC which only
formed fluid phase bilayers at 46°C and 98% RH. This finding is in agreement with
the calorimetry study (Chapter 3), which has shown that bromolipid has a lower gel
to fluid phase transition temperature than DPPC.
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PLATE 7.2 The diffraction pattern collected from pure bromolipid bilayers in the
fluid (La) phase. The pattern was collected from an oriented bromolipid sample at
46°C and 74% RH. Six orders of diffraction are clearly visible on the film.
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Eight orders of diffraction were collected from the fluid phase bromolipid
bilayers at 46°C (Table 7.3) compared with twelve at 20°C (Table 5.2). The
collection of only five orders at 53 °C may either be due to the continuous Fourier
transform sampling genuine zero amplitude values at 53°C, as the higher orders
measured at 46°C are all small in magnitude, or due to increased disorder in the
bilayer sample. The swelling series method was used to assign phases to the
bromolipid diffraction data (Figure 7.4). The phases assigned to the fluid phase
bromolipid bilayers (Tables 7.3 and 7.4) match those assigned to the gel phase data
(Table 5.2), supporting their validity.
7.3.1 Electron density maps of fluid (La) phase bromolipid bilayers.
Electron density distribution maps of fluid phase bromolipid bilayers were
constructed using the maximum number of orders available for each data set and the
swelling series phase assignments (Figure 7.5). Like DPPC, fluid phase bromolipid
bilayers have a smaller bilayer thickness than gel phase bilayers (50.1-48.5A versus
56.7-54.7A), as a result of the bilayers passing through the gel to fluid phase
transition, and disordering in the bilayer structure, with increasing temperature.
Decreasing the sample humidity at both 46°C and 53°C decreases the fluid phase
bromolipid bilayer thickness (Table 7.3), indicating dehydration of the bilayer water
layer. The electron density maps (Figure 7.5) locate the bromolipid phosphate
groups at +19A at 46°C and + 18A at 53°C, which are 4A closer, across the lipid
layer, at 46°C than at 20°C (38A versus 42A, Figures 7.5 and 5.5). A similar
decrease in phosphate separation was found between DPPC bilayers at 46 °C and
20°C (Figures 5.2 and 7.2).
The effects of truncation error on the bromolipid electron density map
construction have been estimated using a data set containing eight orders
(bromolipid at 46°C and 57% RH). Bromolipid electron density maps were
calculated using between five and eight orders of diffraction i.e. constructed using a
truncated Fourier series (Figure 7.6). The generated electron density maps all
depict similar structures, where the bromolipid phosphate headgroup at ± 19A
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Figure 7.4 The swelling series plot used to phase the diffraction data
collected from fluid phase bromolipid bilayers. The diffraction data
were collected from oriented bilayer samples at either 46°C (top) or
53°C (bottom) and between 98% and 57% RH. A maximum of eight
orders of diffraction were collected from the fluid phase bromolipid
samples. The symbols represent the structure factor amplitude of
each order plotted against h/D (h is the order number and D is the
bilayer thickness). The plotted lines are spline curves fitted to the
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Figure 7.5 The electron density distribution maps of fluid phase
bromolipid bilayers at 46°C (top) and 53°C (bottom). Diffraction
data were collected from oriented bilayer samples, at 46°C and 53°C
and between 98% and 57% RH, and phased using the swelling series
method (Figure 7.4). The centre of the water layer, phosphate
headgroups and centre of the lipid layer can be located at ±24A,
±19-18A and OA respectively. The bromolipid bromine atoms form
an electron dense peak at -5A to +5A.
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Figure 7.6 Fluid phase bromolipid bilayer electron density maps,
constructed using a variable number of diffraction orders. The
diffraction data were collected from oriented bilayer samples, at
46°C and 74% RH, and phased using the swelling series method
(Figure 7.4). The electron density maps of the 57% RF1 data have
been constructed using either five, six, seven or eight orders of
diffraction. The graph indicates the effect that increasing orders of
diffraction have on the electron density map construction. The graph
also indicates the level of truncation error present in electron density
maps constructed using less than the maximum available orders and
the level of error that would be introduced into the bilayer structure
by the incorrect phasing of an order, i.e. double the effect of not
using that order in the construction. The position of the bromolipid
phosphate headgroup (19A) only varies slightly, depending on the
number of orders used, with greater variation occurring in the lipid
layer (-15A to +15A).
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Table 7.3 Bromolipid diffraction data at 46°C.
Diffraction
order
Phased structure factor amplitude data collected
from bromolipid bilayers at 53 °C
1 -0.163 -0.163 -0.167 -0.167 -0.172
2 +0.018 +0.013 +0.020 +0.047 +0.070
3 +0.164 +0.172 +0.156 +0.146 +0.128
4 -0.076 -0.063 -0.073 -0.072 -0.055
5 +0.046 +0.031 +0.042 +0.054 +0.038
6 -0.019 -0.013 -0.026




98% 90% 81% 74% 57%
Bilayer
Repeat (A)
50.1 50.1 49.9 49.7 49.3
Table 7.4 Bromolipid diffraction data at 53°C.
Phased structure factor amplitude data collected
from bromolipid bilayers at 53°C
1 -0.161 -0.164 -0.172 -0.180 -0.172
2 +0.043 40.031 40.023 40.026 +0.051
3 +0.177 40.172 40.154 40.129 40.146
4 -0.047 -0.050 -0.047 -0.056 -0.060
5 +0.015 40.024 40.022 40.029 40.024
Relative
humidity
98% 90% 81% 74% 57%
Bilayer
Repeat (A)
49.6 49.6 49.4 48.6 48.5
particular the bromine atom peak (OA) at the centre of the lipid layer, varies more
with the number of diffraction orders used. The higher order (6-8) structure factors
of the bromolipid have small values and therefore only contribute a small amount to
the electron density map construction. Fluid phase bromolipid bilayers at 53 °C only
diffracted out to five orders, compared with eight orders at 46°C. If the higher
orders (6-8) are not genuine zero values, the level of truncation errors that might be
present in the five order structures of bromolipid at 53 °C (Figure 7.5, Bottom) can
be estimated by comparing the five and eight order structures of Figure 7.6.
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7,4 Comparison of bromolipid and DPPC bilayers.
Both the fluid and the gel phase DPPC and bromolipid electron density maps
were only placed on a relative scale. To scale the electron density maps to one
another, the DPPC electron density map was multiplied by a factor which matched
the height of its electron dense phosphate headgroup with that of the bromolipid
(Figure 5.7). To match the headgroup peak heights, the fluid phase DPPC electron
density profiles were multiplied by a factor of 1.2, the same multiplication factor
used in the gel phase (Section 5.4).
Fluid phase DPPC bilayers were consistently thicker than those formed by
bromolipid. The difference in bilayer thickness of the fluid phase bilayers (2.2-
3.8A) is wider than that found between the gel phase bilayers (Tables 7.2, 7.3, 5.1
and 5.2). The electron density profiles of DPPC and bromolipid have been
compared at both 46°C and 53°C (Figure 7.7), showing that at both temperatures
the two bilayer structures differ mainly in the lipid chain region, between -10A and
+ 10A. The bromolipid bilayer electron density is greater between -4A and +4A
(due to bromine atoms) but lesser between ±4-12A (along the lipid chain layer).
The electron density maps compared in Figures 7.7 were constructed using
various numbers of orders (bromolipid at 46°C and 53°C used seven and five
orders respectively, DPPC at 46°C and 53°C used six and eight orders
respectively). Although all the electron density maps were constructed using the
maximum number of orders available, the electron density map comparisons may
therefore be between structures containing truncation error, similar to that
demonstrated in Figures 7.3 and 7.6. The truncation errors involved, however,
would be unlikely to be large enough to discount the differences observed between
the DPPC and bromolipid structures.
7.5 Estimating the confidence limits of the electron density maps.
The 95% confidence limits for the electron density distribution across the
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Figure 7.7 Comparison of the fluid phase bromolipid and DPPC
bilayer electron density maps, at either 46°C and 98% RH (top) or
53°C and 81% RH (bottom). Diffraction data were collected from
oriented bilayer samples and phased using the swelling series
method. The 46°C bromolipid and DPPC electron density maps were
constructed using seven and six orders respectively and 53°C maps
using five and eight orders respectively. At both temperatures, the
two bilayer structures were scaled to one another by multiplying the
DPPC profile by a factor of 1.2. The phospholipid phosphate
headgroups and the centre of the lipid layer can be located at ±18-
22A and OA respectively. The DPPC and bromolipid structures
differ, at 46°C and 53 °C, both in their bilayer thickness and their
electron density between -10 and +10A.
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simulation program with a structure factor amplitude error level of 6% for each
order. Comparison of the 95 % confidence limits for DPPC and bromolipid bilayers
(Figure 7.8, 46°C and 98% RH data) shows that the two bilayer structures differ
significantly over the majority of the lipid chain layer (-10A to +10A). In contrast,
the DPPC and bromolipid headgroups (+ 18-20A) are similar in shape and size.
The 95 % confidence limits for the bromolipid minus DPPC electron density
difference map have also been calculated (Figure 7.9, 46°C and 98% RH data),
using a difference structure factor amplitude error limit of 8.5% (equivalent to
structure factor limit of 6% as V((6)2+{6)2)=8.5). The 95% confidence limits
suggest that the difference map bromine peak has a height of 0.30 ±0.04 relative
units and a width of 9.0A+0.5A. The accuracy of the bromine atom difference
peak (Figure 7.9, peak centred at OA) is limited by both truncation errors and the
accuracy with which diffraction data can be measured. Whilst the calculation of
95% confidence limits attempts to estimate the effect of diffraction data accuracy,
truncation error can significantly alter both the DPPC and the bromolipid electron
density maps at the centre of the lipid layer (Figures 7.3 and 7.6). Gaussian
distribution fitting, to estimate the size and separation of the two bromine atoms at
the centre of the bilayer, has not been undertaken, as the results would be of limited
value.
7.6 Direction and size of change, of structure factor amplitudes, on exchanging
bromolipid for DPPC in fluid phase bilayers.
The difference between bromolipid and DPPC diffraction data at 46 °C and
98% RH are summarised in Table 7.5. As was the case for gel phase bilayers, the
fluid phase structure factor amplitude values (orders 1-6, Table 7.5) shift in the
positive direction, on exchanging DPPC for bromolipid. The predictable change in
diffraction data, on adding bromolipid to fluid phase bilayers, should allow the
bromolipid to act as an isomorphous replacement phasing agent in fluid phase
bilayers. The change in diffraction intensity, on exchanging the bromolipid for
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Figure 7.8 Comparison of the 95% confidence limits for the fluid
phase bromolipid and DPPC electron density distributions across the
bilayer. Diffraction data were collected from oriented bilayer
samples, at 46°C and 98%, and phased using the swelling series
method. The 95 % confidence limits were calculated using a Monte
Carlo simulation program, using seven and six orders of diffraction
for bromolipid and DPPC respectively, with a structure factor
amplitude error limit of 6% (SD) for all orders. The two bilayer
structures were scaled to one another by multiplying the DPPC
profile limits by a factor of 1.2. The bromolipid and DPPC
headgroups ( + 18-20A) are of a similar shape and size, although the
DPPC headgroup appears to have a slightly wider distribution. The
bromolipid bromine atoms, however, clearly increase the electron
density at the centre of the lipid layer (0-4A). There also appears to
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Figure 7.9 The 95% confidence limits calculated for the bromolipid
minus DPPC electron density difference map. Diffraction data were
collected from oriented bilayer samples, at 46°C and 98% RH, and
phased using the swelling series method. The 95 % confidence limits
were calculated using a Monte Carlo simulation program, six orders
of difference structure factor values, and an error limit of 8.5% (SD)
for all difference orders. The 95% confidence limits suggest that the
bromine peak has a height of 0.30±0.04 relative units and a width of
9.0+0.5A. The 95% confidence limits do not, however, take into
account possible errors from truncation effects, or incorrect phase
assignment.
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smaller on addition of bromolipid then the original DPPC bilayer phase was
negative and vice versa.
As well as the changes in diffraction intensity on replacing DPPC with
bromolipid, Table 7.5 shows the phases that would be assigned to the DPPC data
(from analysing diffraction pattern changes on addition of bromolipid). The phase
assignments to the DPPC data match those obtained from the swelling series method
(Figure 7.1), suggesting that the bromolipid has indeed the potential to be used as a
phasing agent in fluid phase bilayers.
Table 7.5 Structure factor amplitude data differences between fluid phase















1 +0.037 +0.006 smaller -
2 +0.113 +0.019 smaller -
3 +0.055 +0.009 bigger +
4 +0.039 +0.007 smaller -
5 +0.046 +0.008 bigger +
6 +0.007 +0.001 smaller -
7.7 Conclusions of bromolipid in the fluid phase.
X-ray diffraction patterns were collected from fluid phase DPPC and
bromolipid bilayer samples at 46°C, 50°C and 53 °C and between 98% and 57%
RH. The diffraction data of each phospholipid were phased using the swelling series
method (Figures 7.1 and 7.4). The difference in bilayer thickness, between gel
phase DPPC and bromolipid bilayers (1 to 2.3A at 20°C), also exists in the fluid
phase (3.8A at 46°C and 2.2 to 3.2A at 53°C). Raising the DPPC and bromolipid
bilayer systems above the chain melting temperature did not abolish the thickness
difference, that cannot therefore be ascribed to a chain tilt effect, as fluid phase
lipids chains are untilted.
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The phased diffraction data were used to construct bromolipid and DPPC
electron density maps (Figures 7.2 and 7.5). Comparison of these profiles (Figure
7.7) locates the major difference between the two systems as being an electron
dense peak (the bromine atoms) at the centre of the lipid layer. Whilst the
bromolipid and DPPC headgroups appear to be similar, there are discernible
differences between the two bilayer structures along the length of the lipid chain
layer (-10A to+lOA, Figures 7.7 and 7.8). Similar differences were also found to
exist between the gel phase bromolipid and DPPC bilayers, centred at ±10A
(Figures 5.7 and 5.8). In spite of the structural differences induced by the
bromolipid, the diffraction data (Table 7.5) suggest that the exchange of the




Summary of the thesis.
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8.1 The interaction of amantadine FB and HC1 with fluid phase DOPC bilayers.
The interaction of the small drug molecule amantadine (Figure 3.4) with
fluid phase DOPC bilayers was studied by X-ray diffraction and the swelling series
method. To establish whether the charge state of amantadine affects the drug-
membrane interaction, amantadine was studied in both the FB and HC1 forms.
Swelling series data were compiled for three different systems:
1) Pure DOPC bilayers at 20°C and between 98% and 57% RH.
2) DOPC plus amantadine FB bilayers at 20°C and between 98% and 57% RH.
3) DOPC plus amantadine HC1 bilayers at 20°C and between 98% and 57% RH.
Adding amantadine of either form to DOPC reduced the bilayer thickness by
between 1A and 2.5A, depending on the humidity of the sample (Figure 4.1).
Although the DOPC based bilayers diffracted to a maximum of eight orders, the
swelling series method was only able to phase the first five orders of diffraction
(Figures 4.3, 4.6 and 4.9). DOPC based bilayer electron density maps could,
therefore, only be constructed using five orders of diffraction, the limit of phase
assignment. The five order electron density maps, therefore, all have an associated
truncation error (Figures 4.4, 4.7 and 4.10). The level of error in the bilayer
structures means that little can be concluded from comparisons made between the
bilayer structures with and without amantadine present (Figures 4.12, 4.13 and
4.14), or between the two charge states of amantadine (Figure 4.15).
The DOPC bilayer structure and, therefore, the form of the continuous
Fourier transform sampled during the diffraction process, altered significantly with
humidity. As the continuous Fourier transform changed with the humidity, the
ability of the swelling series method to assign phases to the higher orders was
diminished. A more complete analysis of the interaction of amantadine with DOPC
bilayers would require the diffraction data to be phased out to higher orders than
has been achieved here using the swelling series method.
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8.2 Studies of bromolipid and DPPC bilayers by X-ray diffraction.
A bromolipid was synthesised and studied, primarily by X-ray diffraction,
as a phospholipid molecule labelled with a bromine atom might provide an
alternative phasing method to the swelling series approach. The bromolipid is a
novel phospholipid derivative, where the sn-2 palmitoyl chain terminal methyl
group of DPPC has been exchanged for a bromine atom. The bromolipid offers two
methods of phasing diffraction data: firstly by the bromolipid bromine atom acting
as a heavy atom in isomorphous replacement experiments, or secondly by the
bromine atom acting as an anomalous scatterer in multiple anomalous dispersion
(MAD) experiments. The bromolipid and DPPC were studied and compared in
three different bilayer forms:
1) Pure DPPC and bromolipid bilayers in the gel (Lp<) phase, at 20°C and between
98% and 57% RH (Chapter 5).
2) Three different DPPC:bromolipid mixture (1:1, 7:2 and 4:1) bilayers in the gel
(Lp) phase, at 20°C and between 98% and 57% RH (Chapter 6).
3) Pure DPPC and bromolipid bilayers in the fluid (La) phase, at either 46°C,
50°C or 53°C and between 98% and 57% RH (Chapter 7).
Calorimetric (DSC) experiments were also performed on samples of DPPC,
bromolipid and a 1:1 mixture of the two phospholipids (Chapter 5).
8.2,1 Study of DPPC and bromolipid bilayers in the gel (LpQ phase.
X-ray diffraction patterns were collected from the gel phase DPPC and
bromolipid bilayers out to fourteen and twelve orders, respectively (Tables 5.1 and
5.2). Both DPPC and bromolipid formed gel (Lp<) phase bilayers at 20°C and
between 98% and 57% RH (Plates 5.1 and 5.2). The two phospholipids formed
bilayers that differed in thickness by 1 to 2.3A (Table 5.3), depending on humidity.
The gel phase DPPC and bromolipid diffraction data were phased using the swelling
series methods (Figures 5.1 and 5.5). Electron density map construction has shown
that the bromolipid forms bilayers of a similar, but not identical, structure to those
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of DPPC (Figures 5.7 and 5.8), with the major difference being the presence of an
electron dense region at the centre of the bromolipid lipid layer. The bromine
atoms, linked to the sn-2 lipid chain of bromolipid, would account for this electron
density peak at the centre of the lipid layer. The bromolipid and DPPC bilayers,
however, differ significantly across the entire lipid layer (0 to 15A, Figure 5.8),
showing the bromolipid not to be isomorphous with DPPC.
The bromolipid was synthesised for use in X-ray diffraction studies,
primarily in mixtures with DPPC. The disruptive effect of bromolipid on the DPPC
bilayer structure should decrease with the concentration of the bromolipid in the
bilayer. Calorimetry (DSC) results (Table 5.4) show that mixing bromolipid 1:1
with DPPC produces a bilayer with physical properties that approach those of pure
DPPC.
8.2.2 Study of mixture bilayers of DPPC and bromolipid.
Three different DPPC:bromolipid mixture ratios (1:1, 7:2 and 4:1) were
studied by X-ray diffraction and the swelling series method. Both the 4:1 and 7:2
DPPC:bromolipid mixture bilayers were found to have a bilayer thickness similar to
that of pure DPPC bilayers (Table 6.4). The 1:1 DPPC:bromolipid mixture formed
bilayers with a thickness that was closer in magnitude to that of pure bromolipid
than pure DPPC bilayers (Table 6.4). The swelling series method assigned the same
phases to both the 4:1 and 7:2 DPPC:bromolipid mixture bilayer data that had
previously been assigned to the pure DPPC bilayer data, supporting their validity
(Figures 5.1, 7.2 and 7.3).
The electron density maps of the mixture bilayers (Figures 6.4, 6.5 and 6.6)
show that the phospholipid headgroup position (+21-22A) varies little with either
humidity or, unlike the bilayer thickness, bromolipid concentration (Table 6.4). As
the bromolipid concentration in the bilayer increased, a growth in electron density
at the centre of the lipid layer was observed (Figure 6.7, 6.14). Confidence limits
(95%) calculated for the electron density distributions reinforced the observation of
an electron density peak at OA, due to the bromolipid (Figures 6.9 and 6.10). The
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confidence limits also indicated that a significant decrease in electron density
occurred, centred at ±10A, as the bromolipid concentration increased (Figure 6.10,
middle). Electron density difference maps also highlighted both the growth of the
bromine atom peak at OA and the decrease in electron density at ± 10A as the
bromolipid concentration in the bilayer increased (Figures 6.12, 6.13 and 6.14).
In general, the addition of bromolipid to the DPPC bilayer shifted the
structure factor amplitude data in the positive direction (Figure 6.15, Table 6.5).
This shift in the diffraction data can be used as a phasing method, as changes in the
magnitude of the observed intensity are dependent on the original phase of the
order. The bromolipid method of data phasing has the potential to be more
conclusive than the swelling series method. Not only will the diffraction data of a
bilayer sample vary in a predictable way with bromolipid concentration, that allows
the data to be phased, but the reconstructed electron density maps must also show a
bromine atom peak of a predictable size and position in the bilayer.
8.2.3 Study of DPPC and bromolipid bilayers in the fluid (La) phase.
Fluid (La) phase bilayers of the bromolipid and DPPC were also studied by
X-ray diffraction and the swelling series method, with the aim of investigating the
potential use of the bromolipid as a phasing agent in fluid phase bilayers. X-ray
diffraction patterns were collected from oriented bilayer samples and phased using
the swelling series method (Figures 7.1 and 7.4). Raising the bromolipid and DPPC
bilayer systems above the chain melting temperature did not abolish the bilayer
thickness difference between the two. The difference in the thickness could not be
ascribed to a chain tilt effect, as fluid phase lipids chains are untilted. Comparison
of the fluid phase DPPC and bromolipid electron density maps (Figure 7.7) located
the electron dense bromolipid bromine atoms at the centre of the lipid layer. Whilst
the bromolipid and DPPC headgroups appeared to have a similar structure, there
was a discernible difference between the two bilayer structures along the length of
the lipid chain layer (-10A to +10A, Figures 7.7 and 7.8). A similar difference
o
was also found between gel phase bromolipid and DPPC bilayers, centred at ± 10A
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(Figures 5.7 and 5.8). In spite of the structural differences between the bromolipid
and DPPC bilayers, the diffraction data (Table 7.5) suggested that the bromolipid
could be used as an isomorphous replacement phasing agent.
8.2.4 Lipid layer differences between DPPC and the bromolipid.
The DPPC and bromolipid bilayers differ by approximately 1A-2A in the
gel phase (Tables 5.1 and 5.2) and by 2A-4A in the fluid phase (Tables 7.2, 7.3 and
7.4). The bilayer thickness difference is attributable to a change in the lipid layer
width (Table 6.4), rather than a difference in headgroup conformation. The
observed decrease in lipid layer thickness is not, however, due to a change in the
lipid chain tilt angle (Table 5.3), a fact highlighted by the thickness difference
existing in the fluid (La) phase. Comparison of pure DPPC and pure bromolipid
bilayers shows that the two structures differ significantly across the entire lipid
layer in both the gel (Figure 5.8) and fluid phases (Figure 7.7), with the bromolipid
lipid layer having a lower relative electron density than that of DPPC (excluding the
bromine atom peak). Both the DPPC:bromolipid mixture bilayer lipid layer relative
electron density (centred at ± 10A ) and thickness decrease with increasing
concentration of bromolipid in the bilayer (Figures 6.9 and 6.10). The DPPC and
bromolipid lipid chains, therefore, differ in their conformation, a fact highlighted
by their differing lipid layer widths and relative electron densities. One possible
explanation for the observed differences might be that the heavy bromine atom
disrupts the lipid chain packing, increasing the spacing between the lipid chains and
decreasing the average density of the lipid layer.
8.2.5 The bromolipid as a phasing agent.
The synthesis of the bromolipid molecule has allowed electron dense
bromine atoms to be inserted into a bilayer structure. The X-ray diffraction study
has located the bromine atoms at the centre of the lipid layer, a result consistent
with the bromine atoms having been attached to the sn-2 lipid chain terminus of a
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phospholipid. The ability to place heavy atoms at a specific site in a membrane
structure allows diffraction data to be phased by the isomorphous replacement
technique. Structural changes that occurred on the addition of bromolipid to DPPC,
such as the decrease in bilayer thickness, do not exclude the use of the bromolipid
in isomorphous replacement experiments, as the changes appear to be continuous
and predictable. The bromolipid may also offer a new phasing approach to
membrane diffraction in the form ofMAD experiments. Neither the concentration
of bromolipid in the bilayer nor the structure of the bilayer would need to change
during a MAD experiment, thus increasing the certainty of the phasing process.
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Concomitant neutron and X-ray studies were undertaken in order to locate accurately the anti-influenza and Parkinson's disease
drug amantadine in multilayers of l,2-dioleoyl-in-glycero-3-phosphocholine. The X-ray data were phased using the swelling
series method and the neutron data were phased using D20/H20 exchange and a variation of the isomorphous replacement
technique. The sets of data complement each other and reveal two populations of amantadine within the bilayer. One site is
close to the bilayer surface, the other is much deeper. The majority of the amantadine occupies the surface site. The relative
occupancy, but not the position, of the two locations appears to be dependent upon the initial protonation state of the drug. No
evidence of bilayer perturbation was observed with either the protonated or the deprotonated forms of amantadine.
Introduction
Amantadine (1-aminoadamantane hydrochloride) is
licensed for the prophylaxis of influenza A infection
and for treatment of both influenza and Parkinson's
disease [1,2]. In the case of influenza, the efficacy of
amantadine is postulated to involve interruption of
viral-host cell membrane fusion and/or interference in
haemagglutinin maturation [3,4]. The mechanism of
action of amantadine in Parkinson's disease is probably
related to its ability to increase presynaptic synthesis
and release of dopamine. This effect is potentiated by
the drug inhibiting dopamine reuptake [5]. These ther¬
apeutic processes are thought to include the involve¬
ment of the hydrophobic, lipophilic properties of the
molecule [6],
Amantadine studies undertaken so far have been
wide-ranging, including its effect on influenza infection
and, more recently, its specific molecular effect on the
viral protein which is implicated in this drug-induced
Correspondence to: J.P. Bradshaw, Department of Biochemistry,
University of Edinburgh, Hugh Robson Building, George Square,
Edinburgh, EH8 9XK, UK.
Abbreviations: amantadine FB, 1-amino adamantane free base;
amantadine HC1, 1-amino adamantane hydrochloride; DOPC, 1,2-di-
oleoyl-sn-glycero-3-phosphocholine; DOPE, 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine; NMR, nuclear magnetic resonance spec¬
troscopy; rh, relative humidity.
prophylaxis, namely M2 [7]. A recent study has exam¬
ined the role of amantadine in the stabilisation of
clathrin-coated membrane vesicles, similar to those
formed upon initial viral penetration by influenza,
Semliki Forest and vesicular stomatitus virus [6]. How¬
ever, other authors have reported that, although tro-
mantadine (an amantadine derivative: (V-l-adamantyl-
A-[2-(dimethylamino)ethoxy]acetamide hydrochloride)
appears to stabilise phospholipid bilayers, amantadine
itself slightly lowers the temperature of the bilayer to
hexagonal phase transition. Also, NMR studies have
shown that amantadine is perturbing to the organisa¬
tion and motional properties of phospholipids in the
bilayer phase [8]. These results indicate an amanta-
dine-mediated increase in disorder. It can therefore be
seen that a certain degree of ambiguity exists in the
available data.
As a prerequisite of further mechanistic studies of
amantadine, we have undertaken a series of experi¬
ments to investigate the location of the drug within
bilayers of l,2-dioleoyl-5/r-glycero-3-phosphocholine
(DOPC). To reduce possible ambiguity in the results a
single lipid species was used, DOPC being the most
physiologically representative. We have also examined
any differences between amantadine hydrochloride
(HC1) and amantadine in its free base form (FB).
This report describes the use of a specific deuterium
labelling technique to locate amantadine in synthetic
multilayer membranes using neutron diffraction. These
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(a) (b)
Fig. 1. The two forms of 1-aminoadamantane used in this study: (a)
amantadine free base, (b) amantadine hydrochloride.
results are both quantitatively and qualitatively sup¬




was purchased from Sigma (Fancy Road, Poole, UK)
and confirmed to be a single species by thin-layer
chromatography. Amantadine was obtained from the
same source in both free base and hydrochloride forms
(Fig. 1). Deuterated amantadine FB was obtained from
Dr. M.R. Alecio of the Shell Research Centre (Sit-
tingbourne, Kent, UK).
X-ray diffraction
Oriented phospholipid bilayer stacks were prepared
as follows. Samples comprising 5 mg of DOPC with or
without 5% (mol) amantadine were dissolved in
methanol and applied to a curved glass support of
approx. 1 cm2 area. The solvent was allowed to evapo¬
rate before the slide was dried in vacuo for 2 h.
Subsequently, the samples were hydrated for at least 2
h at 20°C and 100% humidity. Once fully hydrated, the
samples were transferred to the sample cell of the
X-ray camera.
For at least 1 h before and subsequently throughout
the diffraction experiment, the samples were held in a
purpose built environmental cell which allowed the
temperature and humidity of the sample to be con¬
trolled. Temperature control was achieved by circulat¬
ing water from a thermostat bath through tubes in the
brass walls of the cell; all samples were run at 20°C at
which DOPC adopts the La-phase. The humidity, and
therefore the bilayer spacing, was controlled by passing
air through containers of saturated salt solutions and
then through the sample cell. Saturated solutions of
ZnS04 (90% rh), KC1 (81% rh), NaCl (74% rh) and
NaBr (57% rh) were used in addition to distilled water
(98% rh).
In the camera used to produce the diffraction pat¬
terns, 0.3 mm collimated, Nickel filtered copper K
°
radiation of 1.54 A from a Marconi-Elliot GX-13 rotat¬
ing anode X-ray generator was scattered by the sample
onto a pack of four 130 X 180 mm Agfa-Gevaert Osray
X-ray films positioned 175 mm from the sample. The
diffracted beam path was evacuated to reduce back¬
ground noise from air-scattered radiation. To record
the complete range of intensities without exceeding the
films' dynamic range, each sample was exposed twice,
typically for 20 h followed by a separate 4 min expo¬
sure. The developed films were scanned on a Joyce
Loebl Chromoscan 3 microdensitometer.
Neutron diffraction
Sample preparation was essentially the same as de¬
scribed for the X-ray experiments, with the exception
that each sample was 20 mg in weight and prepared on
a quartz microscope slide. D20/H20 exchange was
achieved by dehydrating the samples in vacuo before
re-equilibration over the new solvent.
Neutron diffraction data were collected using the
D16 instrument at the Institut Max von Laue - Paul
Langevin, Grenoble, France. After rehydration the
quartz slide bearing its oriented multi-bilayer phospho¬
lipid sample was placed in the temperature controlled
cell of the instrument along with water baths contain¬
ing either D20 or H20 where it was allowed a further
period of equilibration of 0.5-1 h. During this period
the equilibration process was monitored by recording
the angular position of the third or fourth order of
lamellar diffraction which increased as the multilayers
dehydrated and decreased as they took up water from
the atmosphere. Each sample was judged to have
achieved equilibrium when there was no further shift
in the position of the Bragg peaks and the calculated
lamellar repeat distance was that predicted for the
experimental conditions by previous X-ray work. Any
sample which did not fulfil both of these criteria was
discarded. Each recorded diffraction pattern consisted
of at least eight well defined orders. The mosaic spread
of each sample was determined using the D16 soft¬
ware.
X-ray data analysis
The background scattering level was estimated by
measuring the optical density of each X-ray film in the
region immediately adjacent to a diffraction peak and
interpolating across its base. Any peaks in which the
dynamic range of the film had been exceeded were
ignored. After integration of the diffracted intensities
the films were scaled together using overlapping peaks
and averaged to obtain the final set of intensities. A
Lorentz factor was applied to take into account the
spreading of the intensity in reciprocal space and the
sampling of the peaks by the Ewald sphere. The
diffraction peaks were discrete and well defined and
were restricted to the meridional region of the film. In
such situations, the Lorentz factor takes the form of
sin(20/l), where 9 is the Bragg angle and h the order of
diffraction. A further correction was applied for ab¬
sorption of the incident and diffracted beams by the
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lipid film [9], Data sets of Bragg intensities (Ih) were
scaled to each other using the expression:
LIh = D/Dmm
where D is the Bragg spacing (bilayer repeat distance)
and Dmin represents the minimum Bragg spacing of a
series run at different humidities.
D for each sample was determined using the Bragg
equation. The instrument offset angle for each sample
was calculated by iterative least squares regression of
this equation over all observed orders of diffraction.
Neutron data analysis
Once the diffracted intensities had been corrected
for detector response and background then integrated,
the following corrections were applied:
(1) Acceptance angle. The projection of the quartz
slide along the normal to the neutron beam is depen¬
dent upon its relative angle to the beam. If the slide
presents a very low angle (9) to the incident beam, it
only samples a small fraction of the total neutron beam
width and, therefore, flux. This means that the diffrac¬
tion peaks recorded for the lower orders will be corre¬
spondingly weaker than if the slide were able to sample
the whole width of the neutron beam. As long as the
neutron beam is wider than the maximum projected
width of the sample slide and the neutron flux constant
across the width of the beam, the angular correction
factor, takes the form:
CAngw = i/sin eh
(2) Lorentz factor. For the geometry used in this
study, the appropriate correction factor is:
Clot(/I) ~ sin(20/,)
(3) Absorption. When the angle of diffraction is low,
the incident and diffracted beam have a significant
path length within the sample and thus will be subject
to a greater degree of absorption than when the angle
is high and the corresponding path lengths low. More¬
over, the degree of absorption will also be affected by
the H20/D20 composition of the sample. The appro¬
priate correction for absorption by the lipid film, was
applied:
^Ahsc/i) = l/(sin 0/2ut)(\- exp[ — 2wt/sin 6])
where u = (6.04-0.75^), d being the mole fraction of
DzO [10]. The mass of lipid on each slide, the area
over which it was spread and the unit cell size, as
determined by diffraction, were used to calculate a
value of 30 /am for t, the thickness of the lipid film.
(4) Sampling by the detector. As a result of lattice
disorder in the sample, the diffraction peaks may be so
wide that the whole of each diffraction peak is not
recorded by the detector, and a correction must be
applied to the data to account for this. In this study the
mosaic spread of each sample was small enough to
ensure that each diffraction peak was regular in shape
and contained wholly within the central part of the
detector so no correction was applied in this case.
The final neutron structure factor amplitudes were
therefore calculated as:
Fh = Ih ' ^-Ang(h) ' ^Lor(.h) ' ^Abs(h)
Phasing
Electron density or neutron scattering profiles may
only be obtained upon solving the individual phases of
the recorded amplitudes. In this study three different
techniques were employed to phase the data sets:
swelling series, D20/H20 exchange and isomorphous
replacement.
The X-ray structure factors were phased using a five
point swelling series [11]. Our methodology comprised
of selecting from the swelling series one working set of
eight diffraction peaks and using this to compute a
continuous transform [12] against which the fit of all
the other observed sets were compared. The best fit
minimised the difference between the calculated and
the observed intensities for each of the possible 256
phase combinations. The selected working set alter¬
nated until all five had been used and sampled against.
The resulting transform represented the best, inte¬
grated fit for all data over all possible phases. This
process was carried out independently for the DOPC,
DOPC/amantadine HC1 and DOPC/amantadine FB
swelling series.
Neutron data are routinely phased by carrying out
experiments hydrated at various H20/D20 ratios
[9,10,13,14], This method was used in the present study,
with additional phasing information coming from a
variation of the isomorphous derivative technique [15]
in which use was made of the presence or absence of
amantadine in the multilayers. Assigning phases to the
neutron data proceeded by altering the sign of the
individual structure factors until a result was achieved
in which both the differences caused by replacing HzO
with D20 and the DOPC/amantadine minus DOPC
differences were consistent within each set of compara¬
ble data.
The two techniques, using X-rays and neutrons,
emphasise different features within the bilayer struc¬
ture, and further confirmation that the correct phases
had been assigned was given by the fact that the two
methods agreed and thereby showed the complemen¬
tary nature of the techniques.
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White and his co-workers [16] have produced an
elegant method for scaling neutron data. This ap¬
proach was used in the present study and basically
involved using the size of the D20 and the amantadine
distributions to scale the different sets of data to each
other. The results put the profiles on a 'relative abso¬
lute' scale in which they are scaled with respect to the
unit cell contents, but not on an absolute per volume
scale. The method is also readily applicable to X-ray
data, although for this there is no equivalent of the
DzO peak therefore scaling is carried out on the size of
the amantadine distribution alone.
Results
Fig. 2 is a representative X-ray diffraction pattern,
in this instance obtained from DOPC with 5% (mol)
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Relative Humidity
Fig. 3. The relationship between the relative humidity at 20°C of the
sample and the observed bilayer spacing (in angstroms, A), v, pure
DOPC; A, amantadine hydrochloride; O, amantadine free base. The
error bars represent the standard deviation for each point. Sample
size varied from 3 to 9.
±
Fig. 2. X-ray diffraction pattern of lamellar arrays of DOPC with 5%
(mol) amantadine FB at 90% relative humidity and 20°C.
ship between the relative humidity of the sample cham¬
ber and the bilayer repeat distance as observed by
X-ray and neutron diffraction. Fig. 4 shows the swelling
series data used to phase the X-ray diffraction patterns
of pure DOPC (a), DOPC with 5% (mol) amantadine
HC1 (b) and DOPC with 5% (mol) amantadine FB (c).
In each case the continuous transform calculated from
98% rh data is shown superimposed upon the obseived
diffraction amplitudes for 98, 90, 81, 74 and 57% rh.
T able 1 gives the corrected, scaled neutron diffraction
structure factors for all three samples at 0% and 100%
D20. Fig. 5 shows reconstructed transbilayer profiles
of DOPC alone (a, b) and difference profiles calcu¬
lated by subtraction of structure factor data sets of
corresponding D-repeat to define the distribution of
amantadine HC1 (c, d) and FB (e, f), respectively.
The mosaic spread of the DOPC bilayers ranged
from 0.4° to 0.6°, these very low values being quite
characteristic of unsaturated fatty acyl phospholipids.
The mosaic spread was not significantly changed upon
the addition of amantadine.
Discussion
DOPC
Fig. 5 displays both X-ray and neutron scattering
density profiles across the phospholipid bilayer with
the water component occupying the outer region of the
graphs. With X-rays, the DOPC profile (a) agrees with
previously published data [17,18] in that it displays the
classic phospholipid leaflet form with a main peak
representing the electron-dense region which encom-
pases the phosphate groups and fatty acyl ester bonds.
A secondary peak appears within the hydrophobic re¬
gion which corresponds to the double-bond in the oleic
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acid chains. It can be seen from (b) that less detail
results from the neutron data. This is probably due to
the lower contrast characteristic of neutron scattering
(all diffraction experiments were sampled through eight
orders so this phenomenon does not involve the X-ray
data being collected to a higher resolution than the
neutron).
The differences between the X-ray and neutron
profiles are due to inherent atomic scattering differ¬
ences across the unit cell. X-rays are more strongly
scattered by the phosphate groups in the repeat motif
whereas maximum neutron scattering corresponds to
the fatty acyl ester bond positions [19]. Profile (b)
clearly displays this scattering dichotomy with the neu¬
tron data peak appearing markedly closer to the hy¬
drophobic interior of the bilayer than the X-ray result
(a). The sharper X-ray profile displays a second highly
defined peak in the fatty acyl chain region of the
leaflet.
TABLE I
Relative absolute neutron structure factors of lamellar arrays of pure
DOPC and DOPC with 5% (mol) amantadine HCI or FB at 98% rh
and 20°C. The accuracy is estimated to be ± 0.15 units
Reciprocal Distance
Fig. 4. Structure factors of lamellar arrays of bilayers of (a) pure
DOPC, (b) DOPC with 5% (mol) amantadine HCI and (c) DOPC
with 5% (mol) amantadine FB, plotted against corresponding recip¬
rocals of Bragg spacings (A-1). The amplitudes of the structure
factors are equal to the square roots of the Bragg intensities, their
signs are those derived from the phasing procedure described in the
text. The swelling series data sets were collected at 98, 90, 81, 74 and
57% relative humidity. The continuous transforms calculated from
the 98% rh data is shown.
Order DOPC DOPC+ 5 mol% DOPC+ 5 mol%
20°C, 98%rh amantadine HCI D-amantadine FB
(d2o) 20°C, 98%rh (DzO) 20°C, 98%rh (D20)
1 -89.31 -61.22 -96.41
2 25.56 10.02 18.80
3 -4.34 -1.68 -2.76
4 1.00 0.32 1.21
5 -2.84 -1.86 -2.97
6 0.77 0.06 0.57
7 -0.67 0.15 -0.16
8 0.00 -0.27 -0.15
Order DOPC DOPC+ 5 mol% DOPC+ 5 mol%
20°C, 98%rh amantadine HCI D-amantadine FB
(HzO) 20°C, 98%rh (HzO) 20°C, 98%rh (HzO)
1 -6.47 -19.74 -13.55
2 -12.09 -8.66 -17.65
3 5.16 3.17 6.53
4 0.34 0.00 0.00
5 -1.44 -1.37 -1.98
6 0.33 -0.18 0.33
7 -0.30 0.26 0.00
8 0.00 -0.30 0.00
Amantadine HCI
Fig. 5. (c) to (f) are difference profiles which were
calculated by subtracting the lipid component from the
lipid + amantadine structure factors and therefore rep¬
resent only the amantadine distribution across the bi¬
layer. They are displayed in the same orientation as the
pure DOPC but it can be seen that these profiles, both
X-ray and neutron, are substantially different from the
DOPC data. Amantadine, in both its hydrochloride
and free base forms, appears to have been incorpo¬
rated into the multilayer system.
The highest peak in the X-ray profile (c), represent¬
ing the greatest distribution of amantadine HCI, lies
between the phosphate and ester linkages. This surface
location is also represented in the neutron (d) profile
but its shape has changed with additional density en¬
croaching into the water. It is proposed that the differ¬
ence between the X-ray and neutron profiles is due to
the relatively higher scattering length of nitrogen for
neutrons compared to that for X-rays, which empha¬
sises the amine group in the neutron profiles. These
results therefore orientate amantadine HCI in the bi¬
layer; the hydrophobic, cyclic region of the drug lo¬
cated between the phosphate and ester linkages of the
phospholipids with the NHj group protruding into the
water space.
This interpretation is supported by changes in the
distribution of water between adjacent bilayers when
amantadine HCI is added. Fig. 6 shows difference
profiles representing the location of the deuterons of
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heavy water, calculated by subtracting neutron scatter¬
ing profiles of multi-bilayers containing H20 from cor¬
responding ones hydrated with D20. It can be seen
that incorporation of amantadine HC1 into the DOPC
bilayers reduces the area under the water profiles,
indicating that the drug is displacing some of the water
from the system.
Both profiles (c) and (d) of Fig. 5 include additional
features in the lipid tail region which may be caused by
termination error. The resolution of the present study
procludes unambiguous assignment of these features to
the presence of amantadine deep within the bilayer,
but it should be noted that evidence from the FB
profiles (see below) indicates that full penetration of
the bilayer by a proportion of the amantadine can
occur. This is particularly noticeable in the neutron
profiles and is either a product of the relatively high





































Fig. 5. Reconstructed trans-bilayer X-ray scattering profile of pure
DOPC (a, left-hand scale) and neutron scattering profile of pure
DOPC (b, right-hand scale) at 98% rh and 20°C. (d) and (f) are
neutron scattering difference profiles of amantadine hydrochloride
and amantadine free base, respectively, (c) and (e) are the corre¬
sponding X-ray scattering difference profiles. The difference profiles
were calculated by subtracting structure factors of pure DOPC from
those of DOPC with 5% (mol) amantadine, after correction for
variations in bilayer repeat and placed on a relative absolute scale
using the method of Weiner et al. [18]). The horizontal scale (Z) is


















' Fitted h= 8 Gaussians
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Fig. 6. Difference neutron density scattering profiles showing the
distribution of water between bilayers of (a) pure DOPC, (b) DOPC
with 5% (mol) amantadine FIC1 and (c) DOPC with 5% (mol)
amantadine FB, all at 20°C. Also shown are Gaussian distributions
fitted to the water profiles in reciprocal space over all eight observed
orders of diffraction, using a development of the method of Wiener
et al. [18]. Each curve consists of the sum of two Gaussians with the
following parameters: (a) Z (distance from centre of bilayer) =
±26.53 ±0.35 A, Aw (1/e halfwidth) = 8.82 ±0.20 A; (b) Z = 26.04
±0.55 A, Aw = 8.75±0.25 A; (c) Z = ±25.58±0.45 A, Aw = 8.65 ±
0.25 A. The difference between the observed and modelled water
profiles may be taken as a crude approximation of error in the
reconstructions. Each graph therefore also shows this difference,
plotted on an enlarged scale, corresponding to that used in Fig. 5
(right-hand side).
face sites, or it may represent amantadine which has
reverted to the uncharged, FB form by deprotonation.
Amantadine FB
At this resolution, both amantadine peaks are in the
same position in the X-ray profile (e) as in the amanta¬
dine HC1 result (c). Positionally, therefore, the data are
identical. However, there is a difference in the propor¬
tional representation of amantadine across the bilayer
with relatively more now appearing in the fatty acid tail
region of the phospholipids. The neutron results (f)
support these findings. Here the main scattering den¬
sity at the surface location has moved slightly into the
bilayer reflecting the fact that the amantadine FB is
deuterated on the hydrophobic carbons only and that
the NH2 amine group is unlabelled and therefore
scatters much less intensely compared to the labelled
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mass; it can be observed as a shoulder on the water
side of the main peak. This observation again orien¬
tates the amantadine with its NH2 group at the lipid/
water interface.
Profiles (e) and (f) clearly show that a proportion of
amantadine has penetrated almost to the centre of the
bilayer. Once again, the features in this region may
represent some part of the amantadine structure, or
may just be termination error. However, the height of
the profiles above zero can only be explained in terms
of a considerable mass of drug being present in this
region. Consistent with this finding, the amount of
water associated with the bilayers containing amanta¬
dine FB is much greater than that for bilayers contain¬
ing amantadine HC1 (Fig. 6) and almost equates with
that present in the bilayers in the absence of either
form of amantadine. Clearly a proportion of the drug
has moved away from the water-penetrated surface of
the bilayers to take up a deeper location in the bilay¬
ers. This evidence, taken together with the HC1 results,
leads us to propose that the interaction between aman¬
tadine and DOPC bilayers takes the form of an equi¬
librium between two possible regions. One of these is
located at the water/bilayer interface, the other is less
defined and broadly represents the fatty acid tail re¬
gion. The balance of this equilibrium between the two
sites appears to' depend upon the starting protonation
state of amantadine. However, this does not necessarily
imply that the initial charge state of the amine is
preserved throughout the experiment. This result com¬
pares with tetracaine where its interaction with phos¬
pholipids is also reported to be influenced by the
charge state of the drug [20,21].
Amantadine-phospholipid interactions
If the optical parameters and the sample dimensions
are kept constant throughout a series of diffraction
experiments then the mosaic spread may be used as a
measure of the macroscopic order of each sample; the
smaller the mosaic spread, the less the degree of
disorder of the bilayers [22,23]. The values obtained for
stacked bilayers of pure DOPC in this study are in
good agreement with previous observations [16,17], The
mosaic spread did not change upon the addition of 5
mol% amantadine, which indicates that the interaction
between the drug and the bilayer did not disturb the
macroscopic order of the system. There was no evi¬
dence of phase separation in the multilayers containing
amantadine. Unfortunately, in the liquid phase, DOPC
does not give discrete 4.5-4.8 A reflections so we are
unable to comment on the effect of amantadine on
chain packing. We can, however, conclude that, under
these experimental conditions, amantadine does not
markedly perturb the bilayer system.
It has been reported that amantadine reduces the
extent of dissociation of clathrin from coated vesicles
[6] in a study which used relatively small amounts of
the amine. The ability of amantadine and related com¬
pounds to stabilise or destabilise phospholipid bilayers
has also been extensively investigated. Cheetam and
Epand [8] concluded from NMR studies that amanta¬
dine perturbs the organisation and increases the fluid¬
ity of bilayers. Our present study, using a much lower
drug/lipid molar ratio, does not indicate any such
perturbation but it may be that this anomaly reflects
the different drug concentrations used in such studies.
Another variable involves the lipid type used. The
work reported here employed DOPC which has a large
headgroup and two unsaturated chains giving the phos¬
pholipid a quasi-hourglass shape, creating an area of
increased steric freedom in the neck region when the
lipids are formed into a bilayer. The amantadine may
be accomodated within such an area, fitting in between
the phospholipid molecules. Our data, which indicate
that the cyclic carbon component of amantadine orien¬
tates on the hydrophobic side of the phospholipid
headgroup, support this model. This would suggest that
the effects of amantadine upon bilayer structure and
stability are likely to be complex and to be dependant
upon intrinsic and environmental factors.
Fig. 2 shows that the bilayer repeat distance was
reduced by up to 2.5 A at low humidities. A similar
effect is produced by the addition of 1,2-dioleoyl-x-
glycero-3-phosphoethanolamine (DOPE) [17] to DOPC,
where the smaller PE headgroup allows the choline
moiety of DOPC to lie in a more perpendicular orien¬
tation and therefore closer to the plane of the bilayer
surface (unpublished data). Amantadine may have a
similar effect on DOPC. Unfortunately, the relatively
low contrast between the PC headgroup and water
makes it impossible to determine the headgroup con¬
formation with the present data. However, this does
mean that any drug-induced changes in headgroup
conformation will not have an adverse effect on the
profile subtractions. Future neutron work using specifi¬
cally deuterated phospholipid headgroups may be able
to resolve this question.
Our finding that uncharged, amantadine FB has the
ability to penetrate more easily into the bilayer is
supported by diffusion data performed on other similar
compounds [24]. This phenomenon could be related to
the zwitterionic nature of DOPC, the lipid chosen for
our study. Further work will investigate the possible
relationship between the lipid composition of the bi¬
layer and the nature of its interaction with amantadine.
For example, including a proportion of negatively-
charged lipid may induce major changes [25] particu¬
larly with the charged amantadine HC1.
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Abstract
A novel brominated phospholipid has been designed and synthesised for future use in X-ray diffraction
studies. It is an analogue of dipalmitoyl-phosphatidylcholine (DPPC), with the sn-2 chain terminal methyl
group exchanged for a bromine atom. This bromine atom "label" has been incorporated into a phospholipid
by substitution for a group of similar atomic radius, 1.85 versus 2.00 A, thus creating a molecule which is
sterically similar to its unlabelled analogue. The "bromolipid" has been studied using the swelling series
method in conjunction with Patterson mapping in the gel phase at 20°C. It diffracts well to 12 orders in its
pure form at 20°C and between 57% and 98% relative humidity. A combination of two phasing methods have
allowed the diffraction patterns of bilayers incorporating the bromolipid to be phased unambiguously. We
suggest that the bromolipid is excellently suited as a phasing agent for use in future isomorphous replacement
and multiple anomalous diffraction (MAD) experiments.
Keywords: X-ray diffraction; Phospholipid; Bromolipid; Patterson mapping
1. Introduction
Brominated phospholipids have been utilised
before in the study of lipid bilayers [1], Synthetic
bromolipids have been used in fluorescence, as
well as X-ray diffraction, studies [2,3], These
studies have however focused on the production
of a bromolipid, typically by the addition of two
bromine atoms across a double bond, resulting in
a phospholipid "isomorph" lacking a double bond,
with two relatively large atoms sticking out from
* Corresponding author.
the lipid chain. Other methods of placing bromine
in a bilayer include the approach of labelling a
small molecule with bromine, which is then in¬
serted into the bilayer [4],
The present study has set out to make and
study a close structural isomorph of dipalmi-
toylphosphatidylcholine, which can be used as a
phasing agent in isomorphous replacement stud¬
ies. DPPC, a benchmark lipid, has been studied
many times and is well characterised [5], This
bromolipid was designed so that it would have
only one bromine per molecule, would not hinder
chain packing by having been added across a
double bond, and would have approximately the
0301-4622/94/S07.00 © 1994 - Elsevier Science B.V. All rights reserved
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PALMITOYL CHAIN ( C-16)
Fig. 1. The structure of the bromolipid used in this study. This
shows the position of the bromine atom in the molecule,
which replaces the sn-2 palmitoyl terminal methyl group of
DPPC.
same molecular volume as DPPC. The optimum
place to locate such a phasing agent "label"
would be in the centre of the bilayer. This has
been achieved by switching the terminal methyl
of the sn-2 palmitoly chain of DPPC for a bromine
atom, see fig. 1. The methyl group and bromine
atom are of similar radius and so the substitution
results in little difference in the overall volume of
the two molecules and therefore similar packing
in the membrane.
In this paper the fully hydrated structure of
bromolipid has been studied, together with that
for pure DPPC at 20°C. X-ray diffraction pho¬
tographs of each have been collected to at least
12 orders, and swelling series have been created
by repeating the experiments at varying sample
humidity, using the method of Torbet and Wilkins,
[6]. Diffraction spots have been phased using a
combination of this swelling series method and by
using one-dimensional Patterson maps to help
phase ambiguous reflections. From these results
electron density maps have been created showing
the structure of bromolipid and DPPC to 4 A.
2. Possible future uses of the bromolipid
2.1. Isomorphous replacement
This is a method, used extensively in protein
crystalography for phasing, where a heavy atom is
added into the sample as a "label". On introduc¬
ing a known amount of heavy atoms into a sys¬
tem, one has a way of scaling the relative electron
density scale into one of absolute density per unit
cell. This is a great advantage over the swelling
series which is always only on a relative scale.
The use of heavy atom methods go back some
time and have had limited success with biological
membranes [7-9]. Phases have been determined
for bilayer of fatty acids associated with a series
of alkaline earth metals [10]. Franks et al. [11]
have used halogenated cholesterol analogues in
isomorphous experiments. They showed that the
analogue could be isomorphously exchanged with
cholesterol and this exchange be used to phase
the signs of the lamellar reflections. This choles¬
terol labelled method works well, but obviously,
only when one is studying a cholesterol contain¬
ing system.
2.2. Multiple anomalous dispersion (MAD) experi¬
ments
Anomalous scattering as a method of phasing
is still very new to protein crystalography [12,13],
and has still yet to be used in membrane diffrac¬
tion experiments. If possible this method would
be the finest application for a phospholipid such
as the bromolipid synthesised and studied as re¬
ported here.
MAD experiments have a major advantage
over isomorphous replacement experiments. In a
typical isomorphous replacement experiment one
might study several samples, each with increasing
amounts of heavy atom present, and hope for
phase assignment to be successful, that there is
no major structural change around the heavy
atom. In the MAD experiment one need only
study one sample with a percentage of label in¬
corporated. The experiment is performed using
X-rays, at energies either side of a heavy atom
absorption edge, the difference being used as the
phasing method, Hendrickson [14], Therefore
throughout the experiment there are no struc¬
tural variations in the sample whatsoever, as it is
the X-ray source and not the sample that is
varied.
By using the swelling series as the phasing
method to characterise this novel molecule, we
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have shown that this molecule has great poten¬
tial, in itself, as a phasing agent.
3. Materials and methods
l,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) was purchased from Sigma Chemical
Company Ltd. (Fancy Road, Poole, U.K.). The
synthesis of the novel bromolipid shall be covered
elsewhere. Both phospholipids were confirmed to
be a single species by thin layer chromatography
prior to use.
3.1. X-ray diffraction
Oriented bilayer stacks of phospholipid were
prepared by pipetting 2 mg of sample, dissolved
in chloroform, onto a curved glass slide of area 1
cm2. The chloroform was then evaporated off by
a stream of nitrogen, before the slide was placed
in a vacuum for 2 h. The sample was then rehy-
drated over water, and reannealled at 70°C for 1
h. Samples were then held in a temperature con¬
trolled cell at 20°C. The relative humidity of the
cell was varied from 57% to 98%, using varying
salt solutions in a bath under the sample, for the
swelling series experiments. The data were cor¬
rected for absorption, as described in Franks and
Leib [15], and with the Lorentz factor. For the
geometry used, this latter factor takes the form of
h2, where h is the order of diffraction.
Previous methods which attempt the determi¬
nation of phases using only a single data set have
been attempted. Luzzati et al. [16] used a pattern
recognition approach. In this procedure all possi¬
ble phase combinations are considered and the
correct solution chosen on the basis of known or
postulated properties of the electron density pro¬
file, such as levels of electron density and partial
specific thicknesses of particular components. For
a good pattern however, with a large number of
orders, there are a large number of possibilities.
Using only one data set also can allow in errors in
data collection, that would stand out in a data
series. This paper however uses a similar ap¬
proach to this method for distinguishing ambigu¬
ous phases, i.e. the case where most phases are
determined from the swelling series but one or
two orders could be either phase. The properties
of the electron density profile, in this case, com¬
ing from the Patterson maps.
3.2. Differential scanning calorimetry
The lipids, DPPC and bromolipid, were pre¬
pared by dissolving the weighed out mixtures in
chloroform, drying down in a rotary evaporator,
washing twice with acetone and again drying down
to a mixed solid in a rotary evaporator. The dry
phospholipid was then placed in a platinum pan
and the mass of lipid weighed using a four point
balance. An exact amount of water, 40 pul of
water to 7 mg of lipid for water in excess experi¬
ments, were then measured into a sample pan, of
volume 50 p.1, by syringe. A lid was placed on top
of the pan and sealed by cold welding using a
Perkin Elmer sealing press. A reference pan con¬
taining only water was prepared in the same way
as the sample pans. Samples were loaded into a
Perkin Elmer DSC 7 machine with a Perkin Elmer
Tac 7/7 instrument controller. Samples were then
typically cycled from 10°C to 70°C, so as to anneal
and homogenise the sample. The sample was
then allowed to sit at 10°C for 30 minutes before
an experimental run from 10°C to 70°C was
recorded. A scan rate of 3.0°C per minute was
used.
4. Results and discussion
The DSC results, table 1, compare the phase
behaviour of two lipids, DPPC and bromolipid,
calorimetrically. The results show that the phase
behaviour of bromolipid is similar to that of
Table 1
DSC results for DPPC and bromolipid samples
Lipid Main Pretransition Main Main peak
transition temperature transition width at
temperature (°C) enthalpy half height
CC) (J/g) AT1/2 CO
DPPC 42.3 37.1 54.5 1.45
bromolipid 33.4 30.5 52.4 1.55
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DPPC. Although the main phase transition tem¬
perature, for the bromolipid, occurs at ~ 9°C
lower than that found for DPPC, it melts with a
similar enthalpy. The width of the melting peak,
which is an indicator of the cooperativity of the
event [17], is also similar for the two species. The
bromolipid also has a pretransition peak, indicat¬
ing it too forms the pretransition ripple phase,
found for DPPC.
Scheme 1 shows a typical X-ray diffraction
photograph of pure bromolipid, showing twelve
orders of diffraction. Films were scanned and
data corrected before a Patterson map of each
data set was constructed. The Patterson maps
show the interatomic distances of the major elec¬
tron dense regions of the molecule in the bilayer
without using any phase information whatsoever.
An electron density graph constructed using data
that is putatively phased should therefore show
the same approximate interatomic distances. Be¬
cause the Patterson map has no phase informa¬
tion involved in its construction it is a useful
alternative test of accurate phasing.
Fig. 2 shows the Patterson map for pure bro¬
molipid and pure DPPC, see also table 1. The
graph for pure bromolipid naturally has more
features to it, it having extra regions of high
electron density, compared with DPPC. The
bromines are close together giving rise to a peak
from the origin out to ~ 1 A. The phosphate
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Fig. 2. One-dimensional Patterson maps of bromolipid (solid)
and DPPC (dash), fully hydrated at 20°C. The bromolipid has
increased intensity near the origin due to the closeness in
space of the bromine atoms in the center of the bilayer. It also
shows the bromine to phosphate distance as being about
18.5 A.
O
peak at 18.5 A. This partially masks the head-
group separation peak at = 14 A. Swelling series
have been constructed for pure bromolipid and
pure DPPC, figs. 3 and 4, using the method of
Torbet and Wilkins [6]. Although ideally for phas¬
ing using the swelling series method, water lost
Scheme 1.
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RECIPROCAL DISTANCE (A)
Fig. 3. Swelling series data for pure DPPC at 20°C. The
humidity was varied from 57% to 98% using varying salt
solutions. The corrected square roots of intensity are plotted
against reciprocals of Bragg spacing.
DISTANCE ACROSS BILAYER (A)
Fig. 5. Reconstructed electron density maps of bromolipid
(solid) and DPPC (dash) using the phases from the swelling
series, figs. 3 and 4. The maps clearly show the bromine atoms
at the centre of the bilayer.
from the water layer is the only structural change
in the sample, varying humidity has other known
effects on the structure and thickness of the
-0.25 1 1 1 1
0.00 0.05 0.10 0.15 0.20 0.25
RECIPROCAL DISTANCE (A)
Fig. 4. Swelling series data for pure bromolipid at 20°C. The
relative structure factors show a general displacement in the
positive direction compared with those for pure DPPC.
bilayer. As the humidity decreases so does the
chain tilt angle, which acts to increase the bilayer
thickness [18,19]. At the same time water is re¬
moved from around the head group, and the N +
end of the phosphocholine group moves closer to
the hydrocarbon layer, acting to reduce the bi¬
layer thickness [20]. In spite of this the swelling
series method is still usable. The phases shown
have been constructed by fitting data to continu¬
ous Fourier transforms, and comparison of puta-
tively phased electron density graphs to Patterson
maps. These show data collected out to fourteen
orders in one case for DPPC and twelve orders
for bromolipid. One can note the general ten¬
dency of the continuous transform of bromolipid
being positively shifted, compared with DPPC, as
one would expect for a large atom placed in the
centre of the DPPC bilayer [21].
Fig. 5 shows the electron density graph of both
pure bromolipid and DPPC each to twelve orders
using the phases shown. From the electron den¬
sity graph can be measured the same interatomic
distances that give rise to maxima in the Patter¬
son function. Table 2 summarises these distances,
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Table 2
Inter-atomic distances inferred from Patterson functions ver¬










= 14 A = 18.5 APatterson
electron density map 13.6 A 18.7 A
DPPC
Patterson = 13.2 A
electron density map 13.0 A
as obtained from the Patterson function or elec¬
tron density map. The correlation of the two are
very good suggesting the right phases have been
used in obtaining the electron density maps.
5. Summary
A novel structural isomorph of the benchmark
phospholipid DPPC has been successfully synthe-
sised for use in X-ray diffraction experiments.
This bromolipid analogue of DPPC has a termi¬
nal bromine on the sn-2 lipid chain in place of a
methyl group. This new molecule forms mem¬
brane bilayers very similar to those of pure DPPC
and diffracts well to twelve orders. The diffrac¬
tion patterns here have been successfully phased
using the swelling series method and one-dimen¬
sional Pattersons. The resultant electron density
maps show the two bromines close together in the
centre of the bilayer structure.
We hope that in this paper we have prepared
the way for future X-ray experiments where the
bromolipid hopefully can be used as a phasing
agent in isomorphous replacement experiments
or in anomalous dispersion experiments which
should be able to utilise the absorption edge of
the bromine atom.
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